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Abstract 
A novel method for monitoring of pharmaceutically relevant reactions using PADI-MS has 
been developed in this study. The visible non-thermal plasma plume from a coaxial helium 
gas flow non-thermal RF plasma was optimised using a range of samples. PADI-MS was 
found to be a powerful analytical technique for pharmaceutically relevant solid and liquid 
samples and can readily be adapted for use in reaction monitoring. This study has 
determined that PADI-MS is fast, easy to set up and requires little or no sample 
preparation. PADI-MS has significant advantages over other techniques as it is faster, more 
sensitive and more convenient and suitable for investigation of complex molecules and 
mixtures. However, two limitations of PADI-MS are that the plasma can affect the sample 
surface chemistry upon exposure and quantification is not always trivial. 
A number of other analytical methods were used in conjunction with PADI-MS: TLC, 
HPLC, FTIR and Raman spectroscopy. Chapter 3 investigated PADI-MS and Raman 
analysis of paracetamol tablet as model for pharmaceutically relevant solids.  Raman 
microscopy was used to develop an understanding of how the plasma affects the sample 
surface. The plasma effect was also studied by examining changes in PADI-MS spectra. 
In Chapter 4, PADI-MS acquisition settings were improved by adding water vapour to the 
outer He flow gas and increasing the plasma power to 8 W, optimising the analysis of 
mixture solutions from TLC plates. Although molecules could be identified with optimum 
sensitivity after separation, this may not be necessary, unless the highest possible 
sensitivity is required.  
Chapter 5 deals with PADI-MS for direct analysis of pharmaceutical compounds in solid 
and liquid forms from glass slides and cotton swabs. PADI-MS was determined to be 
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suitable for analysis of pharmaceutical tablets from solutions via both substrates, with 
distinct advantages for the latter.  
The final Chapter studied PADI-MS for the monitoring of imine formation as model 
pharmaceutical reaction. Both FTIR and PADI-MS were successfully used, but the latter is 
faster and more versatile. TLC and HPLC could not be used for this reaction. PADI-MS 
was successfully used for this reaction using cotton swabs without preparation or pre-
concentration of sample solutions.  
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CHAPTER 1: Introduction
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1.1. General introduction 
The pharmaceutical industry is an essential component of healthcare systems around the 
world. It includes many public and private organizations which discover, develop, 
manufacture and market pharmaceuticals for human and animal health. Pharmaceutical 
companies have competed on the basis of innovation through new drugs to meet 
developing medical needs. There are challenges within the pharmaceutical industry 
revolving around novel drug formulation and new synthetic routes to reduce costs and 
increase the safety standard for manufacturer employees and patients. Therefore, 
companies innovate continuously to maximise benefit from a limited patent life. 
According to a recent review, developing drugs to marketing approval costs an estimated 
$802 million for each new drug (1). Research and development (R&D) costs are expected 
to remain at current levels or slightly increase in the future. When combined with other 
factors, such as increase in competition, opening new markets and lower uptake, there is a 
need for the industry to find ways to reduce costs. Similar cost and quality drivers which 
have affected other industries are forcing the pharmaceutical industry to find ways to 
improve quality while maintaining or reducing manufacturing costs, which today represent 
36% of the industry's cost (2). For example, the annual report of pharmaceutical company 
AstraZeneca for 2013 indicated that sales declined in the United States by 9% to 9.691 
million from $10,655 million and $13,426 million in 2010 and 2011 respectively (3), in a 
European pharmaceutical market worth $205 billion. 
The pharmaceutical industry at present predominantly uses batch production processes, 
involving the synthesis of unique compounds from organic and/or inorganic starting 
material, often involving several reaction steps. Reactants react with each other after being 
mixed in a reaction vessel: while the desired substance is formed, the original reactants are 
consumed. It is desirable to produce a batch as rapidly as possible. Therefore, it is desired 
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to determine when the reaction is completed, i.e. the reactants are no longer present and the 
desired product(s) formed.  In addition, undesired products can be formed in the reaction 
vessel and require detection and characterisation, enforced by regulatory authorities. A 
common method for determining when the reaction is completed is to measure the 
concentration of the product molecule. This is often combined with a measurement of the 
concentration of one or more of the reactants. The active pharmaceutical ingredients 
produced can be formulated into a range of pharmaceutical products, including solids 
(tablets and capsules), liquids, creams and gases (4). A crucial product analysis concerns 
pharmaceutical tablets which may contain several active pharmaceutical ingredients 
(APIs). Identification and distribution of these APIs in tablets is particularly important (5). 
Therefore, testing of the pharmaceutical product to certify the quality includes chemical 
and physical analysis. 
1.2. Reaction monitoring 
Reaction monitoring ideally provides information about the conversion rate and the 
formation of impurities as well as products. In addition, it can be used to develop and 
validate continuous manufacturing based on the customers‟ requirements such as lowest 
cost and highest yield. Therefore, development of a novel, fast and sensitive method to use 
for monitoring of pharmaceutical synthesis reactions is required in order to avoid the 
problems of traditional techniques, which can be time-consuming, lack sensitivity and 
require sample pre-treatment. Reaction times depend on reaction type and can be 
completed in minutes, hours or days (6), so a fast analytical method is desirable. 
Companies spend considerable resources on new methods and equipment to perform this 
task. Chemical reactions must be monitored by analytical methods to determine their 
kinetics, completion time, purity, quantity and product yield. Spectroscopic techniques, in 
particular ultraviolet (UV) and infrared (IR), are used for this purpose (7). 
4 
 
A wide range of process analytical technology (PAT) approaches have been developed for 
monitoring of chemical reactions (7). There has been increasing interest in the use of PAT 
to follow the process of reactions in pharmaceutical and chemical industries and for quality 
confirmation of final products (7). Monitoring of quality in the pharmaceutical industry 
includes several steps starting from the analysis of raw materials to final products. Analysis 
methods should be accurate and ideally require little or no sample pre-treatment (8). 
Manufacturing of traditional pharmaceuticals is achieved using batch processing with 
laboratory screening conducted on samples collected to appraise the quality (7). Detection 
and identification of substances in a mixture are important aspects for the development and 
production of pharmaceutical compounds, including analysis of reactants, intermediates 
and final products (8). To assess compounds in mixtures (including quantity if necessary) 
chromatography is often employed to separate individual components prior to chemical 
analysis. 
Several separation and analysis techniques including chromatography, spectroscopy and 
ambient mass spectrometry were used in this study for identification and monitoring of 
pharmaceutical reactions. 
1.3. Pharmaceutical applications of separation techniques 
1.3.1. Chromatography 
Chromatography is a separation technique for mixtures exploiting the distribution of 
analytes between two phases: the stationary and mobile phase. The chromatographic 
separation is based on differential partitioning between these phases. For example, analytes 
partitioning between stationary and mobile phase take longer to pass through a HPLC 
system based on the relative affinity for mobile and stationary phase. These phases could 
be liquid-liquid, solid-liquid or gas-liquid. Chromatography plays a critical role in the 
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separation, identification and quantification of mixture components. Chromatography is a 
powerful technique that is extensively used to analyse different kinds of samples (solid, 
liquid or gaseous) (9, 10). Chromatographic separation techniques have been used for 
separation of compounds of various polarities (hydrophilic and hydrophobic). These 
techniques can be used to separate volatile compounds such as polycyclic aromatic 
hydrocarbons (PAHs), alcohol, epoxides, aromatic amines, aromatic esters, nitriles and 
volatile carboxylic acids. They can also be used to separate non-volatile compounds such 
as amino acids, sugars, phospholipids, glyphosate, antibiotics, synthetic food dyes, 
enzymes and phenols. 
1.3.1.1. Thin layer chromatography (TLC) 
Thin layer chromatography is a simple and inexpensive separation method routinely used 
to separate and identify substances. Although several materials are used as stationary 
phases for TLC plates such as silica gel, alumina, zirconium oxide, florisil and ion 
exchanger, silica gel is still the most commonly used. Chemically bonded is also another 
type of stationary phase which is formed by combining silica gel and transitional ions and 
use to detect and separate organic mixtures on TLC plate (11).  
TLC is a solid-liquid chromatography technique in which the stationary phase is a polar 
absorbent and the mobile phase is normally a mixture of solvents. The equilibrium of 
molecules between the stationary phase and mobile phase for different analytes is not the 
same. This equilibrium depends on the polarity of the analyte molecules, the stationary 
phase and the mobile phase. Molecules that strongly interact with the stationary phase will 
spend more time in the stationary phase, and conversely, molecules that weakly interact 
with the stationary phase will spend more time in the mobile phase and hence progress 
across the stationary phase faster. For the qualitative analysis, each separate spot on TLC 
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plate will be identified by using retention factor (Rf), because each spot has a different Rf. 
The equation of retention factor is that dividing the distance travelled by sample on 
distance travelled by solvent: 
   
                            
                             
 
There are four essential aspects to optimise TLC separation: sample preparation, sample 
application, chromatogram development and qualitative and quantitative analysis. In the 
sample preparation step, to obtain good results, samples must meet requirements such as 
filtration, extraction and clean-up to remove contaminants and it sometimes also necessary 
to increase concentration. The stationary phase must contact the solvent in the bottle and 
capped with a cover and then leave the TLC plate until the solvent moves and spots rise 
and reaches the end of the TLC plate. The next procedure step is leaving the TLC plate for 
drying (evaporation of solvent) for few minutes and circle the spots by pencil after marking 
their location under UV light. In the quantitative analysis, spots can be determined by 
direct and indirect quantification. In the direct method, sample spots can be determined, 
and spot area is measured directly from the TLC plate by measuring the calibration. In 
indirect quantification, sample spots must be transferred from a TLC plate for analysis by 
another technique such as mass spectrometry. The modification of silica stationary phase 
with polar and non-polar ligands is important for a wide range of scientific and industrial 
processes (12). A balanced force of molecules depends on the polarity of stationary phase 
of TLC plate, the polarity of mobile phase and the polarity of components in the solution to 
be analysed. The main disadvantage of silica gel bonded is that a high concentration highly 
acidic free silanol groups increases the retention time with basic compounds and this will 
lead to occurrence of some of the chromatographic problems such as broad peak tailing for 
these compounds. Alumina is the second most commonly used absorbent for TLC plate 
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after silica gel. Alumina is prepared by calcination from aluminium hydroxide. Aluminium 
oxide (Al2O3) is the most widely used type and the functional groups on the alumina 
surface are oxide ions, a hydroxyl group and aluminium cation (13). Compared to silica 
gel, anhydrous alumina is stronger to adsorb analytes particularly for nonpolar compounds 
such as ethers, hydrocarbons, aldehydes and ketones, while to separate polar compounds 
such as amines, alcohols and carboxylic acids, silica gel is more used. When combining 
TLC with diffuse-reflectance Fourier transform infrared (DR-FTIR), zirconium oxide has 
used as stationary phase in the detection of unknown samples (14). In comparison with 
silica gel and alumina, zirconium oxide is higher infrared (IR) reflectivity. Ion exchanger 
plays a crucial role in separating of positive and negative ions (cations and anions) from a 
mixture of metallic ions. The silica gel surface is modified with positive materials to 
separate the cations and modified with negative materials to separate anions. 
Even though a number of more advanced analytical methods have been developed, TLC is 
still widely used in the food and pharmaceutical industries (15). TLC can be used for 
monitoring of synthesis reactions but without providing the information about structural 
information on the molecules (16). TLC is combined with spectroscopic detection methods 
such as UV/Vis, Fourier transform infrared (FTIR) and nuclear magnetic resonance (NMR) 
to use for qualitative and quantitative analysis of the separated compounds (17). However, 
limitations of TLC are: the position of the spot gives limited information on the nature and 
quantity of molecules unless used with advanced analytical techniques such as mass 
spectrometry (MS). The time delay is another limitation due to having to wait for the TLC 
plate to develop. TLC is most commonly used combined with a broad-band UV/VIS 
source to identify analytes and this is quite a limited technique, hence the drive to use 
alternatives and in particular (ambient) MS. Due to these practical constraints, TLC 
method cannot provide enough structure details of chemical compounds (15). TLC-MS is 
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used to identify and quantify small and large molecules such as peptides, proteins and 
amino acids (18). To improve the detection of spots on TLC plates, several mass 
spectrometric techniques have been combined with TLC such as electrospray-assisted laser 
desorption/ionisation (ELDI) MS, DESI, DART or matrix-assisted laser 
desorption/ionisation (MALDI) (12). In a study by Van Berkel, electrospray mass 
spectrometry has been used to monitor a dyes mixture consisting of crystal violet, 
rhodamine and methylene after separation on a TLC plate (19). TLC and easy ambient 
sonic-spray ionisation mass spectrometry (TLC- EASY-MS) has been applied in 
qualitative monitoring of drugs and synthesis chemistry (20). The mixture spots of allyl 
phenylamine, phenyl amine and ethyl pyridine on the TLC plate were detected by EASY-
MS after developing the TLC plate. TLC- EASY-MS has been used to analyse tablets of 
propranolol and amlodipine after dissolving them in water, and monitor the synthesis of 
oxazoline-5-carboxylic ester (20). A TLC plate coupled with desorption electrospray 
ionisation mass spectrometry (DESI-MS) has been used to monitor rhodamine and the 
mixture solution of aspirin, caffeine and acetaminophen after separation on a silica gel 
plate (21). Several organic compounds including starting materials and reaction mixtures 
of glycopeptides, peptides and carbohydrate reactions were monitored by matrix-assisted 
laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOFMS) after 
separation on TLC plate (22). Danigel and co-workers have shown that TLC coupled with 
TOFMS was used for monitoring and quantification of etoposide (23). Analysis of organic 
compounds including amines using ELDI/MS technique after separation on a TLC plates 
was successfully carried out by Lin et al. (24). TLC also coupled to mass ionisation 
techniques such as matrix-assisted laser desorption and ionisation (MALDI) to analyse 
glycolipids and phospholipids. In a study conducted by Van Berkel et al., it was shown that 
the DESI-MS method can be used directly to analyse the spots of goldenseal alkaloids on 
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TLC plates (25). Planar chromatography has been coupled with real time-of-flight mass 
spectrometry (DART-TOF-MS) and used for direct analysis of pharmaceutical mixtures 
including caffeine (26). 
1.3.1.2. High-performance liquid chromatography (HPLC) 
Liquid chromatography (LC) is a chromatographic separation technique important for a 
wide range of scientific and industrial applications. In LC, the sample and mobile phases 
are liquid, and the stationary phase is solid. A small volume (20 µL) of liquid sample is 
required to penetrate the porous stationary phase. The individual components of the sample 
are transferred to the column by liquid mobile phase and then separated, collected and 
identified by a spectrometric technique, most commonly UV/VIS spectrophotometry. The 
past century has seen the rapid development of liquid chromatography in many fields. 
High-performance liquid chromatography or high-pressure liquid chromatography (HPLC) 
is a further development of LC, which is now widely used to separate, identify and 
quantify compounds in solution. The history of HPLC started in 1960. After that and 
especially from 1970, the technique including column and other instrumentations has 
improved significantly and became widely known as high-performance liquid 
chromatography. Several further developments have been introduced since 2006, in 
particular Ultra performance liquid chromatography (UPLC) which uses even higher 
pressures. Compared to HPLC, UPLC is faster, has better resolution and separation and 
reduced solvent consumption. However, in UPLC, increased pressure reduces the average 
life of columns (27). HPLC is still the standard technique, with increasing use of UPLC in 
industrial applications. HPLC is widely used for qualitative and quantitative analysis in the 
pharmaceutical industry (28), including R&D applications to discover, develop and 
manufacture novel pharmaceutical compounds (29-32). 
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The HPLC instrument consists of the column which holds the stationary phase, a pump to 
move the mobile phase through this column and a detector to measure the retention times 
of the compounds in a mixture (33). The retention time of compounds on HPLC columns, 
as for the stationary phase in TLC, varies based on their polarity and on the chemical or 
physical interactions between the mobile phase and stationary phase. Methanol and 
acetonitrile are the most common solvents used as an organic mobile phase in HPLC and 
water as aqueous mobile phase (34, 35). Data collection on HPLC provides important 
information about the qualitative and quantitative analysis of molecules. Identification of 
components can be achieved by measuring their retention times, their quantities by 
measuring the peak area or peak height. 
1.3.1.2.1. HPLC components 
HPLC consists of five main components as shown in Figure 1.1. 
 
Figure 1. 1. Schematic diagram of high-pressure liquid chromatography (HPLC). 
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1-Pump 
A pump pushes the liquid (mobile phase and sample) through the column at an accurate 
flow rate usually of the order of 1-2 mL/min for HPLC. In isocratic chromatography, a 
constant mobile phase composition is passing through the column. 
2-Injector 
The injector is used to introduce liquid samples into the mobile phase flow stream. Normal 
volumes of the liquid sample are between 5 and 20 μL. The injector has to withstand the 
high pressures of the chromatographic system, in particular when using UPLC. 
3- Column 
The column is the component in HPLC in which the analyte mixture is separated into its 
constituent components. Because of its small particle size, the stationary phase can 
separate the analyte by the interaction between the analyte, the stationary phase and the 
mobile phase. 
4- Detector 
The detector in HPLC detects and quantifies the individual components which elute from 
the column. The first detector for HPLC was ultraviolet (UV) and introduced in the 1960s. 
After that, other detectors have been developed for a wide range of scientific and industrial 
HPLC applications (36). 
5- Data acquisition system 
Database comparison allows identification of molecules by retention time (qualitative 
analysis) and determination of the amount present (quantitative analysis) by peak height or 
area. 
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1.3.1.2.2. Types of columns in HPLC 
Types of column based on internal diameter and length- 
 Preparative column: i.d. > 4.6 mm; length 50- 250 mm and the flow rate is 1 
mL/min. This type of column is used for purification of a sample. Therefore, the 
peak shape and injected amount are not important. 
 Analytical column: i.d. 1.0- 4.6 mm; length 15-250 mm. 
 Capillary column: i.d. 0.1- 1.0; various lengths. 
 Nano column; < 0.1 mm. 
Types of column based on the construction materials for the tubing- 
 Stainless steel: the most used because it gives high-pressure ability. 
 Glass: used for biomolecules. 
 Polymer: used for biocompatible. 
Types of column based on separation method- 
 Normal phase column: The packing of the column consists of a polar material, 
usually silica. Because water is more polar than silica, it cannot be used as a mobile 
phase, therefore hexane and methylene chloride are often used as mobile phase. 
 Reverse phase column: A polar solvent mixture such as water-acetonitrile or water-
methanol is used as mobile phase. 
 Ion exchange column: in this type of column, the stationary phase must be acidic or 
basic and has positive or negative charge. The mobile phase is a polar liquid. 
Separation of molecules will occur by exchange of sample ions with the ions of the 
stationary phase. 
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 Size exclusion column: molecules in these columns will separate according to their 
size. The stationary phase in these columns is a polymer. Small molecules will 
infiltrate into the pores of the stationary phase while the large molecules will 
infiltrate partially into the pores. In this case, larger molecules will elute first from 
the column, before smaller molecules. 
1.3.1.2.3. Types of HPLC detectors 
 Ultraviolet-visible (UV-Vis) absorbance detectors: because most compounds 
absorb in the ultraviolet or visible region of 190-600 nm, UV-Vis detection is still 
commonly used for HPLC. UV should have a chromophore, and the solvents must 
be transported. 
 Fluorescence (FL) detector: solute samples are excited at higher energy wavelength 
and fluorescent emission is detected (37).  The sensitivity of FL detector can be 
100X better than a UV detector, for samples with low analyte concentrations. FL 
detectors have some limitations such as cost, and they are suitable for analysis of 
fluorescing compounds only. 
 Electrochemical (EC) detector: because the EC detector is a very sensitive and 
selective HPLC detector, it can be used to detect oxidising or reducing compounds 
(38, 39). 
 Radioactivity detector: it is also named radio flow detector which is used to analyse 
radioactive samples that flow from the HPLC column. These detectors are very 
sensitive and can be used to detect the radiolabelled compounds in metabolism or 
toxicological studies (36). The limitation of radioactivity detectors is that using 
large flow cell volumes leads to decreased resolution and increase peak broadening. 
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 Conductivity detector: it is one of the most widely used detectors for HPLC and 
measures the conductivity of the mobile phase. They are used for ion exchange 
chromatography particularly for detection of molecules that do not have a UV 
chromophore (40, 41). However, the limitation of conductivity detectors is that not 
all compounds can be analysed by these detectors. They also require a dedicated 
HPLC column. 
 Chemiluminescent nitrogen detector (CLND): it is also called a gas phase detector 
and is use particularly for nitrogen-containing compounds when the column 
outflowing with oxygen and transporters gas like helium or argon. CLND is 
sensitive and it can be used to analyse petroleum and food flavour samples (42-44). 
 Chiral detector (CD): these detectors are used to analyse the absorbance difference 
of right and left polarised light. 
 Refractive index (RI) detector: it is the oldest detector for liquid chromatography. 
RI has been extensively used for measuring the difference in optical refractive 
index between the analyte and mobile phase. However, RI detectors have limited 
sensitivity. 
 Light scattering detector (LSD): Evaporative light scattering detector (ELSD) is 
one of the most popular detectors of LSD and can be used with gradients. However, 
limitation of the LSD is that buffers must be volatile.   
 Corona discharge detector (CDD): it is an important detector in the liquid 
chromatography technologies. CDD is highly sensitive, simple and easy to use (10). 
CDD has been used for a wide range of analysis such as drug discovery (45), 
impurities (46), and natural product isolation (47). On the other hand, limitation of 
CDD is that the volatile buffers are required to use.  
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1.3.1.2.4. Types of HPLC  
A) Normal phase HPLC 
In this method, the retention times of the compounds on HPLC column depends on their 
polarity. Normal phase HPLC (NP-HPLC) often called normal phase chromatography uses 
nonpolar mobile phases such as hexane, ethyl acetate and methylene chloride and polar 
stationary phases such as silica gel. NP-HPLC is used to separate and analyse water 
sensitive molecules, cis-trans isomers and chiral compounds. 
B) Reverse phase HPLC 
Reverse phase high-performance liquid chromatography (RP-HPLC) was developed at the 
end of the 1970s for separation of small organic compounds (31). The RP-HPLC method 
uses a polar mobile phase and a non-polar stationary phase. Reverse phase is more 
popularly used than normal phase due to the hydrophobic interaction between the 
stationary phase and analytes, it suitable to use for separation of organic compounds. In 
reverse phase, separation of the analytes can be improved by optimising the pH and using 
several solvents mixed. In addition, the RP-HPLC method can also be used to analyse 
polar, nonpolar and ionic compounds and this makes the method very versatile. 
HPLC is used to isolate and purify compounds, including combinatorial synthesis (48). 
HPLC is one of the most widely used techniques in the analysis of complex mixtures 
containing biomolecules (49, 50). HPLC is used to ensure the quality and quantity of a 
drug and other potentially harmful molecules and it also can be used for monitoring 
progress of disease treatment. Applications can be in R&D to develop new medicines; in 
research to monitor the effectiveness of such medicines; in a more routine production of 
medicines and in more routine monitoring of patients. HPLC has been developed and used 
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in multiple reaction monitoring for describing many fatty aldehydes including 4-hydroxy 
nominal and acrolein in plasma and brain samples of animals (51). The reaction between 
aniline and 4-fluoro benzaldehyde was monitored over time using online HPLC-UV 
method (52). A reversed-phase high-performance liquid chromatographic (RP-HPLC) 
method has been developed to monitor the synthesis of 4-amino-2-chloro-6,7- 
dimethoxyquinazoline during reaction time (53). The reaction mixtures (cationic) of 
cisplatin with methionine and nucleotides were monitored using a RP-HPLC method (54). 
Online reaction monitoring is important and has been one of the most widely used methods 
for a wide range of scientific and industrial processes. These methods are developed to 
provide information and understand the mechanism of organic reactions. On-line HPLC 
has been used to monitor the reaction of DMAP catalysed acylation of phenols and acetic 
anhydride (55). Online HPLC has also been used with multivariate statistical process 
control for monitoring of a steady state reaction (56). There are crucial limitations in terms 
of necessary sample preparation, solution only sampling, the length of time needed for 
sampling, lack of inherent molecular information and the need for trained laboratory staff 
for HPLC sampling. 
1.4. Pharmaceutical applications of spectroscopic techniques 
1.4.1. Spectrophotometry 
1.4.1.1. Ultraviolet-visible (UV/Vis) spectroscopy 
UV/Vis is very common spectroscopy method and widely used to measure the spectral 
absorption of molecules in the regions between 200 and 800 nm (57). UV/Vis light can 
excite the electrons in an analyte to higher energy states upon absorbing photons of a 
specific wavelength. The Beer-Lambert law applies for concentrations in the linear range 
for specific spectrophotometers (A= a. b. c). 
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Where A is the measured absorbance of the sample, at a specific wavelength, usually that 
of maximum absorbance a(λmax), b is the path length, c is the concentration of the sample. 
When using molarity concentration, the law above is written as A= ε. b. c. In the 
quantitative analysis of the individual compounds, the selection of wavelength in the 
derivative spectra is difficult compared to absorbance spectra. Although UV/Vis 
spectroscopy is simple and cheap, it suffers from limited sensitivity. The main problem is 
mixture analysis, in particular when several components absorb at the same or similar 
wavelength, which occurs readily given the inherently broad peaks. UV/Vis spectroscopy 
indicates the presence and nature of unadded functional groups. Conversely, molecules 
which only have electron bonding s orbitals (s → s* transition) are difficult to detect by 
UV-Vis. For example, methane only has C-H bonds and hence cannot be observed in the 
range of UV-Vis. Organic compounds that have more conjugated bonds will shift to longer 
wavelengths. For instance, the peak of anthracene (three aromatic rings) in the spectrum 
shifts toward longer wavelengths than benzene (one aromatic ring). UV detection is 
commonly used in HPLC instrumentation. 
1.4.1.1.1. UV/Vis instrumentation 
1- Light source such as deuterium or tungsten lamp to produce the radiation at a suitable 
wavelength. However, a xenon flash lamp was used in this study. 
2- A monochromator is the most common selector that filters used as a wavelength selector 
in the UV/Vis due to its ability for scanning broad ranges of wavelengths with good 
resolution. 
3- Quartz or fused silica is used as a sample cuvette in the UV region, whereas quartz or 
glass is used in the visible region. In this study, quartz was used in the UV region. 
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4- The detector of UV is like that used by Vis. 
5- A PC to record the signal. A schematic illustration of a UV/Vis spectrophotometer is 
shown in Figure 1.2. 
 
Figure 1. 2. Schematic diagram of a UV/Vis Spectrophotometer. 
 
UV/Vis can be used for qualitative and quantitative analysis of molecules. UV-Vis 
spectroscopy is used in the pharmaceutical industry to monitor the manufacturing process 
and product quality of drugs. UV-Vis has several important applications in the biochemical 
and the environment areas. Recently, UV-Vis spectroscopy has been used as a quantitative 
analysis method in the study of breast and cervix cancers (58). UV method has been 
developed for the determination of didanosine and gliclazide in a pure and tablet 
formulation (59, 60). Wang and co-workers have shown that UV-Vis method was applied 
for online monitoring of photochemical reactions including methylene blue and methyl 
orange (57). In a study by Berg et al., UV-Vis spectroscopy has been successfully used as 
an online method to monitor the cleaning in place of membrane plants in water. The results 
showed that UV-Vis is a stable, suitable and fast method for this application and saves 
time, energy and chemicals compared to alternatives (61). UV-Vis spectroscopy has been 
used for the monitoring of imine (Schiff Base) formation between the carbonyl group of 4-
nitrobenzaldehyde and amine group of ethylenediamine (62). 
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The UV-Vis method was also applied to monitor the extent of 5-hydroxymethylfurfural by 
reaction between glucose and cellulose (solid-liquid reaction) at high temperature using 
hydrothermal conditions (63). UV-Vis absorbance has been used to monitor the reaction of 
polyvinyl chloride with methyl piperazine over time. The product (aminated polyvinyl 
chloride) was formed at 90 C° for 6 hours (64). Three types of contaminations such as 
polycyclic aromatic, monocyclic aromatic and organic acids compounds were detected and 
monitored in water using UV-Vis spectroscopy method (65). 
1.4.2. Vibrational spectroscopies 
1.4.2.1. Infrared spectroscopy (IR) 
Infrared spectroscopy (IR) is an analytical technique used to identify and study organic and 
inorganic compounds. The main aim of IR is to identify the functional groups of 
molecules. The most widely used spectral range for chemical analysis is in the mid-IR. 
Most organic compounds absorb IR radiation within this range (4000 cm
-1
 to 400 cm
-1
). 
The regions > 1650 cm
-1
 are the most important widely used of the IR spectrum. To 
explain and understand the IR spectra it should first understand the essential principles of 
IR spectroscopy. The IR spectrum is divided into three regions; near infrared (NIR), mid-
infrared (MID-IR, often referred to as Fourier-transform IR or FTIR) and far infrared 
(FAR-IR). Mid-IR can detect functional groups for the biological and organic compounds 
through vibrating dipoles. Far-IR, although promising for some aspects, is yet to be widely 
used in the pharmaceutical industry. The NIR region covers 14000-4000 cm
˗1
 
wavenumbers, the MID-IR region covers 4000-400 cm
˗1
 and the FAR-IR region covers 
400-10 cm
˗1
. Near-infrared spectroscopy (NIRS) is the first non-visible region in the 
infrared spectrum introduced by Herschel in 1800 (66). Since 1960 NIR spectroscopy has 
improved rapidly and there have been many publications for identification of unknown 
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compounds using this method (66). NIRS has become most widely used for direct analysis 
of pharmaceutical compounds without sample treatment (67). NIRS is used as a process 
analytical technology (PAT) method in the pharmaceutical industry to monitor the quality 
or process of drug manufacturing including tablet manufacture, freeze drying and pellet 
formation (68-70). Reich has shown that NIRS can be applied to study the physical and 
chemical characterization of different dosage forms such as tablets, capsules and implants 
(71). 
MID-IR can be used to analyse various types of samples such as solids, liquids and gas, 
and it is not only used for identification analysis, but also for quantification. It is an 
important method for a wide range of scientific and industrial processes. Fourier transform 
infrared spectroscopy (FTIR) is one of the vibrational techniques and has been extensively 
used to identify the functional groups of molecules. It also can be used for qualitative and 
quantitative analysis of mixture components. FTIR is simple and inexpensive 
instrumentation and plays an important role in a wide range of applications (72). In FTIR 
spectroscopy, a little amount of sample is required to give a good spectrum in a short time. 
FTIR spectroscopy coupled to partial least squares has been used to analyse paracetamol 
and caffeine in pharmaceutical mixtures (73). 
FTIR also plays a critical role to keep the pharmaceutical characteristics of peptides and 
nucleotides and there are several efforts have been made on the synthesis of small organic 
compounds. The FTIR method has been applied as a powerful tool to monitor solid-phase 
reactions. FTIR spectra showed that all starting materials were converted to product (74). It 
has also been used to monitor the reaction of alkoxysilane-terminated polybutadiene 
polymer over time, and this study showed that the monitoring was limited to qualitative 
analysis (75). FTIR has been successfully used for monitoring of enaminones synthesis by 
reaction between aniline and 3-buytn-2-one using ethanol as solvent (76). However, FTIR 
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provides limited structural information, and it is not a suitable method for all types of 
compounds especially for complex systems due to its difficulty to identify these 
compounds (77). In addition, FTIR is not playing a major role in the quantification analysis 
of vibration groups of the surfaces (62). 
1.4.1.2.1. Basic principles of IR spectroscopy 
In order to calculate the vibrational frequencies, the period r is given by     √
 
 
 . 
1- The force constant (k): this constant is proportional to bond strength. For example, in 
mid-IR the stretching frequency, and hence absorbance wavelength, of the carbonyl 
group (C=O) is higher than carbon-oxygen bond group (C-O). 
2- The reduced mass (µ): in general, heavier atoms will have slower vibration and lower 
energy (wavelength). For example, in mid-IR compare C-O versus H-O. 
3- Overtone peaks: For organic compounds that have not C=O or C-H bonds, it can see a 
small peak at 3450 cm-1 and this due to the overtone peak of C=O is lower twice than 
normal C=O frequency. This is commonly studied in NIR spectroscopy. 
4-  Dipole moment: it is a selection rule that a change in dipole is required for a vibration 
to generate a peak in the IR spectrum. Because carbonyl group is strongly polar, it has 
intensive bands, due to the higher electronegativity of oxygen compared to carbon. 
However, if a vibration is symmetrical, it will not cause any change in dipole moment 
and not be visible in the IR spectrum. 
5- Vibrational modes: there two types of the molecular vibrations in IR: stretching and 
bending. In stretching vibrations, the bond length is changed, these occur at higher 
energy. Stretching vibrations can be divided into symmetrical and asymmetrical. 
Bending vibrations, also named deformations, occur at low energy. Bending vibrations 
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can be divided into in-plane (scissoring and rocking) and out-of-plane (wagging and 
twisting). 
An FTIR spectrometer consists of light source, interferometer, sample compartment and 
detector. The light source emits radial light within the mid-IR range and going directly to 
the beam splitter. The interferometer contains two mirrors, one moving and one fixed. The 
beam splitter reflects half of light beam to the fixed mirror, while the other half is 
transmitted to the moving mirror. The mirrors reflect both light beams and return them to 
the beam splitter. After recombination of these beams, the Fourier-transformed light travels 
to the detector after interaction with the sample, Figure 1.3. After mathematical 
deconvolution of the detected light a spectrum is constructed. For the work presented here 
an Attenuated Total Reflection (ATR) accessory was used for sampling. 
 
Figure 1. 3. Schematic diagram of an FT spectrometer. 
 
1.4.1.2.2. Steps of generating the FTIR spectrum 
1- Fourier transform is used to calculate the frequency versus intensity plot: the spectrum. 
2- All frequencies can be seen by the detector at the same time, making FT more efficient 
than dispersive IR and hence the standard method. 
 Fixed mirror 
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3- Because FTIR spectroscopy is a single beam technique, background spectra should be 
recorded. 
1.4.2.2. Raman spectroscopy 
Raman spectroscopy is a vibrational technique that can be used for identification and 
quantification of molecules and can provide structural information on the molecules. 
Raman spectroscopy detects different vibrations in which polar disability rather than dipole 
changes. Raman spectroscopy can be applied in several areas including pharmaceutical and 
biomedical analysis because it allows a view of the chemical distribution using optical 
microscopy. Because Raman spectroscopy covers a wide spectral range from 3500 cm
-1
 to 
50 cm
-1
 and the bands are sharper than for mid-IR, it can more often than that technique be 
used for both qualitative and quantitative analysis. 
1.4.2.2.1. Basic principles of Raman spectroscopy 
Raman spectroscopy depends on the scattering of radiation by interaction with molecular 
vibrations (78). When monochromatic laser light interacts with vibrating molecules, the 
laser photon energy is shifted up or down and this shift can provide information about 
those vibrations. If the laser photons scatter from the sample in standard Raman 
spectroscopy this will mostly be elastic in which case the scattered photons have the same 
energy and wavelength as the incoming ones. This is known as Rayleigh scattering and 
carries no chemical information, Figure 2.4 (79). Non-elastic scattering can involve loss or 
increase of energy of the scattered photons. 
Very few photons can excite a vibration to a higher energy virtual state, from which it can 
drop back to a real excited state, leaving the scattered photon with a decreased energy. This 
is known as Stokes or Raman scattering. This can be analysed by measuring the energy of 
24 
 
the scattered light (80). The scattered photon shifts away from the excitation wavelength 
by an amount equal to the vibration wavelength, comparable to an IR absorption. Anti-
Stokes scattering involves scattering photons gaining energy from a vibration dropping 
from an excited state into the ground state, Figure 1.4. This very weak effect is not 
normally used in Raman spectroscopy (81-83). 
To observe the scattered photons, the light is collected at an angle and the excitation 
wavelength filtered out. While Raman scattering depends on it (84), the Raman shift is not 
depending on the wavelength of radiation obtained (81), and can be directly linked to a 
vibration. The Raman effect depends on vibrations with changes in polarizability, in 
contrast to IR where dipole changes are observed. Hence different vibrations will be 
detected with these complementary techniques. Symmetric vibrations can be detected 
strongly by Raman, while asymmetric vibrations can be detected strongly by IR. Vibration 
polar bonds such C-O, N-O and O-H have weak Raman scatters, whereas neutral bonds 
such as C-C, C-H and C=C have strong Raman scatters, but weak IR absorption. 
Raman spectroscopy can be more specific than FTIR due to narrow bands (85). Raman 
spectroscopy is still limited for quantitative reaction monitoring due to limited sensitivity 
or non-resonant Raman, instability of laser systems, equipment costs and fluorescence 
effects. 
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Figure 1. 4. Schematic illustration of excitation states of molecules via Rayleigh, Stokes 
and anti-Stokes Raman scattering. 
Raman spectroscopy has several useful applications in the pharmaceutical analysis such as 
quantification of tablets, qualitative analysis of polymorphs, monitoring of production, in-
line quantitative monitoring of active coating and monitoring of process induced 
transformations in pharmaceutical manufacturing (86-90). Raman spectroscopy can also be 
used for monitoring of pharmaceutical synthesis of chemical reactions and crystallisation 
of solid state (91). Raman spectroscopy is also a sensitive technique to monitor impurities 
within the reaction (92). Raman spectroscopy has been used for quantitative in-line 
monitoring of the crystallisation process of flufenamic acid as a function of time and 
temperature (93). Raman spectroscopy has also been used for online monitoring of 
different semi-continuous emulsions such as homo and copolymerization reactions (94). 
Raman spectroscopy has been successfully used to monitor the reaction of α-bromo-o-
toluic acid in 80% aqueous ethanol. The results showed that the C-Br stretching peak for 
the starting material (α-bromo-o-toluic acid) decreases in intensity with time, while they 
show an increase in intensity for the vibrational peak of the product (phthalide) (95). 
Raman spectroscopy was combined with micro TOF mass spectrometry and used as an 
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online technique for monitoring of 1,3-diamino propane and benzaldehyde reactions using 
tissue paper as a substrate, and the reactants materials and product were identified (96). 
There are a number of important differences between these techniques including separation 
and spectroscopic techniques. UV-Vis spectroscopy has crucial limitations, in particular, 
difficult interpretation because of interfering absorption bands. Compared to IR, the UV-
Vis development studies are slower due to its methodological difficulties and this lead to 
far-UV bands for most organic compounds. UV-Vis provides limited structural 
information on the molecules (97). Compared to other techniques such as GC, HPLC and 
NMR, FTIR is a fast, cheap and accurate method particularly for monitoring of fast 
reversible reactions (98). Mid-IR can detect functional groups through vibrating dipoles. A 
limitation is that only such functional groups are detected and as the same ones may occur 
in different molecules in a mixture, or indeed in different places in the same molecule, IR 
is of limited value when analysing complex molecules or mixtures. Compared to FTIR 
methods, Raman spectroscopy is more expensive and more specific than FTIR, but it is 
less sensitive unless in resonant mode or under surface-enhanced conditions. However, 
Raman spectroscopy is still limited for quantitative reaction monitoring due to the 
instability of the laser and shows sometimes narrow bands (99). 
1.5. Mass spectrometry (MS) 
Mass spectrometry is a powerful, accurate and sensitive analytical method that can be used 
to analyse mixtures by detecting the mass to charge ratio of gas phase ions without the 
need for separation of components (100). It has unique abilities to detect a wide range of 
chemical species at low concentrations and small sample amounts, and directly measure 
their molecular weight as well as determine molecular structure through analysis of 
fragmentation patterns. MS is widely used for qualitative and quantitative analysis (101). 
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MS provides critical information for a wide range of applications such as environmental, 
geological, biotechnology and pharmaceutical including drug discovery, combinatorial 
chemistry, pharmacokinetics and drug metabolism studies. MS has been extensively used 
for qualitative and quantitative analysis of large molecules such as biomolecules and small 
organic molecules. MS can provide useful information about the structure of the molecules 
during the fragmentation process. Compared to other techniques such as FTIR, Raman 
microscope and HPLC-UV/Vis, MS is highly sensitive, specific, requires little or no 
sample preparation and provides structural information for the analyte molecules. 
Separation is sometimes crucial because it is difficult to distinguish the molecules without 
separating them, hence techniques coupled to chromatography. 
In mass spectrometry (MS), chemical compounds are ionised to produce charged 
fragments and molecules which are then analysed according to their mass to charge ratio 
(m/z). The first step in MS analysis is the generation of gas-phase ions. These ions are then 
separated and detected after passing through an electromagnetic field (102). Mass 
spectrometers consist of three basic parts: a source region in which ionization takes place, 
a mass-selective analyser and an ion detector. Analytes are submitted to a series of steps 
(102): ionisation, acceleration, separation and detection. In the mass analysis, the sample 
could be solid, liquid or gas. The type of mass spectrometry used depends on the sample 
phase. Solid phase samples can be ionised using a plasma-desorption method. Liquid or 
solution samples can be analysed using electrospray ionisation (ESI) and matrix-assisted 
laser desorption/ionisation (MALDI). Chemical ionisation (CI) and electron ionisation (EI) 
can be used to ionise gas or volatile samples. 
MS instruments consist of three main components: an ion source, analyser and detector as 
shown in Figure 1.5: ion source to produce ions from the molecule after transfer into the 
gaseous state, the analyser to separate the ions according to their mass to charge ratio and 
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detector to detect and record the separated ions. An MS spectrum provides highly detailed 
information about the chemical structure of compounds through interpretation of molecular 
ion and fragmentation pattern. 
 
Figure 1. 5. Components of a mass spectrometer. 
 
1.5.1. Practical steps in mass spectrometry 
1-Ionise the sample in the ionisation chamber ion source after evaporation. In the 
ionisation chamber, the ions are produced by shelling the vapour compounds by electrons. 
2- In the ionisation chamber, the positive ions are accelerated into an analyse tube and 
produce radical cations. 
3- Separate the produced ions in the analyser using quadrupole and then identify based on 
their mass to charge ratio. 
4- Fragment and analyse these ions in the second analyser. After ionising the molecule, the 
radical ions which are produced will have enough energy to break the bonds to give 
fragment ions. These radical ions can also give radical new cations and neutral molecules 
during the fragmentation process. 
5- Detect and measure the ions and then convert them into a spectrum of intensity versus 
m/z. 
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Mass spectrometers have become key tools in of the pharmaceutical industry, including for 
drug discovery, combinatorial chemistry, pharmacokinetics and drug metabolism 
investigations. Mass spectrometry has a pivotal role in reaction monitoring in various areas 
due to its high specificity (103). Because MS is rapid, highly sensitive and specific, it can 
overcome limitations of spectroscopic reaction monitoring techniques such as UV/Vis, IR 
and electron spin resonance (ESR), to detect reactants, intermediates and products and 
fully characterise a reaction mixture (104, 105). Mass spectrometry plays a critical role in 
reaction monitoring and there have been several studies that have reported using mass 
spectrometry techniques in this field (104). 
In recent years, there has been an increasing interest in on-line monitoring of trace 
compounds in industrial and environmental applications. Electrochemistry (EC) coupled 
with mass spectrometry was found to be a very sensitive online technique for identification 
of reactants and products of chemical reactions for non- polar compound detection (106-
109). Proton transfer reaction mass spectrometry (PTR-MS) has been used as on-line 
monitoring technique to measure the trace concentrations of volatile organic compounds 
such as benzene and acetonitrile in human breath (110). The PTR-MS technique has also 
been used as a tool for on-line monitoring of 2-propenamide (acrylamide) in the headspace 
of food products samples (111). 
Electrospray ionisation (ESI) is a soft ionisation technique that can be used to ionise small 
and large molecules at atmospheric pressure. Compared to other ionisation techniques, ESI 
adds multiple charges to large molecules, and this can increase with molecular weight. 
ESI-MS is important for a wide range of pharmaceutical and biological compounds (112). 
ESI-MS is applied to monitor synthetic chemical reactions and study the intermediate 
compounds and mechanisms. ESI-MS spectra provide clear signals about the structure 
information on the molecules (113). Nanoelectrospray mass spectrometry (nano ESI) is 
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one of the ionisation techniques and has been developed for monitoring of chemical 
reaction of proteins and peptides in humans and animals such as cytochrome, angiotensin 
and pepsin (114). 
1.5.2. Hyphenated techniques using mass spectrometry 
Mass spectrometry combined with chromatographic or spectroscopic techniques plays an 
important role in the pharmaceutical analysis including monitoring and identification of 
impurities. Hyphenated techniques have a pivotal role in identification and quantification 
of unknown chemical components in complex mixtures. The past decades have seen a 
growing trend towards hyphenated techniques in many (pharmaceutical) applications 
(115). Studies have shown the beneficial effect of these hyphenated techniques (116, 117), 
in practical applications to ensure the quality and safety of pharmaceuticals. The main 
advantage of these combined techniques is to increase the sensitivity and selectivity of 
qualitative and quantitative analysis, particularly for unknown chemical components, in a 
mixture. Other advantages of using hyphenated techniques are a very low limit of detection 
and limit of quantification and high precision in the determination (118). There are several 
types of hyphenated techniques such as LC-MS (119, 120), GC-MS (117, 121), LC-FTIR 
(122) and LC-NMR (123). LC- (and HPLC)-MS are the most in use in the pharmaceutical 
industry. The most explored/used hyphenated techniques combine chromatographic 
separation, principally using gas chromatography (GC) and (HPLC)LC, with mass 
spectrometry. HPLC (125, 126), GC (127, 128) and LC (117, 129) have been combined 
with mass spectrometry for qualitative and quantitative analysis of mixtures (130). 
Different approaches based on mass spectrometry were applied to develop a simple method 
that can be used to monitor chemical reactions to save time, sample and solvents and to 
provide structural information on the analytes (130). HPLC is developing by connection 
with mass spectrometry (HPLC-MS) as a hyphenated method to use in pharmaceutical 
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analysis for monitoring of drug substances and dosage forms. HPLC-MS-MS has been 
used to monitor the reaction of the oxidation of isothiazolium salt by investigation of the 
intermediates and products over time (131). LC-MS and capillary electrophoresis mass 
spectrometry (CE-MS) have been used for monitoring of anticancer drugs such as 
tamoxifen (for breast cancer treatment) and oxazaphosphorines (for solid malignancies 
treatment) (132). Turbulent flow liquid chromatography was coupled with tandem mass 
spectrometry (TFC-MS-MS) and used to monitor antidepressant drugs in human serum, 
including citalopram, doxepin and imipramine (133). There is increasing concern that 
some of these techniques are being limited and disadvantaged for pharmaceutical analysis. 
For example, the procedures of LC-MS including sample pre-treatment such as extraction, 
filtration, and separation are required and they are also time consuming. Another problem 
of LC-MS is the use of short columns and this might be that chromatographic separation is 
likely to be incomplete (116). GC-MS and LC-MS were used as monitoring methods for 
chemical reactions, but chromatographic fractionation of reaction mixtures can be before 
the analysis (131). Ion mobility mass spectrometry (IM-MS) has been successfully applied 
as a fast and sensitive technique for identification and quantification monitoring of bio 
catalytic reactions (134). Limitations of standard MS are: it is not a direct analysis of the 
sample and a sample preparation is required (pre-concentration and extraction). 
1.5.2.1. LC/MS instrumentation  
A schematic diagram of a mass spectrometer linked to LC is shown in Figure 1.6. Mixtures 
are separated in the LC system, and for each component, a mass spectrum is generated. LC 
combined with MS is a powerful analytical technique that can be used to separate and 
identify compounds. Electrospray ionisation (ESI) is the most widely used ionisation 
method in LC/MS due to it being most suitable for polar compounds and readily coupled to 
LC instrumentation. However, limitation of combined LC/MS with ionisation methods 
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gives little fragmentation which is not useful for providing information about the molecule 
structure. 
 
Figure 1. 6. Schematic diagram of mass spectrometer linked to LC. 
 
1.5.3. Ambient mass spectrometry (AMS) 
Recently, researchers have shown an increased interest in directly analysing samples under 
atmospheric conditions using the relatively new range of ambient mass spectrometric 
(AMS) techniques. Since they were reported in the last two decades, they have attracted a 
lot of interest. AMS has important advantages over other traditional mass techniques: as it 
is a direct ionisation of the sample at ambient conditions, little or no sample preparation is 
generally required, and it can readily be interfaced with a diversity of mass spectrometers. 
Ambient ionisation mass spectrometric methods have been applied for a wide range of 
fields such as pharmaceuticals (quality control of pharmaceutical products and drug 
packaging materials), biomedicine and environmental pollution (135). 
MS requires molecules in the vapour phase and this is not the case for ambient ionisation 
approaches to MS. In the ambient ionisation methods of the mass spectrometry, there is no 
sample preparation and ion formation in ambient conditions. Several important stages of 
direct ionisation methods have been developed to analyse the sample and these make 
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ambient ionisation methods powerful techniques that can be used for rapid analysis of 
complex mixtures (136). Different kinds of samples such as solid, liquid, gas, cream and 
gel can be analysed by these techniques. 
Several traditional ionisation techniques have been used for analysis of samples such as 
matrix-assisted laser desorption (MALDI) and chemical ionisation (CI). However, 
limitations of these techniques are the ionisation of a sample is completed in a closed 
device like a capillary and sample pre-treatment is required, Figure 1.7. 
 
Figure 1. 7. Components of traditional ways to produce ions of samples. 
 
In the ambient ionisation techniques, the energy is generated from the source and it 
interacts with analytes to produce ions and these ions are moved to the MS for detection. 
Desorption electrospray ionisation (DESI) is an example of the ambient ionisation 
techniques that use a solvent as a source. It uses an electrical source of charged aqueous 
spray that interacts with samples on the solid surface. The charged droplets will dissolve 
all chemicals in the samples during the reaction. Furthermore, the small droplets that are 
produced from the sample surface lead to rapid evaporation of the solvent (136, 137). 
Several ambient desorption/ionisation techniques were introduced at the inception of the 
field, notably desorption electrospray ionisation (DESI), direct analysis in real time 
(DART) and plasma-assisted desorption ionisation (PADI) (138). Studies over the past 
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years using ambient ionisation mass spectrometric techniques have provided important 
information on the chemical composition of compounds. A rapid development of new 
ambient ionisation techniques with mass spectrometry has been seen in several areas, 
which has led to shortening analysis time and extended the sample formats that can be 
analysed (135). DESI and DART are still the AMS techniques most frequently used for 
identification of chemical compounds including polar compounds such as peptides and 
proteins and non-polar analytes such as coniceine and lycopene (139), DESI and DART 
have been used to identify molecules in organic synthesis, human skin and food (140). 
1.5.3.1. Plasma-based ambient mass spectrometry 
A number of ambient MS techniques use different types of plasma for the ionisation and 
desorption of analytes, prior to analysis in the mass spectrometer. Here only two will be 
discussed in some detail: DART as the most frequently used and commercially available 
technique and PADI, which is used throughout the investigation reported on in this thesis. 
Plasma is considered to be the fourth state of matter in addition to solid, liquid and gas. 
Plasmas can be divided into two groups depending on the type and amount of energy: the 
excited species (ions, electrons, photons, neutrals) can be at high or low temperature. Low 
temperature plasmas can be sub-divided into two main classifications; thermal and non-
thermal (cold) plasmas. In thermal plasmas, molecules are fully ionised, while they are 
partly ionised in non-thermal plasmas (141). The plasma, often He-based and containing 
He*, can upon interaction with the ambient atmosphere, as is the case in ambient MS 
applications, form a range of reactive species, including (H2O)n H
+
,  e-, UV, N2
+
 (142). 
Any of these excited species can in principle ionise and volatilise analyte molecules so 
they can be detected by mass spectrometry (143). A plasma forms can be electrons, 
positive and negative ions, atoms, free radicals and photons. Plasma is generated at low 
pressure or atmospheric pressure by a combination of energy to gas by various ways 
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including mechanical, voltage and radio frequency (144-146). In general, the activity of 
plasmas depends on the generation source of temperature and this may help to use plasma 
technologies for a wide range of applications including gas treatment and chemical 
synthesis (144). PADI plasma is generated by a radio frequency field using helium gas, 
while DART plasma is generated by discharge gas (helium or nitrogen). Characteristics 
and parameters of PADI and DART are different. PADI uses low voltage (hundreds of 
volts) to drive the electrical discharge compared to that used by DART (kV). PADI uses 
non-thermal plasma, while DART uses thermal plasma and the temperature must be 
between 150 
◦
C and 250 
◦
C. 
Plasma can play an important role in addressing the issue of growth of bacteria and can 
reduce the number of bacteria in the human body in a few seconds (147). Plasma sources 
are essential for a wide range of applications such as spectroscopic analysis, gas treatment, 
material processing and lamps. The last decades have seen a growing trend towards the use 
of atmospheric plasma sources in atomic and mass spectrometry. Microwave plasma 
sources have been used as detectors in atomic emission and gas chromatographic 
techniques to produce surface wave plasma using mixture gases such as helium, nitrogen 
and argon. The results showed that the use of a mixed of these gases can improve the 
method sensitivity (148). Plasma needle is a type of atmospheric plasma technologies that 
operate at room temperature, and it was developed to remove cancer cells and can also use 
as a treatment for wound healing and bacterial infections (142). 
In recent years, there has been an increasing interest in applications of non-thermal 
atmospheric pressure plasmas (149). Because of the rapid development of non-thermal 
atmospheric pressure plasmas at low temperature, it plays an important role for treatment 
of infected or chronic wounds (150). Biomaterials treatment has been studied by many 
researchers using non-thermal plasmas (NTP) with various techniques (143). NTP is not 
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only used in the medical applications for sterilization, but it also can be used as a key tool 
in several medical treatments such as corneal infections, dental diseases, cancers 
leishmaniasis and blood coagulation (151). Non-thermal atmospheric plasma plays a 
critical role in the maintenance of the characteristics of the substance such as molecular 
weight and volume, and this can impact on the substance composition of devices (152, 
153). It can also play an important role by addressing the heat issue, because some of the 
sterilization technologies need 120°C and this causes degradation of medical devices, and 
vacuum chambers are required. However, non-thermal atmospheric plasma needs below 
40°C and without the need for vacuum chambers (152). A novel method of NTP has been 
developed for skin cleansing by killing pathogens of skin infections such as bacteria and 
fungus (154). NTP also plays an important role in the treatment of atmospheric pollution 
by removal of volatile organic compounds (VOC) using chemical reaction engineering. 
This action occurs by reacting reactive species produced by NTP with pollutant 
compounds. In this case, the atomic oxygen produced by plasma will oxidise the volatile 
organic compounds and produce CO or CO2 (155). NTP has also been developed and used 
to remove non- catalytic and catalytic VOC abatement and nitrogen oxide (NOx) as 
atmospheric pollutants from exhaust gases (156, 157). NTP is important for a wide range 
of scientific and industrial processes such as antiseptic of cell surfaces damage (158), 
accelerate wound healing (159) and for cancer treatment due to its ability to stop tumour 
cells growing (160, 151). Although both thermal and non-thermal plasmas are beneficial, 
there are little differences between them. In thermal plasma, the energy from electrons to 
heavy particles equals the energy from heavy particles to the environment and the 
temperature is the same for both. However, in non-thermal plasma, the energy transfer is 
not so effective, and the gas temperature is low. Non-thermal plasmas are also named non-
equilibrium plasmas (151). 
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1.5.3.2. Ambient mass spectrometry techniques 
1.5.3.2.1. Desorption electrospray ionisation (DESI) 
DESI is the first AMS technique for MS and was introduced by the Cooks group in 2004. 
It uses a solvent as a source to ionise the molecule at ambient conditions. The mechanism 
of ionisation is that the electrical source sprays the droplets of solvent to produce the ions 
from the surface of the molecule (161). The produced ions are detected, separated and 
identified using the suitable mass spectrometer. ESI is a standard ionisation technique in 
MS and LC-MS. The electrospray part of ESI-MS aimed at a sample surface, generating 
ions from it by solution phase ionisation which are propelled into the MS inlet by the 
impact of subsequent droplets. Compared to electrospray ionisation (ESI), a lot of 
fragmentation can be gained from DESI. In DESI, the molecules can be ionised at 
atmospheric pressure with little sample preparation. DESI has a wide range of applications 
and it can be used for direct analysis of different types of samples as it is highly sensitive 
and fast. DESI-MS has been used as an on-line monitoring method for investigation of 
pharmaceutical ingredients such as tablets (aspirin, folic acid and acetaminophen), salve 
and liquids as samples (162). 
1.5.3.2.2. Direct analysis in real time (DART) 
DART was introduced by Laramee and Cody in 2005. In DART, the atoms and ions are 
excited from a gas using the plasma at atmospheric pressure. All charged species are 
filtered out so that the sample is only exposed to excited neutrals. Positive or negative ions 
even electrons can be produced in DART ionisation. In DART, a stream of gas (helium or 
nitrogen), but helium is mostly used with an electric discharge uses to produce electrons, 
ions and excited state gas. With using helium, the excited-state helium reacts with water in 
the air to produce protonated water, after which the proton is transferred to the molecule 
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(ionisation). Another ionisation mechanism is that the excited-state helium reacts with a 
neutral to produce a radical cation and electron (163). In DART, the only helium can 
interact with the sample when the plasma is filtered, while in PADI and LTP the plasma 
reacts with the analyte (164). 
DART was applied successfully for quality assurance in pharmaceutical manufacturing. 
Direct analysis in real time (DART) coupled to mass spectrometry and has been used for 
monitoring of pesticides in the agricultural products such as tomatoes and apples (165), for 
a quality monitor of olive oil (166) and for reaction monitoring of indolin-2, 3-dione Schiff 
bases (167). DART was developed to analyse liquids and solids samples without the need 
for extraction (141) and for analysis of non-polar compounds (168). 
1.5.3.2.3. Low-temperature plasma probe (LTP) 
LTP was introduced after PADI. In LTP, the plasma interacts with the sample on the 
probe, and then ions are produced from the surface (169). Numerous micro-discharges 
produce streamer like jets, a voltage is applied to cylindrical electrode outside of the 
discharge chamber with a grounded needle inside. Compared to DESI, the investigation 
LTP does not need to spray solvent and it has a simple construction. Compared to DART, 
LTP uses non-thermal plasma. In LTP, the non-thermal plasma is generated at atmospheric 
pressure like PADI. LTP has been developed as cheap and easy AMS method when 
coupled to mass spectrometry (103). Low-temperature plasma mass spectrometry (LTP-
MS) has been successfully applied to monitor several reactions including ethylenediamine 
with acetic anhydride and methanol with acetic anhydride (135). 
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1.5.3.2.4. Plasma assisted desorption ionisation-mass spectrometry (PADI-MS) 
PADI-MS was introduced after DESI and DART in 2007. It uses plasma for direct analysis 
of analytes on a surface. PADI-MS employs non-thermal plasma generated by a radio 
frequency field using helium (170, 136). Compared to DESI, PADI utilises non-thermal 
plasma gas as a source, while DESI uses the solvent spray to analyse samples (171). 
Compared to DART, the PADI source is a cold atmospheric glow discharge that is 
differentiated by low voltage and power (170). There are some of the similarities between 
PADI and other ambient ionisation techniques. The plasma source for PADI is similar to 
that used for DART and dielectric barrier discharge ionisation (DBDI). PADI and LTP are 
used non-thermal plasma without the need for heating the sample (135). 
PADI has also some advantages over spectroscopic methods such as UV/Vis, IR, and 
NMR, and chromatographic methods such HPLC, LC-MS and GC-MS. PADI is easy to set 
up, little or no sample preparation is required, it has short analysing time and can be 
applied for direct analysis of various compounds such as solids, creams and liquids (170). 
In addition, PADI-MS provides information about chemical speciation, whilst also 
allowing spatial localisation of sampling onto individual glass slides and cotton swabs. 
Several applications of PADI have been used for direct analysis of mixture components in 
various pharmaceutical compounds (170), and it can be used for analysis of polar and non-
polar analytes (172). Salter and co-workers have shown the effect and optimisation of 
analytical parameters of PADI such as the distance between the plasma flame and sample 
surface, radio frequency power and surface temperature for some polymers on signal 
intensities (164). In a study by Bowfield et al., two different sources of PADI such as 
micro-PADI and needle PADI have been used to analyse several species of 
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pharmaceuticals including paracetamol and ibuprofen tablets from the surfaces after 
optimising the parameters (173). 
A more versatile, faster and more sensitive method is needed in the pharmaceutical 
industry to use for rapid, affordable characterisation of the pharmaceutical mixtures. This 
would give rise to better and lower cost, and could have a significant impact on the 
analysis of chemical compounds in other areas. Therefore, the aim of the study was to 
develop a novel method for detailed and rapid monitoring of pharmaceutically relevant 
reactions with a little or no sample preparation. A novel analytical approach for monitoring 
pharmaceutically relevant reactions is reported in this thesis using plasma assisted 
desorption ionisation mass spectrometry (PADI-MS). Ambient mass spectrometry in the 
form of plasma assisted desorption ionisation mass spectrometry (PADI-MS) has the 
potential to fill this important gap in the pharmaceutical industry‟s analytical arsenal. 
This thesis has been divided into four parts. The first part deals with plasma-substrate 
interaction studied by PADI-MS and Raman microscopy using paracetamol tablets as a 
model system. This was achieved by the surface characterisation of tablets by Raman 
microscopy after exposure to the non-thermal PADI plasma flame. This was compared 
with time-resolved PADI-MS experiments. The second part was concerned with PADI 
mass spectrometry analysis of mixtures from TLC plates. This involved analysis of 
mixture solutions of paracetamol and caffeine after deposition on TLC plates, both with 
and without the separation of spots. Part three of the study presented PADI-MS for the 
analysis of pharmaceutical solids and liquids from glass slides and cotton swabs as 
convenient and cost-effective substrates. This was achieved by analysing solid and liquid 
samples of paracetamol, caffeine and Panadol using PADI-MS from glass slides and cotton 
swabs. The fourth section presented PADI-MS for the monitoring of imine (Schiff Base) 
formation as a model pharmaceutical reaction. This was achieved by comparing the 
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findings of PADI-MS with other analytical techniques: TLC, HPLC and FTIR using cotton 
swabs as a substrate.
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CHAPTER 2: Experimental details 
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2.1. Chemicals 
All chemicals were used without any further purification. 
2.2. Standard and Sample Preparation 
Fresh samples of paracetamol, caffeine and Panadol were used for most analysis using 
PADI-MS without the need for preparation and that only for Raman sample preparation 
was required (for more information see Chapter 3 and Chapter 5). Pure compounds and 
sample solutions which are described and used in this thesis including individual and 
mixtures of paracetamol, caffeine and Panadol were prepared in high purity deionised 
water (details can be found in Chapter 4 and Chapter 5). In addition, solutions of para-
anisidine and 4-nitrobenzaldehyde were prepared in dichloromethane for imine formation 
purpose (for more details see Chapter 6). 
2.3. Experimental techniques 
2.3.1. Chromatographic techniques 
2.3.1.1. Thin layer chromatography (TLC) 
TLC plates consisting of silica gel 60 F254, 25 on aluminium sheets of size 20 × 20 cm 
were supplied by Merck KGaA, Darmstadt, Germany. TLC spots were visualised by 
means of a handheld UV lamp (Upland CA, City, U.S.A). 
2.3.1.2. High-performance liquid chromatography (HPLC) 
HPLC was carried out using a Perkin Elmer system consisting of a Flexar LC 
Autosampler, a Flexar LC Detector, Flexar Quaternary LC pump and ODS-C18 column 150 
mm × 4.6 mm (Matlab, UK). HPLC experiments were performed in the isocratic mode. 
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2.3.2. Spectroscopic techniques 
2.3.2.1. Ultraviolet-visible (UV/Vis) spectrophotometer 
A UV-Vis spectrophotometer, model Cary 50 Bio, Varian, UK was used in this work. 
Absorbance spectra of blank (solvent) and samples were recorded using quartz cells. To 
ensure a linear response, a maximum absorbance of 3 was used, using dilutions as 
required. 
2.3.3. Vibrations spectroscopy techniques 
2.3.3.1. Fourier transform infrared spectroscopy (FTIR) 
FTIR spectrometry was carried out using a Thermo Fisher Scientific iS10 instrument 
(Hemel Hempstead, UK) fitted with a DTGS detector and a single bounce germanium 
ATR smart accessory. 
2.3.3.2. Raman spectroscopy 
A Thermo FT DXR Raman microscope (Thermo Fisher, Hemel Hempstead, UK) with 
spectral range 3500-50 cm
-1
 was used in this study. 
2.3.4. Plasma-assisted desorption ionisation-Mass spectrometry (PADI-MS) 
The PADI-MS instrumentation used here was built in-house following a previous design 
by Ratcliffe et al. (1). A single quadrupole (Waters Micromass ZQ, Manchester, UK) was 
used with the ESI front-end removed to accept a modified Stoffels-design plasma pencil 
ionisation source (2). The plasma pencil was fabricated to provide coaxial dual gas flow; 
an inner ceramic tube (outer diameter ~2 mm) was encompassed within a quartz glass tube 
(outer diameter ~5 mm). Helium gas was flowed through both tubes controlled using 
separate flow meters, the flow inside the ceramic tube will in this work be referred to as 
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inner flow, the flow between the ceramic and quartz tubes as outer flow. A thickness 
tungsten filament provided the connection of the RF. 5-15 W was used for all experiments 
as reported. A non-thermal plasma was generated using a 13.56 MHz RF power source 
(Kurt J. Lesker, USA) and a matching network (1). 
The PADI-MS technique has been divided into two main parts: PADI source and MS 
instrument. The PADI source consists of non-thermal (cold) plasma, radio frequency (RF), 
inflow gas such as helium, argon or nitrogen. The main advantage of non-thermal plasma 
in the field of applications such as organic compounds and the aqueous environment is that 
it does not cause any thermal or electric damage to the sample surface. Outer flow is 
possible to obtain high intensity and stable signals of molecules and extra peaks can be 
detected. Compared to the traditional mass spectrometers, the sample in the PADI-MS 
system is ionised outside the vacuum chamber. The basic principles of PADI-MS work are: 
a non-thermal plasma “needle” operates by RF using specific plasma power inflow gas 
under atmospheric pressure conditions at low voltages. The plasma visible flame interacts 
with the sample surface and then the volatile ions are produced from the surface. 
The schematic of the PADI source including a pencil without the outer quartz tube is 
shown in Figure 2.1, while the end of the plasma pencil, sample and mass spectrometer 
inlet geometry is shown in Figure 2.3. The visible non-thermal plasma plume emerging 
from a coaxial helium gas flow 13.65 MHz RF plasma pen was near-contact (5 mm 
separation) with the sample under investigation, using optimised PADI-MS acquisition 
settings of 8 W and a carrier gas flow of 224 mL/min (inner flow) and (224 mL/min outer 
flow). Sample ions were directed into a single quadrupole MS by use of a sniffer tube, each 
acquisition being 1 minute. 
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Figure 2. 1. Schematic of the PADI probe and source in operation. 
 
Figure 2. 2. Schematic diagram of PADI-MS instrument.
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CHAPTER 3: PADI Plasma-substrate interaction 
studied by PADI-MS and Raman spectroscopy using 
paracetamol tablets as a model system
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Abstract 
PADI-MS and Raman spectroscopy were used in this chapter as different analytical 
techniques to yield complementary information. Raman microscopy is a scattering 
vibrational spectroscopic method that can yield spectra without the need for sample 
preparation. Raman samples the chemical composition of the top layer of the tablet through 
the laser approximately1 µm into a sample. Complementary to these features, PADI-MS is 
able to produce positive and negative ions from a substantially thinner layer and it can 
detected molecules in seconds. Raman microscopy has been used to examine the chemical 
changes in the surface layer of paracetamol tablets due to interaction with a low 
temperature helium to plasma flame. Raman microscopy conditions were optimised of 532 
nm laser wavelength, 5.0 mW laser power and a 10x objective with a 2.0 seconds 
collection time. PADI-MS used helium with flow rate of 224 mL/min, and the distance 
between the plasma flame and sample was 5 mm. Sample ions were directed into a single 
quadrupole MS through a sniffer tube, each acquisition being 1 minute. Pure and 
paracetamol tablets were analysed directly after exposure to the room temperature non-
thermal plasma flame up to a specific time. The results showed that the chemistry of 
paracetamol was affected after exposure to non-thermal plasma due to the changes in 
intensities of the diagnostic, adduct and fragment peaks. PADI-MS can be applied for 
direct analysis of pure and pharmaceutical tablets with little or no sample preparation 
required, and it also provides information about chemical speciation in seconds. The results 
of this study indicate that the PADI-MS technique is suitable for analysis of 
pharmaceutical tablets directly. However, the measurement time until the onset of damage 
to a sample is 50 seconds.  
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3.1. Introduction 
Plasma is the fourth state of matter in addition to solid, liquid and gas. Plasmas are 
important for a wide range of scientific and industrial processes. The plasma used in this 
work, upon interaction with the ambient atmosphere, contains a range of reactive species, 
including (H2O)n H
+
, He*,  e-, UV, N2
+
. These species react with atoms from the sample 
surface (1). It would be interesting to study the effect of plasma on the chemical 
composition of compounds using one of the ambient mass spectrometry (AMS) techniques 
because no previous study has investigated this effect. Plasma technologies can be divided 
into two parts: thermal and non-thermal plasma (NTP). In thermal plasma, molecules are 
fully ionised, while in NTP, they are partly ionised (2). In recent years, researchers have 
shown an increased interest in using NTP at atmospheric conditions in medical 
applications (3-7). 
One of the main advantages of the NTP under atmospheric pressure is the ability for 
desorption of molecules from a surface without the need for elevated temperatures (8). 
This has led to the wide use of NTP in applications which need low temperature such as 
biomedical and materials processing applications (9-12). Non-thermal atmospheric plasma 
plays a critical role in the maintenance of the substances characteristics such as molecular 
weight and volume, and this can impact on the substance composition of devices (13, 14). 
It can also play an important role by addressing the heat issue because some of the 
sterilization technologies need 120°C that causes degradation of medical devices and need 
vacuum chambers, while non-thermal atmospheric plasma needs below 40°C without using 
vacuum chambers (13). Recent trends in the treatment of environmental pollution have led 
to a proliferation of studies that use plasma technologies to remove pharmaceutical 
compounds from surface and ground water. Degradation and removal of pharmaceutical 
pollutants such as ibuprofen and diclofenac from aqueous solutions have been studied by 
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several research groups using nonthermal plasmas (13, 14). Recently, NTP has been also 
developed and used as cleaning technologies to remove multi-pollutants such as SO2, NOx 
and Hg from coal (15). Because NTP is increasingly important in the industrial 
applications especially in medicine and biology, generation of NTP at atmospheric 
pressure has been studied using innovative technologies covering a wide range of areas 
(12). In addition, NTP is important for a wide range of scientific and industrial processes 
such as antiseptic of cell surfaces damage (16), accelerate wound healing (17) and for 
cancer treatment due to its ability to stop tumour cells growing (18, 19). 
Several analytical methods including spectroscopic techniques such as nuclear magnetic 
resonance (NMR), near infrared (NIR), Fourier transformed infrared (FTIR) and Raman 
spectroscopy, and chromatographic techniques such as HPLC have been used in the 
analysis of pharmaceutical solids (20). Limitations of FTIR are: it has a single beam in 
comparison with MS and cannot provide details about the structure of compounds; not a 
suitable method for all types of compounds; not playing a major role in the quantification 
analysis of vibration groups of the surfaces (21). HPLC is expensive, chemicals, time and 
solvent consuming and sample preparation is required. Compared to spectroscopic and 
chromatographic techniques, mass spectrometry is more sensitive, faster, small sample 
amounts are required, and ability to directly measure molecular weight. Hyphenated mass 
techniques such as liquid chromatography-mass spectrometry (LC-MS) (22) and gas 
chromatography-mass spectrometry (GC-MS) (23, 24) were developed to support and 
ensure the quality and safety of pharmaceuticals. However, workup procedures such as 
extraction, filtration, and separation are required when using these techniques (25). 
Ambient mass spectrometry (AMS) has some advantages over spectroscopic, 
chromatographic and hyphenated mass techniques which are that samples are desorbed and 
ionised directly from surfaces at atmosphere pressure with little or no sample preparation. 
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Desorption electrospray ionisation (DESI) and direct analysis in real time (DART) are the 
most common techniques of AMS. The detection of produced ions is the same for both 
methods, but DESI uses a solvent as a source to ionise the molecule, while DART uses a 
stream of gas (helium or nitrogen) (for more details see Chapter 2). However, the spray 
solvents in DESI make this method a bit messy (26), and the spectra need more 
investigation. DART is an expensive technique and has lower detection selectivity and this 
due to the lack of a separation, and is not suitable method for all kinds of compounds such 
as the analysis of polymers (27). 
The work presented here investigates the use of direct PADI-MS and Raman analysis for 
paracetamol tablets as a model for pharmaceutically relevant solids. PADI-MS and Raman 
microscopy methods can give good signals without the need for sample preparation. In 
addition, they are able to show the chemical composition of the top layer of a tablet. 
Paracetamol tablet was selected in this study as model drug due to its being small molecule 
and most drugs are still in this category. The specific objective of this study was in three 
stages: 1) many samples of the paracetamol tablets were exposed to visible plasma from 0 
seconds to 5 minutes; 2) Raman microscopy was used to know the chemical composition 
of the top layer of the exposed tablets; 3) changes and behaviours of intensity for the 
adduct and fragment peaks of these exposed tablets were seen using PADI-MS. In this 
study, these methods were successfully used to analyse the paracetamol tablets using the 
optimal conditions. Raman microscopy showed that the differences between the peak area 
of vibrations and exposure times to plasma flame were significant and changed after 20 
seconds. However, no significant changes were found between the shape and position of 
vibration peaks. Further analysis using PADI-MS showed that the changes in intensity of 
the signals were observed during the exposure time to plasma flame. These changes may 
be due to damage to the sample after exposure to the plasma flame. The analysis of these 
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methods provided an important opportunity to advance the understanding of the behaviour 
of molecules with time after exposure to the NTP. The main aim of this study was to 
develop a novel simple, fast, sensitive and cost-effective method, that can be used to show 
the chemical composition of the top layer of the paracetamol tablets after exposure to the 
plasma flame. This study also aims to compare PADI-MS (ambient mass spectrometry) 
with Raman microscopy (vibrational technique) for this type of analysis. In this Chapter, 
the objectives used to reach some conclusions about this sampling method were: 
1- Sample paracetamol (tablet) as model for pharmaceutically relevant solids. 
2- Investigation of the chemical composition of the top layers for tablets by Raman 
microscopy after exposure to non-thermal plasma flame. 
3- Use direct non-thermal plasma interaction to analyse the tablet without any 
preparation by PADI-MS. 
3.2. Materials and methods 
3.2.1. Apparatus: 
In the PADI-MS instrumentation, a single quadrupole (Waters Micromass ZQ, 
Manchester, UK) was used with a Stoffels-design source (28). The flow helium 
measurment was calibrated and found to be 224 mL/min through flow tube, and a distance 
between the visible plasma flame and sample of 5 mm. The effect of water vapour on 
ionisation efficiency was investigated by flowing the He through a water vapour added 
environment before the plasma pencil being directed to the plasma pen outflow (for more 
information see Chapter 2). A Thermo DXR Raman microscope with spectral range 3500-
50 cm
-1
 was used in this study. The conditions for Raman spectroscopy were optimised for 
all samples in this study and found to be: laser wavelength 532 nm, laser power 5.0 mW, 
75 
 
10x objective, collect exposure time 2.0 sec, sample exposure 2 and aperture 25 µm 
pinhole. 
3.2.2. Chemicals: 
Pure paracetamol was manufactured by Alfa Aesar, UK (purity 98%). Paracetamol tablets 
containing 500 mg paracetamol per tablet were supplied by Galpharm International Ltd, 
UK. Helium gas was supplied by British Oxygen Company (BOC) gases, UK (purity 
99%). Deionised water was provided through a Pure Lab Option ELGA, with the 
resistivity 18 MΩ, Model Ultra Clear TWF UV. 
3.2.3. Preparation of samples: 
The samples of paracetamol tablets were analysed directly by PADI-MS without any 
preparation and the spectra were recorded as a function of time, while they were prepared 
by exposing to the PADI plasma for set times before using Raman microscopy. 
3.2.4. Procedure: 
Method development for plasma effect on paracetamol tablets over time by Raman 
microscopy and PADI-MS: 
1- Pure paracetamol and several samples of paracetamol tablets were exposed to PADI 
plasma under atmospheric pressure during different times:10 secs, 20 secs, 30 secs, 
50 secs, 1 min, 2 min, 3 min and 5 min. Plasma spot size which focused into the 
sample was approximately 1020 µm, 1080 µm, 1200 µm, 1500 µm, 1800 µm, 2100 
µm, 2400 µm and 3000 µm respectively. Nine sample of paracetamol tablets was 
analysed directly by Raman microscopy using the optimal conditions. Laser spot 
size which focused into the sample was approximately 2 µm. 
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2- A sample of paracetamol tablet was analysed directly by PADI-MS using the 
optimal conditions with a total acquisition time of 5 minutes. 
Although the type of plasma used is often termed as a „cold plasma‟, there is some degree 
of localised heating near the plasma plume. To investigate the potential effects that such 
heating causes on the sample during the analysis, and indeed the quality of mass spectral 
data obtained, thermal imaging was conducted, Figure 3.1. This allowed observation of the 
spatial and temperature changes associated with plasma-sample interaction. 
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Figure 3. 1. Thermal camera images of a sample of paracetamol tablet during exposure to 
the plasma at different times: a 5 secs; b 15 secs; c 35 secs; d 1 min; e 3 min and f 5 min. 
 
 
 
  
  
  
a b 
c d 
e f 
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3.3. Results and discussion 
3.3.1. Method development and optimisation of PADI-MS and Raman spectroscopy 
conditions 
Paracetamol tablets were used to optimise the methodology by maximising the protonated 
peaks for the compound. PADI-MS conditions of interest were plasma power, helium 
carrier gas flow rate and the distance between the visible plasma and sample surface. Dry 
helium delivery adjacent to the needle-tip was used following optimisation of a coaxially 
arranged delivery of inner flow rate of 224 mL/min, and the distance between the visible 
plasma flame and sample was 5 mm. These conditions gave the highest signal-to-noise 
ratio of the sample main ions and this was found to be optimum for all solid samples. With 
shorter plasma pencil to sample distance (< 5 mm), as expected, the noise was increased. A 
possible explanation for this is that the sample is damaged more during exposure to the 
reactive species associated with the plasma, while both sample damage and intensities of 
ions were minimised when using longer plasma pencil to sample distance (> 5 mm), a 
distance of 5 mm being an optimal balance between damage and ion generation. Raman 
microscopy conditions following optimisation comprised: 532 nm laser wavelength, 5.0 
mW laser power and a 10x objective with a 2.0 second collection time. 
3.3.2. Exposure of sample to plasma flame 
This section deals with the difference between the qualitative analysis method using 
Raman microscopy and PADI-MS. This is achieved by comparing the results of Raman 
microscopy with that used in PADI-MS. Both methods have been developed in this 
investigation. Paracetamol samples were prepared by contact to visible plasma by different 
interaction times before analysis. The PADI-MS plasma was used as a source to expose the 
whole sample of paracetamol tablets at 0 secs, 10 secs, 20 secs, 30 secs, 50 secs, 1 min, 2 
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min, 3 min and 5 min using the optimal conditions. Photos of the PADI-MS source set-up 
and paracetamol tablets after exposure to NTP are shown in Figures 3.2 and 3.3. 
 
Figure 3. 2. Photo of the PADI source in operation using helium directly from a cylinder 
with flow rate of 224 mL/min, and the distance between the plasma flame and sample was 
5 mm. 
 
Figure 3. 3. Photos of paracetamol tablets after exposure to room temperature non-thermal 
plasma flame (from 10 secs to 300 secs) at 7W. 
 
Visual inspection indicates cumulative discolouration of the samples as a function of 
plasma exposure time. The red circle in the first exposure sample (10 seconds) shows the 
place of the exposed area, Figure 3.3. The experimental data of the visible damage spot 
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size due to the PADI plasma for each sample as a function of time is shown in Figure 3.4. 
There was an increase in damage spot size to 30 seconds by 1.2x, after which this further 
increased to the end of data acquisition of 5 minutes by 2.5x, Figure 3.3. Clearly there are 
reactive species outside the visible flame. Damage increased during exposure to the plasma 
flame, in particular after 30 seconds. Therefore, chemical analysis is required to investigate 
if there is a limit to get good results without significant change of the surface chemistry. 
The first phase of chemical analysis examined the impact of NTP interaction with 
paracetamol tablets at different exposure times using Raman microscopy. The molecular 
structure of paracetamol is shown in Figure 3.5. The vibrations of paracetamol in the 
Raman spectra were identified successfully.  
In the second phase of chemical analysis, a paracetamol tablet was analysed directly using 
PADI-MS with a total acquisition time of 5 minutes without the need for preparation. 
Adduct and fragment peaks of paracetamol in the PADI-MS spectra were detected and 
identified as a function of time. Data were collected and then compared with the results of 
Raman microscopy. 
 
Figure 3. 4. Spot size of PADI plasma as a function of plasma exposure time. 
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Figure 3. 5. Molecular structure for paracetamol. 
 
3.3.3. Raman microscopy 
3.3.3.1.Identification of functional groups of paracetamol 
The first part of analysis studied the detection and identification of pharmaceutical tablets 
using the optimised conditions for Raman microscopy as outlined in Section 3.4.1. 
Changes in signal intensity of the sample tablets after interaction to plasma flame were 
compared to that measured in the 0-second sample. Paracetamol tablets were used as 
pharmaceutically relevant models. Paracetamol (500 mg) tablets were analysed directly 
using Raman microscopy. A 0-second paracetamol tablet was analysed as a control sample 
before analysis of exposed tablets using Raman microscopy. The vibrational peaks of 
paracetamol in the Raman spectrum were observed and identified as listed in Table 1 using 
the optimal conditions. Changes in the chemistry of the samples that were exposed to the 
cold plasma over time were identified by comparison with a 0-second exposure plasma. 
The Raman spectrum shows a clear signal intensity of vibrations for 0-second tablet 
plasma, Figure 3.6. The carbonyl group (C=O) has stretching vibration at 1648 cm
-1
. The 
vibration stretches involve C-NH open, C-NH bend and Aryl C-C were observed at 
OH
N
H
C
CH3
O
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1323.24 cm
-1
, 1559.62 cm
-1
 and 1609.387 cm
-1
 respectively. Other vibrations such as C-O-
H, Aryl CH bend, Aryl CH wag and ring deformation are shown in Table 3.1. Most of 
these vibrations have linked to the molecular structure for paracetamol, Figure 3.5. 
Manadanol tablet contains paracetamol 500 mg, maize starch, colloidal anhydrous silica, 
magnesium stearate and potassium sorbent. The percentage of concentration (w/w) for 
paracetamol in the paracetamol tablet is 87 % by dividing the content of paracetamol in the 
tablet by the weight of tablet (500 mg/570 mg). Changes in intensity with time may, in 
principle, be attributed to either thermal desorption of analytes from the surface, 
degradation or continued excitation of analytes on the surface or in the gas phase. 
 
 
Figure 3. 6. Raman spectrum of 500 mg 0-seconds paracetamol tablet (without exposure to 
plasma). 
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Table 3. 1. Vibrations of paracetamol molecule in Raman spectrum Figure 3.5. 
Peak position cm
-1
 Vibration 
651.52 Ring deformation 
856.43 Aryl CH wag (Para Sub) 
1167.55 Aryl CH bend 
1236.56 C-O-H (OH substitution) 
1323.24 CNH Stretch-open 
1559.62 CNH Stretch-bend 
1609.39 Aryl CC Stretch 
1647.90 (C=O) Stretch 
 
3.3.3.2.Effect of visible plasma on the chemistry of paracetamol tablets 
The analysis in this section examined the impact of plasma flame on the paracetamol 
chemistry. This was achieved by comparing the peak positions and peak heights between 
0- second exposure to plasma and exposed samples. This examination also provides 
information about the behaviour of the intensity of vibration peaks over time. The Raman 
spectra present an overview of vibration peaks of paracetamol tablets after exposure to 
NTP at different times: 10 secs, 20 secs, 30 secs, 50 secs, 1 min, 2 min, 3 min and 5 min, 
Figure 3.7, 3.8, and 3.9. The vibration peaks of exposed samples that observed in all 
spectra including aryl CH, COH, CNH, carbonyl group (C=O) and aryl CC stretch are 
different to that used by the 0-seconds time sample. A negative correlation was found 
between signal intensity of vibration peaks and plasma exposure. It can be seen from 
Figure 3.6, 3.7, and 3.8 that the intensity signal of vibration peaks decreases from 10 
seconds until the end of acquisition time of 5 minutes. In addition, the results showed some 
changes that happened in the shape of vibration peaks for aryl CC stretch and CNH stretch-
bend during the exposure time to plasma, in particular for exposure samples between 10 
seconds and 5 minutes. However, the Raman spectra did not show any important shift for 
any peak. These findings may help us to understand that the positions of vibrations were 
not affected by exposure to visible plasma. However, the chemistry of paracetamol tablets 
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can be affected when interacting with NTP as a function of time. This can be proved by 
looking to visual inspection of exposed tablets in Figure 3.3. It can be seen from the photos 
in this Figure that the size of the burned area increased as a function of time, hence the 
chemical structure of tablet changed. Data from these Figures can be compared with the 
data in Figure 3.6 which show there is difference in the signal intensity between 0-seconds 
exposure to plasma and exposure tablets. 
 
Figure 3. 7. Raman spectra of C=O, aryl CC and CNH stretch-bend of paracetamol tablets 
after exposure to NTP at different times: 10 secs, 20 secs, 30 secs, 50 secs, 1 min, 2 min, 3 
min and 5 min. 
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Figure 3. 8. Raman spectra of CNH stretch-open, C-O-H (OH substitution) and aryl CH 
bend of paracetamol tablets after exposure to NTP at different times: 10 secs, 20 secs, 30 
secs, 50 secs, 1 min, 2 min, 3 min and 5 min.  
 
Figure 3. 9. Raman spectra of aryl CH wag and ring deformation of paracetamol tablets 
after exposure to NTP at different times: 10 secs, 20 secs, 30 secs, 50 secs, 1 min, 2 min, 3 
min and 5 min. 
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The results also show there is a clear difference between the signal intensity of the 
vibration peaks for paracetamol tablet such as CH, COH, CNH and C=O, and exposure 
time to NTP up to 5 minutes, Figure 3.10. The signal intensity of C=O, CNH and C-O-H 
stretchs increased up to ~ 30 seconds, after which they decrease to 5 minutes. This due to 
that the chemistry was not affect by plasma flame and there is no damage in the tablet until 
30 seconds of analysis time. Taken together, these results suggest that there is an 
association between the exposure time to NTP and the intensity signal of each vibration 
peak of paracetamol. 
 
Figure 3. 10. Peak height measurements of the vibration peaks for paracetamol tablet with 
a total acquisition time of 5 minutes using Raman microscopy. 
 
Further analysis showed that there was also a positive relationship between the ratio of 
signal intensity for vibration peaks of paracetamol and exposure plasma time. Data were 
collected by determining the ratios of the intensity of vibrations peaks versus analysis time. 
The intensity of vibrations for paracetamol was normalised in order to show the plasma 
effect on the behaviour of intensities over interaction time. There was a clear trend of 
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increasing in the ratios of intensity signal for C=O/aryl CH bend and C=O/CNH stretch 
open, reaching a peak between 120 seconds and 180 seconds respectively, after which they 
decrease until the end of data acquisition of 5 minutes, Figures 3.11 and 3.12. The reason 
of increasing the intensity for C=O due to oxidising the hydroxyl group generating 
carboxylic acid. The chemical composition of paracetamol was affected and changed after 
120 seconds exposure to plasma. These experiments results confirmed that the paracetamol 
tablet was damaged more at and after 120 seconds exposure to plasma, Figure 3.2. 
 
Figure 3. 11. Intensity ratios measurement of C=O/aryl CH bend of paracetamol tablet 
(500 mg) with an acquisition time of 5 minutes using Raman microscopy. 
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Figure 3. 12. Intensity ratios measurement of C=O/CNH stretch open of paracetamol tablet 
(500 mg) with an acquisition time of 5 minutes using Raman microscopy. 
3.3.4. Plasma-assisted desorption ionisation mass spectrometry (PADI-MS) 
3.3.4.1. Identification of fragment and adduct peaks of paracetamol 
Following additional analysis of paracetamol tablets using Raman microscopy, PADI-MS 
was used to get maximum and different information about the effect of visible plasma on 
the chemistry of paracetamol. Another primary aim of this study is to exploit these 
techniques to learn more about the plasma-tablet interaction and to show if there are any 
differences between Raman microscopy and PADI-MS for analysing paracetamol tablets. 
In this part of the analysis, the detection and identification of pharmaceutical tablets were 
studied using the optimised conditions for PADI-MS as outlined in Section 3.1.1. Pure 
paracetamol and tablet were analysed directly using PADI-MS. Although the paracetamol 
molecular ion M
+
 m/z 151 was detected, protonated paracetamol [M+H]
+
 at m/z 152 was 
more abundant and easy to see in all spectra. This could be attributed to a pKa effect. The 
pKa for paracetamol is 9.5, so it is a basic compound. Therefore, paracetamol would be 
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expected to gain a proton and give the high-intensity signal for 152 in comparison with 
151. 
This analysis showed the effect of NTP with paracetamol tablets over time using PADI-
MS. PADI-MS spectrum of pure paracetamol is shown in Figure 3.13. One sample of 500 
mg paracetamol tablet was exposed and analysed directly at the same time by PADI-MS 
using helium directly from a cylinder with flow rate of 224 mL/min, and the distance 
between the plasma flame and sample was 5 mm with an acquisition time of 5 minutes. 
Several PADI-MS spectra of the paracetamol tablet using different times of exposing to 
NTP up to 5 minutes are shown in Figure 3.14. There are clear intensity signals of adduct 
and fragment peaks observed in the spectrum. These ions were analysed and identified 
according to their mass to charge ratios. Two diagnostic peaks relating to paracetamol‟s 
molecular ion were observed for [M+H]
+ 
at m/z 152 and [2M+H]
+
 at m/z 303, with a 
hydrated peak presented at m/z 320 for [2M+H2O]
+
, Figure 3.13. We can see that the 
signal intensity of the protonated paracetamol peak ([M+H]
+
 m/z 152) increased up to ~ 1 
minute, after which it decreased to the end of data acquisition at 5 minutes. The changes in 
intensity in particular after 1 minute may be due to the sample being affected and damaged 
during exposure to plasma at more than this time. The percentage of concentration (w/w) 
for paracetamol in the paracetamol tablet is 87 %. Therefore, the signal intensity of 152 is 
expected to be higher than others, but it is lower than M+H2O m/z 169. This will be 
improved in the next experimental chapters by using carrier gas additives such as outer 
helium flow added with water vapour prior to interacting with the plasma plume. Further 
adduct and fragment peaks can be identified as listed in Table 3.2. 
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Figure 3. 13. PADI-MS spectra of background and pure paracetamol at exposure time to 
plasma with an acquisition time of 1 minute. 
 
Figure 3. 14. PADI-MS spectra of paracetamol tablet at different exposure times to plasma 
with an acquisition time of 5 minutes. 
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Table 3. 2. Diagnostic, adduct and fragment peaks of paracetamol. 
Diagnostic peaks for paracetamol m/z 
Aromatic ring (C6H5) 77 
[M+H]
+
 152 
[M+H2O]
+
 169 
M+H2O+O 185 
[2M]
+2
 302 
[2M+H]
+2
 303 
2[M+H2O]
+2
 320 
2M+H2O+O 336 
 
3.3.4.2.Effect of plasma flame on paracetamol tablet chemistry using PADI-MS 
In this section, the impact of plasma on the paracetamol chemistry was examined by 
PADI-MS using the optimal conditions, Figures 3.15 and 3.16. Both pure and tablet 
showed the same behaviour of intensity during the exposure time to plasma. The intensity 
of protonated paracetamol [M+H]
+ 
increased and reached a peak at 45 seconds, after which 
it reduced to 5 minutes. This could be attributed to degradation or excitation of analytes on 
the surface or in the gas phase. 
 
Figure 3. 15. PADI-MS signal intensity for [M+H]+ in pure paracetamol. 
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Figure 3. 16. PADI-MS signal intensity for [M+H]+ in paracetamol tablet with a total 
acquisition time of 5 minutes. 
 
To investigate the heating causes on the sample during the analysis, The temperature was 
measured using the exact same PADI parameters using a thermal camera by interacting the 
visible plasma with a tablet (29). The temperature increased dramatically to 75 
o
C at 45 
seconds, after which it increased slowly to 80 
o
C at 1 minute, and then dropped to 36
 o
C 
until 5 minutes. This indicated why the [M+H]
+
 peak for paracetamol increase in intensity 
up to ~ 45 seconds, after which they decrease up to 1 minute (for more details see Chapter 
3). Some of the main intensitieis of the adduct and fragment peaks of exposed samples for 
paracetamol tablets over time are shown in Figure 3.17. There is a general decrease in 
intensities of [M+H]
+
 at m/z 152, 2M at m/z 302 and 2M+H at m/z 303 after 45 seconds. 
This observed decrease in intensity with time may, in principle, be attributed to damage the 
sample after exposure to plasma flame. However, there is a clear increase in the intensity 
of aromatic ring (C6H5) at m/z 77 until the end of data acquisition and this may be due to 
losing the oxygen from the molecule. The intensities of the M+H2O at m/z 169 and 
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2M+H2O at m/z 320 were also decreased after 2 minutes, Figure 3.16. From the data in this 
Figure, it is apparent that the length of analysis time is important to obtain more 
information about the structure compound of paracetamol. This result indicates that the 
analysis time up to ~ 50 seconds is enough mostly to detect and identify the molecule. 
 
Figure 3. 17. Signal intensity of adduct and fragment peaks for each sample of paracetamol 
tablet against acquisition time up to 5 minutes in 5 seconds intervals 5, 45, 85, 115, 195 
and 295 seconds. 
 
The ratios of intensity between adduct peaks of paracetamol and aromatic ring were 
calculated. The results showed that the behaviour of the intensity of ratios for [M+H]
+
 m/z 
152/C6H5 m/z 77, 2M m/z 302/77 and M+H2O m/z 169/77 over time are similar, Figure 
3.18. However, as can be seen from this Figure, the ratio of intensity by a factor of 169/77 
is higher than that used by 152/77, 302/77. The reason of this is the intensity of M+H2O 
m/z 169 was higher than that used of 152 and 302. These results show that the differences 
between the intensity of [M+H]
+
, 2M, M+H2O and C6H5 decreased after 50 seconds. They 
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also show that the intensity of [M+H]
+
, 2M and M+H2O are higher than C6H5. As shown in 
this Figure, the ratios of these factors are almost constant up to ~50 seconds, after which 
they reduced until the end of data acquisition. These results indicate that the paracetamol 
tablet can be damaged after exposing to plasma after 50 seconds. Therefore, it suggests that 
the analysis can be stopped after 30 seconds without the need to wait until the end of 
acquisition time. 
 
Figure 3. 18. Signal intensity ratios of adduct and fragment peaks of paracetamol tablet by 
a factor of 152/77, 302/77 and 169/77 with acquisition time up to 5 minutes using PADI-
MS.
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3.4. Conclusions 
The study has focused on the development of a novel method for use in the study of the 
effect of non-thermal plasma on the chemical structure of pharmaceutical samples. The 
present study was designed to investigate the effect of PADI plasma under atmospheric 
pressure on the chemistry of paracetamol tablets as a model system. In this work, PADI-
MS and Raman microscopy have been successfully used to analyse the tablets after 
exposure to the plasma flame. Both methods are simple, fast and can give informative data 
without the need for sample preparation. In addition, they were used directly to show the 
chemical composition of the tablet. This study has shown that paracetamol in the tablet can 
be detected and identified directly by PADI-MS and Raman microscopy without separation 
from the components. Comparison of both proposed methods has shown that the PADI-MS 
is better than Raman microscopy due to its ability to produce the ions from the surface of 
the sample and detect them in seconds. PADI-MS can provide much information on 
chemical structures for pharmaceutical molecules. Therefore, the PADI-MS method is 
more suitable for pharmaceutical sample analysis.  
This study has found generally the chemistry of paracetamol-containing tablets was 
affected by exposure to the non-thermal plasma. The visible spot size after PADI plasma 
exposure was substantial, growing to a dark, circular area of 3000 µm diameter after 5 min 
exposure. Discolouration of the samples indicated that the chemical composition was 
changed. The Raman spectra show changes in the shape of some peaks of the functional 
groups for paracetamol, but the heights are more strongly affected. It did not show any 
important shift for any peak. The top layer of the tablet showed clear signs of oxidation, 
whilst the blackening also suggests carbonisation, which however could not be 
unequivocally determined from the spectra. 
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The experiments of PADI-MS showed that there are differences in intensity of the 
diagnostic, adduct and fragment peaks. The results indicate that a significant proportion of 
the paracetamol molecules in the tablet were damaged after exposing to plasma beyond 30-
45 seconds. However, until 45 seconds there are no discernible differences in the PADI 
spectra, making 30s the optimal data acquisition time. The PADI-MS spectra showed that 
the signal intensity of 152, which was expected to be higher than others, but it is lower 
than [M+H2O]
+
 m/z 169. This result may be explained by the fact the conditions need to be 
improved using carrier gas additives such as outer helium flow added with water vapour 
prior to interacting with the plasma plume. 
This is the first study to investigate the effect of NTP on a pharmaceutical tablet. It would 
be interesting to compare the analysis of this study including solid samples to those used 
by liquid samples in Chapter 4 and Chapter 5. The analysis of these samples undertaken 
here has extended our knowledge by providing a new understanding of the plasma 
interaction with samples and inform further investigations of chemical ionisation methods. 
The methods used for this study may be applied to other pharmaceuticals such as solids or 
creams. The findings of this study have a number of important implications for future 
practice and they also provide insights for future research. Determining strategies to reduce 
the damage caused by the PADI plasma, including potential temperature effects,  whilst 
further increasing the intensity of diagnostic ions is a priority. 
Overall, the results of this study indicate that PADI-MS is fast, highly sensitive and 
specific, allowing direct analysis in seconds, providing detailed information about the 
chemical structure of pharmaceutical samples when operating below the observed damage 
threshold time of 30 seconds.
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CHAPTER 4: PADI Mass spectrometry analysis of 
mixtures from TLC plates
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Abstract 
In this chapter, a novel analytical approach was developed for identification of chemical 
components in aqueous mixtures of pharmaceutically relevant compounds using a TLC 
plate as a substrate. PADI-MS has been applied for direct analysis of solutions of 
paracetamol and caffeine in pure and mixed form on TLC plates. Samples of paracetamol 
and caffeine were analysed as aqueous solutions applied to TLC plate substrates. PADI-
MS acquisition settings were optimised at 8 W and a helium carrier gas flow of 224 
mL/min (inner flow) and (224 mL/min outer flow). Sample ions were directed into a single 
quadrupole MS by use of a sniffer tube, each acquisition being 1 minute. The sample spots 
on the TLC plate substrate were analysed directly by PADI-MS with and without 
developing the TLC plate, using ethyl acetate as mobile phase. The LOD and LOQ were 
determined for paracetamol and caffeine in a 1:1 mixture solution. The LOD for 
paracetamol and caffeine without developing the TLC plate was found to be 0.14 mg/mL 
and 0.16 mg/mL respectively. This improved to 15 µg/mL and 49 µg/mL, and respectively 
after separation of the spots. The LOQ for paracetamol and caffeine without developing the 
TLC plate was found to be 0.48 mg/mL and 0.54 mg/mL respectively. This improves to 50 
µg/mL and 165 µg/mL respectively after separation of the spots. The LOD and LOQ for 
paracetamol after separation were 10 times lower, while for caffeine the improvement was 
a factor of 3. Therefore, the separation is not always necessary, and spots can be identified 
on TLC plates using PADI-MS without separation. However, the separation of the spots 
can give higher signal-to-noise ratio (S/N) of molecules, and hence the sensitivity of 
diagnostic adduct and fragment peaks can be improved. Therefore, separation was better 
due to no interference was found between compounds.   
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4.1. Introduction 
Analysis of complex reaction mixtures can play an important role in understanding 
mechanisms of reaction pathways and improving products (1). The reason of using a 
mixture of compounds in this study is to identify mixture ingredients and this can help to 
confirm the quality and safety of drugs by determining the presence and quantity of 
components in a mixture. This study aims to establish whether PADI-MS is able to analyse 
mixtures and what are the limitations of the method. Paracetamol and caffeine are two 
important pharmaceutical compounds, used individually or together for treatment. 
Paracetamol is used as an analgesic and antipyretic drug that inhibits the cyclooxygenase 
enzyme (2,3). Caffeine is used to promote the analgesic effect of paracetamol when 
combined (4). Paracetamol is extensively used to reduce a headache, general pain 
including chronic pain and reduce temperature particularly that associated with bacterial 
and viral infection (5-8). Caffeine is a much consumed compound by humans via its 
presence in drinks such as coffee (9, 10). As well as in pharmaceutical formulations, 
caffeine can be extremely harmful to human beings. Excessive consuming of caffeine can 
lead to anxiety and nervousness (11), raised blood pressure and heart disease (12). 
Paracetamol and caffeine are one of the most widely used combinations of pharmaceuticals 
(13). 
Several analytical methods have been reported in the analysis of paracetamol and caffeine 
in the various pharmaceutical mixtures, such as spectroscopic, chromatographic and 
spectrophotometric techniques (14). High-performance liquid chromatography (HPLC) has 
been the most widely used method to analyse the pharmaceutical mixtures. HPLC is also 
the most used of the liquid chromatographic methods for separating the complex mixture 
of compounds (15). HPLC method has been used to analyse a mixture of paracetamol, 
caffeine and chlorphenamine using a C18 column and a mobile phase consisting of 
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methanol and potassium phosphate (45:55 v/v) (16). A RP-HPLC method has been 
successfully applied to analyse the pharmaceutical mixture including paracetamol and 
caffeine using Brownlee Bio C18 column and isocratic mobile phase of water-acetonitrile 
(85:15 v/v) at room temperature, and the analysis time per sample was 6 minutes (17). 
This is because the quantification analysis and the limit of detection is very good. 
However, the disadvantages of HPLC are that it is relatively expensive, chemicals, time-
consuming and sometimes extensive sample preparation required. HPLC also gives one 
peak for each compound and this may not always be specific enough to tell us whether a 
component is present in the sample or not. 
Mass spectrometry is a sensitive and fast analytical method and it can be used to detect and 
monitor a wide range of compounds. In addition, MS methods can measure molecular 
weight directly with small sample amounts. Mass spectrometry techniques are combined 
with chromatography such as gas chromatography-mass spectrometry (GC-MS) (18, 19), 
high-performance liquid chromatography connected with a tandem mass spectrometry 
(HPLC-MS/MS) (20, 21) and liquid chromatography-mass spectrometry (LC-MS) (22) to 
provide more information about the chemical structure of compounds. On the other hand, 
pre-concentration and sample preparation are still required in these techniques (23). 
In recent years, there has been an increasing interest in ambient mass spectrometry (AMS). 
In the AMS techniques, samples are desorbed and ionised directly from surfaces under 
atmosphere pressure (for more information see Chapter 2). Desorption electrospray 
ionisation (DESI) and direct analysis in real time (DART) are the most common 
techniques of AMS, but the type of source is different. DESI uses a solvent to ionise the 
sample, while DART uses a plasma. 
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In this study, a very simple and rapid analysis of (individual and mixture) solutions from 
TLC plates using PADI-MS has been explored in a variety of ways. PADI is another type 
of the modern ambient ionisation techniques that uses non-thermal visible plasma as a 
source to produce ions from the surfaces of molecules. Compared to DESI and DART, 
PADI uses different plasma (non-thermal visible plasma) that does not cause any thermal 
or electric damage to the sample surface. The present study explores, for the first time, the 
effect of type of substrate on identification of paracetamol and caffeine in the mixture 
solutions using a novel method of PADI-MS. This study therefore sets out to assess the 
effect of water vapour, temperature and the effect of matrix on signal intensities of these 
samples. A qualitative analysis method was used in these investigations. The study offers 
important insights on how to develop a new method that can be used to detect and identify 
the pharmaceutical compounds from other substrates. This study can also provide new 
insight into applying this novel method to analyse unknown chemical compounds in many 
fields not only in pharmaceutical analysis. A major advantage of the mixture analysis using 
this method is that it avoids the problems of other analytical methods such as time-
consuming, sensitivity and sample pre-treatment. This method is particularly useful in 
studying of pharmaceutical production. Many researchers have utilized several techniques 
to measure the chemical compounds in the mixture solutions, but the problem with the 
experimental methods is that sample preparation, filtration and extraction are required. 
An objective of this study was to detect and identify paracetamol and caffeine as a mixture 
from a TLC plate before and after the separation of spots. TLC plates as substrate are low 
cost, convenient, good dimensional stability, fast, easier to interpret spectra particularly for 
complex mixtures and they are heat resistant and this makes the spots on the TLC plate and 
the method easy to develop and this also allows the possibility of using strong solvents. 
TLC plates are faster than paper chromatography because the stationary phase of TLC is a 
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thin layer of inert material supported on a flat surface like a glass plate and this allows the 
solvent to move quickly through the stationary phase. The main aim of this study was to 
develop a novel fast, sensitive and cost-effective method that can be used for identification 
of unknown components in pharmaceutically relevant solutions from TLC plates. PADI-
MS provides information about chemical speciation, whilst also allowing spatial 
localisation by sampling individual TLC spots. This study used a qualitative case study 
approach to investigate the measurement of paracetamol and caffeine in single component 
and mixture solutions from TLC plates. The benefit of this approach is that it allows 
qualitative methods analysis to be more useful for identifying and characterising. The 
purpose of using paracetamol and caffeine as model drugs in this study is that they are 
small molecule drugs and most drugs are still in this category. The work presented here 
investigates the use of PADI analysis directly from a TLC plate, using paracetamol and 
caffeine as models for pharmaceutically relevant mixtures. Mixed standard solutions and 
off-the-shelf pain relief pharmaceuticals, Panadol and paracetamol, and caffeine were used. 
The analysis was compared pre- and post TLC- separation. 
The analysis of samples using PADI-MS is divided into two sections. The first section of 
this study shows that PADI-MS has been used to analyse the mixture of paracetamol and 
caffeine directly from TLC plates without separation of spots. In the second section, the 
study set out to detect these compounds using this technique after the separation of spots 
from TLC plates using ethyl acetate as a solvent. This study used qualitative analysis of 
paracetamol and caffeine by placing one drop of the mixture on TLC plate and then 
analysing directly using PADI-MS without any separation to save time and solvents. This 
study was also designed to develop the TLC plate after separation of the spots by 
improving the limit of detection and limit of quantification for these compounds. However, 
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to get an optimal limit of detection is necessary to separate the spots of paracetamol and 
caffeine on the TLC plate prior to PADI-MS analysis. 
Matrix effect is important for the quality of the results particularly for solid samples and 
this might impact on the sensitivity of the analytical response either positvely or negatively 
(24). This study attempts to show that matrix of analytes (paracetamol and caffeine) did 
not affect on the results and this will be discussed in details in the results and discussion 
section. 
Understanding the link between the behaviour of peak intensity and analysis time will 
attempt to improve the measurement of samples by the length of analysis time. This is also 
important to explain the experimental data which are collected by PADI-MS spectra. The 
experiments of this work were examined to show how the best way of pharmaceutical 
mixtures analysis can be chosen. For PADI, the temperature is important for desorption of 
samples. For AMS techniques including PADI, the temperature is important and can play a 
vital role in desorption of samples (25). Therefore, in order to increase the signal intensity 
of the analysis, the temperature of the sample must be increased. Plasma interacts with 
both sample and TLC plates at the same time. Plasma heats the sample to generate the gas 
phase of the molecules then the ions are produced (positive and negative ions) from 
surfaces. After that, MS separates and detects ions. On the other hand, this chapter includes 
the identification of paracetamol and caffeine in the mixture solution from dry TLC plates 
and this will be discussed in detail in the practical evaluation part. In this Chapter, the 
objectives used to reach some conclusions about this sampling method were: 
1) Sample paracetamol and caffeine directly as model for pharmaceutically relevant 
solutions. 
2) Use a TLC plate to present solution samples to PADI-MS. 
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3) Use direct non-thermal plasma interaction to analyse the solution without any 
preparation by PADI-MS. 
4) Compare the PADI-MS results before separation of spots with after separation of 
the spots. 
5) Assess limits of detection and quantification for each combination of the above. 
4.2. Materials and methods 
4.2.1. Apparatus: 
In the PADI-MS instrumentation, a single quadrupole (Waters Micromass ZQ, 
Manchester, UK) was used with the front end removed to accept a Stoffels-design plasma 
pen ionisation source using a 13.56 MHz RF power source (26). The plasma pencil was 
fabricated to provide coaxial dual gas flow; an inner ceramic tube was encompassed within 
a quartz glass tube. The helium gas flow through both tubes was controlled using separate 
flow meters, the flow inside the ceramic tube will henceforth be referred to as inner flow, 
the flow between the ceramic and quartz tube as outer flow. Mass conditions including 
inflow gas, out flow vapour and plasma power were set up for all experiments. The 
conditions of PADI-MS were optimised and set up for all samples in this study using 
preliminary analysis and found to be plasma power of 8 W, He inflow of 224 mL/min and 
the distance between the plasma flame and sample of 5 mm. The effect of water vapour on 
ionisation efficiency was investigated by flowing the He through a water vapour added 
environment before the plasma pencil (for more information see Chapter 2). 
4.2.2. Chemicals:  
Panadol Extra
TM
 tablets containing 500 mg paracetamol and 65 mg caffeine per tablet were 
used as obtained from an over the counter pharmacy. Pure paracetamol was purchased 
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from Alfa Aesar, UK (purity 98%), and pure caffeine was purchased from Organics, China 
(purity 98%). Helium gas was supplied by British Oxygen Company (BOC) gases, UK 
(purity 99%).  Ethyl acetate was supplied by Fisher Scientific, UK with high purity 
laboratory reagent grade (Assay (GLC) > 99%). Deionised water was provided through a 
Pure Lab Option (ELGA) with a conductivity of 0.067 MS/cm. 
4.2.3. Preparation of sample solutions: 
Panadol solutions were prepared by dissolving 1 Panadol Extra tablet in 10 mL deionised 
water. A range of high purity paracetamol and caffeine solution concentrations of 0.02 - 5 
µg/µL were prepared by dissolving the solutes in deionised water. Paracetamol and 
caffeine mixtures were prepared by mixing 2 mL of equally concentrated solutions. These 
were all freshly made prior to use. 
4.2.4. Standard TLC plates: 
Standard TLC plates consisting of Silica gel 60 F254, 25 on aluminum sheets of size 20 × 
20 cm were supplied by Merck KGaA, Darmstadt, Germany. 
4.2.5. Procedure: 
A. Sample substrates without separation: 
1. Squares of 2 x 2 cm TLC plate were cut and used for all analysis in method 
A.  
2. One drop of single paracetamol and single caffeine (both 5 µg/µL) and 
Panadol tablet solution (50 mg/mL paracetamol+6.5 mg/mL caffeine) were 
deposited on the TLC plate using a Pasteur pipette. The droplet size was 
32.4 µL allowing deposition of 162 µg API. Other serial dilutions of 1:1 
(w/w) mixtures of paracetamol and caffeine were also deposited on TLC 
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plate as shown in Table 4.1. For each measurement of a single drop of 
solution with a volume of 32.4 µL (the weight of one drop was 0.032 g) was 
deposited. These droplets contained the following amounts of API / 
paracetamol and caffeine as listed in Table 4.2. 
3. The deposition spot of individual and paracetamol/caffeine mixtures on the 
TLC plate was analysed immediately without drying by PADI-MS with a 
total acquisition time of 1 minute. 
B. Sample substrates with separation: 
1. A large TLC sheet was cut horizontally into plates 6.5 cm by 2.5 cm and 
used for all analysis in method B. 
2. Small spots of single paracetamol and single caffeine (both 5 mg/mL) and 
1:1 (w:w) mixtures were deposited using a spotter tube on TLC plates. The 
droplet size was 0.8 µL (the weight of one spot was 0.0008 g). Further 
details are shown in Table 4.1. 
3. The separation on TLC plates was developed using ethyl acetate as solvent.  
4. Spots were seen and circled using pencil under UV light and were 
identified. 
5. Each spot was analysed immediately without drying by PADI-MS with a 
total acquisition time of 1 minute. 
To investigate the potential effects that such heating causes on the sample during the 
analysis, and indeed the quality of mass spectral data obtained, the temperature was 
measured using the exact same PADI parameters using a thermocouple (chromel-alumel 
type) by contact the visible plasma with TLC plate without a sample. 
 
111 
 
Table 4. 1. Concentrations and amounts of paracetamol and caffeine in the mixtures used 
for methods A and B. 
Concentration of each analyte (mg/mL) 2.5 0.5 0.1 0.01 
Amount of each analyte per droplet (µg) 
Method A: Analysis without separation 81 16.5 3.24 0.324 
Method B: Analysis after separation 2 0.4 0.08 0.008 
 
Table 4. 2. The amount of molecule per mole in the solution of an individual and a mixture 
of paracetamol/caffeine. 
Solution Paracetamol 
µg/ µmole 
Caffeine 
µg/ µmole 
Paracetamol 5 µg/µL 162 / 1.07  
Caffeine 5 µg/µL  162 / 0.83 
Mixture: both 2.5 µg/µL 81 / 0.53 81 / 0.41 
Mixture: both 0.5 µg/µL 16.5 / 0.11 16.5 / 0.08 
Mixture: both 0.1 µg/µL 3.24 / 0.02 3.24 / 0.016 
Mixture: both 0.01 µg/µL 0.324 / 0.002 1.324 0.0016 
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4.3. Results and discussion 
4.3.1. Optimised conditions used for all following experiments 
Solids and solutions of highly pure compounds were used as a control to identify and 
optimise methodology. Paracetamol and caffeine solutions at a range of concentrations 
(Table 4.1) were deposited on TLC plates using procedure A and analysed by PADI-MS. 
To get the best conditions to analyse samples on PADI-MS, repeated measures of the 
single component were used. PADI-MS conditions of interest were plasma power, helium 
carrier gas flow rate and the distance between the visible plasma and sample surface. 
4.3.1.1. Plasma Power 
Plasma power of 8W was found to give the highest intensity of the sample main ions (or 
less noise). This was found to be optimum for all pure samples and also gave good results 
when applied to mixtures of controls in varying ratios, Figure 4.1. The stability of 
spectrum observed with respect to the time of plasma-sample interaction was seen to vary 
somewhat in relation to the intensity of ions observed rather than varying ion composition. 
With higher plasma powers (> 8W), as expected, the noise was increased. The reason for 
this is the sample can be damaged more during exposure to high plasma flame in particular 
more than 8 W. At the same time, intensities of molecules were minimised when using 
lower plasma powers (< 8W). 
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Figure 4. 1. Signal intensity of [M+H]+ in paracetamol tablet against different plasma 
power using helium added with a total acquisition time of 1 minute. 
4.3.1.2. Plasma pencil to sample distance  
The distance between the plasma flame and sample of 5 mm was also found to give the 
highest intensity of the sample, Figure 4.2. The same problems that were mentioned before 
can happen when the plasma pencil to sample distance was higher or less than 5 mm. 
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Figure 4. 2. Signal intensity of [M+H]+ in paracetamol tablet against different plasma 
pencil to sample distance using helium added with a total acquisition time of 1 minute. 
4.3.1.3. Carrier gas flow rate 
A carrier gas flow of 224 mL/min (inner flow) and (224 mL/min outer flow) was also 
found to give the highest intensity of the sample ions. 
4.3.1.4. Carrier gas additives 
Spectral differences were observed when the outer He flow was added with water vapour 
prior to interacting with the plasma plume. This was investigated in order to study possible 
effects of chemical ionisation, with anticipated protonated water being formed within the 
water vapour infused plasma. Results suggest that the analysis of paracetamol and caffeine 
mixture using helium added with water vapour as gas flow is better than using dry helium; 
the signal intensity of diagnostic molecular and fragment ions was significantly improved, 
aiding determination of the chemical composition of dilute mixtures, Figure 4.3. 
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Several solvents including methanol, ethanol, hexane, petroleum spirit, dichloromethane 
and ethyl acetate were trialled as mobile phase to separate the spots of pure paracetamol 
and caffeine in the mixture solution on TLC plates. Ethyl acetate was found to be the most 
suitable solvent for this purpose. Carrier gas additive was investigated to improve the 
signal intensity of diagnostic molecular and fragment peaks of paracetamol and caffeine 
molecules. Results suggest that the analysis of paracetamol and caffeine mixture using 
helium added with water vapour as gas flow is better than using dry helium, Figure 4.3. 
Spectral differences were observed when flowing the outer He flows through added water 
vapour environment prior to reaching the plasma flame. As expected, the gas phase ions 
are formed by the reaction between the helium and water which then produce H3O
+
, and 
then H3O
+
 reacts with a molecule (M) to form protonated molecule (MH
+
) according to 
equations below (35): 
He + nH2O  H3O
+
 + (H2O)n        (1) 
H3O+ (H2O)n + M  MH
+
 + (n+1) H2O      (2) 
As an analog to electrospray ionsation mass spectrometry (ESI-MS) that uses any polar 
solvent such as H2O, ACN and THF for proton donation, here H2O vapour was used to 
achieve a similar effect. 
The results showed that signal intensity of diagnostic molecular and fragment peaks was 
significantly improved when using helium added with water vapour, this aiding 
determination of the chemical composition of dilute mixtures. There is the higher signal 
intensity of protonated paracetamol [M+H]
+
 m/z 152 when using helium added with water 
vapour as gas flow, Figure 4.3. Diagnostic peaks relating to paracetamol molecular ion 
were observed an
 
m/z 152 for [M+H]
+ 
and m/z 304 for [2M+2H]
+
, with a hydrated peak 
presented at m/z 320 [2M+H2O]
+ 
, Figure 4.3. The diagnostic peak m/z 166 could be 
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assigned either to [M+O-H]
+
 or to [M+NH]
+
 (with nitrogen reacting from the air during 
plasma treatment), but it is most likely identified as M+O-H due to the paracetamol 
molecule gaining the hydroxyl group from the water vapour. Further adduct and fragment 
peaks can be identified as listed in Table 4.3. There was also a clear trend of increasing the 
intensity and stable signals of protonated paracetamol when using helium added with water 
vapour, Figure 4.4. The protonated caffeine peak [M+H]
+ 
at m/z 195 could not be detected 
using dry helium (Figure 4.5). The data in Figures 4.4 and 4.5 is that 15 seconds indicate 
enough to see all diagnostic peaks relating to paracetamol and caffeine with stable signals 
without the need to wait until 60 seconds. The diagnostic peak of caffeine was detected 
[M+H]
+
 at m/z 195 when using helium with added water vapour. However, this protonated 
peak was not detected when using dry helium, Figure 4.5. This maybe due to the pKa 
effect. The pKa for caffeine is 14 (basic compound), therefore, it can gain protons from 
water easily. 
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Figure 4. 3. PADI-MS spectra of single paracetamol (5 µg/µL) using dry helium (b) and 
helium added with water vapour (c) with a total acquisition time of 1 minute. Arrows 
indicate diagnostic peaks that link to paracetamol. 
 
Figure 4. 4. Signal intensity of protonated paracetamol m/z = 152 (5 µg/µL) against time 
using dry helium and added with water vapour in 5 seconds intervals 0-5, 10-15 and 20-25 
seconds. 
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Figure 4. 5. Signal intensity of protonated caffeine m/z = 195 (5 µg/µL) against time using 
dry helium and added with water vapour in 5 seconds intervals 0-5, 10-15 and 20-25 
seconds. 
 
Table 4. 3. Diagnostic, adduct and fragment peaks of paracetamol and caffeine. 
Diagnostic peaks for 
paracetamol 
m/z Diagnostic 
peaks for 
caffeine 
m/z 
[M+H]
+
 + 2H2O-COCH3NH 130 M
+
 194 
[M+H]
+
 152 [M+H]
+
 195 
M+O-H or M+NH 166   
[M+H]
+
 + 2H2O-N 174   
[M+H]
+ 
+ CO 180   
M-H+2H2O 186   
2M-CH3 287   
[2M+2H]
+2
 304   
[2M+H2O]
 +
 320   
3M- CH3COH2 408   
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4.3.2. Time dependence of plasma interaction 
Continous sampling of the same area with the visible part of the plasma flame in touch 
with the sample surface gives rise to spectral changes observed over time using helium 
added with water vapour. Changes in intensity with time were compared using initial 
analysis of pure paracetamol and caffeine solutions (both 5 µg/µL) which were measured 
separately, Figure 4.6. The plasma exposure has an effect on signal intensity. Notably, a 
similar behaviour was observed between the behaviour of the two compounds tested 
(paracetamol and caffeine) over time. There were also significant differences observed in 
the signal intensity of protonated paracetamol and caffeine ions. They showed that [M+H]
+
 
m/z 152 is 4x more abundant than M
+
 m/z 194. 
To investigate potential heating of the sample during the analysis, the temperature was 
measured using the exact same PADI parameters using a thermocouple (chromel-alumel 
type) under a TLC plate, Figure 4.6. The temperature was also measured using a thermal 
camera focused at the top of a TLC plate. In both experiments the visible plasma was held 
at the optimised 5 mm distance from the top of the TLC plate (27). During this acquisition 
period, the temperature rose to 45
 o
C in 60 seconds in the thermocouple measurements. 
The thermal camera measured an increase to 60 
o
C in 60 seconds, while it was below 60 
o
C 
when the previously discussed analysis time threshold was reached after 45 seconds. The 
[M+H]
+
 peaks of both paracetamol and caffeine increase in intensity up to ~ 45 seconds, 
after which they decrease up to 1 minute. It seems unlikely that the limited temperature 
increase is the (sole) cause for this. Changes in intensity with time may, in principle, also 
be attributed to loss of analyte due to removal or degradation or continued excitation of 
analytes on the surface or in the gas phase. The porosity of the TLC plate may also have a 
role to play. Although the ratios by a factor of 152/194 and 152/195 are enough to 
investigate the level of fragmentation with time. Data acquisition for 35 seconds was 
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decided as the optimal time for the high-intensity signal of protonated paracetamol and the 
analysis can be stopped at that time in order to avoid any damage to the sample by the 
plasma. 
 
Figure 4. 6. The signal intensity of pure paracetamol and caffeine solutions (both 5 µg/µL) 
deposited on a TLC plate using helium added with water vapour in 5 seconds intervals 0-5, 
10-15, 20-25, 30-35, 40-45 and 55-60 seconds using thermal couple. 
 
The intensity of protonated paracetamol was also normalised to that of the caffeine 
molecular ion and protonated caffeine. The intensity ratios of 152/194 and 152/195 
remained steady over the first 25 seconds, after which they decreased to 45 seconds, and 
then settle at a constant value up to 1 minute, Figure 4.7 and Figure 4.8. The results also 
showed that the intensity behaviour by a factor of 195/194 was similar to that of 152/194 
and 152/195, Figure 4.9. According to these data, we can infer that PADI-MS is limited by 
analysis after 30 seconds due to it gives unstable signals after this time. It also found that 
the signal intensity of protonated paracetamol was higher than that used of caffeine 
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molecular ion and protonated caffeine over time, and this may be attributed to the same 
reasons as mentioned before. 
 
Figure 4. 7. Intensity ratios for paracetamol and caffeine by a factor of 152/194 (both 5 
µg/µL) applied and measured separately using helium added with water vapour in 5 
seconds intervals 0-5, 10-15, 20-25, 30-35, 40-45 and 55-60 seconds. 
 
Figure 4. 8. Intensity ratios for paracetamol and caffeine by a factor of 152/195 (both 5 
µg/µL) applied and measured separately using helium added with water vapour in 5 
seconds intervals 0-5, 10-15, 20-25, 30-35, 40-45 and 55-60 seconds. 
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Figure 4. 9. Intensity ratios for caffeine by a factor of 195/194 (5 µg/µL) measured using 
helium added with water vapour in 5 seconds intervals 0-5, 10-15, 20-25, 30-35, 40-45 and 
55-60 seconds. 
 
4.3.3. Analysis of Mixtures 
Various mixtures of paracetamol and caffeine were analysed as control samples before 
analysis of an off-the-shelf pharmaceutical mixture, Panadol Extra
TM
. In all experiments, 
the same concentrations of 1:1 (w/w) mixed solutions of paracetamol and caffeine were 
used to analyse the mixtures except the Panadol tablet solution as shown in method A and 
B. 
4.3.3.1. Method A: Analysis without separation of spots 
The first set of mixture analysis aimed to identify paracetamol and caffeine spots on TLC 
plates using PADI-MS without separation. Changes in intensity as a function of time were 
compared using dry helium only and helium added with water vapour in the outer flow. 
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The results were compared to 'no sample' which was taken before sampling to spectra 
taken 'with sample' in the plasma plume (Figure 4.10). No sample spectrum shows a little 
of the sample but this fairly low level, and this may be due to contamination of the sniffer 
tube. The sniffer tube was cleaned several times to minimise contamination effects. The 
analysis presented here demonstrates the use of PADI analysis directly from TLC plates, 
using the mixtures of paracetamol/caffeine as models for pharmaceutically relevant 
mixtures. Paracetamol and caffeine aqueous solutions over a range of concentrations were 
deposited on a TLC plate and analysed immediately (without the need to dry) by PADI-MS 
using the optimal conditions as described in Section 4.3.1. High purity mixed solutions 
(1:1) were used as a standard to optimise conditions, Figure 4.10. Changes in intensity with 
time were compared using initial analysis of mixed solutions of paracetamol and caffeine 
(2.5 µg/µL) which were measured from TLC plates without separation of spots using 
helium added with water vapour and dry helium in time upon binning of data in 5 seconds 
intervals. The intensities for most diagnostic, adduct and fragment peaks of paracetamol 
using helium added with water vapour are higher than that used by dry helium, Figure 
4.10. This agrees with the previous results for the separate molecules and again shows that 
using helium added with water vapour for sample analysis can improve peak intensities for 
all diagnostic ions. Protonated peaks of paracetamol and caffeine were used to measure the 
extent of the effect of using helium added with water vapour on mixture analysis. 
The results found increases in the intensity of protonated paracetamol when using helium 
added with water vapour to be 2x higher to that used by dry helium, Figure 4.11. The 
results also showed that the protonated caffeine ([M+H]
+
 m/z 195) is difficult to detect 
when using dry helium, Figure 4.12. This may be due to the caffeine molecule gaining a 
proton easier when using helium added with water vapour. Similar to that mentioned 
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before, 15 seconds is enough time to detect all diagnostic peaks relating to paracetamol and 
caffeine with good signals. 
 
Figure 4. 10. PADI-MS spectra for the mixture solution of paracetamol and caffeine (both 
2.5 µg/µL) from TLC plates using helium added with water vapour (a), dry helium (b) and 
background (c) with acquisition time of 1 minute. 
 
Figure 4. 11. Signal intensity of protonated paracetamol ([M+H]+ m/z 152) (2.5 µg/µL) in 
the mixture solution from TLC plate using dry helium and added with water vapour in 5 
seconds intervals 0-5, 10-15 and 20-25 seconds. 
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Figure 4. 12. Signal intensity of protonated caffeine ([M+H]
+
 m/z 195) (2.5 µg/µL) in the 
mixture solution from TLC plate using dry helium and added with water vapour in 5 
seconds intervals 0-5, 10-15 and 20-25 seconds. 
 
The PADI-MS intensities of molecular ions / protonated ions of 1:1 mixed solutions onto a 
TLC plate are shown in Figure 4.13. As with the pure species, paracetamol gives rise to a 
strong singly charged species [M+H]
+
 at m/z 152, with the presence of caffeine identified 
by M
+
 at m/z 194. Time-dependent analysis of the main identifying peaks shows a similar 
profile as was observed for the pure compound analysis. There is a general increase in all 
peak intensities over the first ~35 seconds, after which the intensity of all peaks reduces. 
Different profiles are observed when using helium alone or when using an outer He flow 
added with water vapour such as sensitivity, with the additional [M+H]
+
 peak of caffeine 
as discussed above and this gives more confirmation of the presence of caffeine in the 
solution. As can be seen from the Figure 4.13 there is more intense signal of protonated 
paracetamol in comparison with intensities of caffeine molecular ion and protonated 
He with added water vapour e ith added ater vapour  ith ad ed water vapour 
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caffeine. The intensity of [M+H]
+
 m/z 152 for paracetamol was higher ~5x compared to 
that of M
+
 m/z 194 for the caffeine molecular ion. The observed increase in the intensity of 
paracetamol in pure and mixture solutions could explored by considering their respective 
pKa values. The pKa for paracetamol and caffeine are 9.5 and 14 respectively, therefore, 
caffeine is more basic (strong basic) than paracetamol (weak basic), hence caffeine 
molecular ion (M
+
 m/z 194) could be expected to give small signal intensity. Another 
contributing factor might be related to the molecular mass of each compound. The 
molecular mass for paracetamol is 151 g/mol while for caffeine is 194, so, each 1 g of 
paracetamol contains 0.0066 moles whereas each 1 g of caffeine contains 0.0051 moles. 
Hence a 1/1 weight ratio means a molar ratio of (66/51). The results, as shown in all 
figures, also indicate that intensity of caffeine molecular is bigger than protonated caffeine. 
This means paracetamol accepts proton easier than caffeine. There are several possible 
explanations for these results. The first reason for this may be related to pKa as mentioned 
before. The second reason could be attributed to the solubility of paracetamol and caffeine 
in the solvent. Because paracetamol is less polar than caffeine, paracetamol moves long 
with ethyl acetate on TLC plate compared to caffeine which interacts with silica gel (polar 
stationary phase) more than paracetamol. Another reason could be attributed to the amount 
of molecules per droplet in the solution of an individual and the mixtures of paracetamol/ 
caffeine. The number of moles of paracetamol in the individual and mixtures is higher than 
caffeine. For example, paracetamol 5 µg/µL contains 162 µg / 1.07 µmole, while caffeine 
5 µg/µL contains 162 µg / 0.83 µmole. Other amounts of paracetamol/caffeine mixtures 
are presented in Table 4.2. 
These findings may help us to understand that the samples can be analysed easily by 
PADI-MS, with rapid analysis of less than 30 seconds giving molecular ion information 
without strongly affecting the sample due to plasma interaction until 30 seconds. For 
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example, the sample measurement can be repeated using specific time by heating the TLC 
plate to 45 
o
C and then put the sample immediately on TLC plate and measured directly by 
PADI-MS. The temperature was measured using the exact same PADI parameters using a 
thermocouple (chromel-alumel type). The results showed that the time is likely not a major 
effect as the temperature increase is so limited, Figures 4.6 and 4.13. Thermal desorption 
requires higher temperatures to become significant, considering that neither molecule 
evaporates very easily. 
 
Figure 4. 13. Signal intensity of mixed solutions (1:1) paracetamol and caffeine (both 2.5 
µg/µL) using helium added with water vapour in 5 seconds intervals 0-5, 10-15, 20-25, 30-
35, 40-45 and 55-60 seconds. 
 
The pure and mixture solutions of paracetamol and caffeine were compared in order to 
indicate whether a matrix effect occurs. The results of this study did not show any 
significant differences in intensities for paracetamol between pure and mixture spectra, 
Figure 4.14. Although the caffeine molecular ion peak cannot be seen at m/z 194 in the 
spectra, it also did not show changes in intensities between pure and mixture solutions. 
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Figure 4. 14. PADI-MS spectra (20-500 m/z) of mixed solutions (1:1) paracetamol and 
caffeine (both 2.5 µg/µL) (a) and single paracetamol (5 µg/µL) from TLC plates using 
helium added with water vapour before separation of spots with a total acquisition time of 
1 minute. 
 
The results obtained from the analysis of paracetamol and caffeine in the mixture solution 
of Panadol are shown in Figure 4.15 a total acquisition time of 1 minute. Diagnostic peaks 
of caffeine were observed at m/z 194 for M
+
 and m/z 195 for [M+H]
+
. From the same 
PADI-MS spectrum, it can see that adduct ions of paracetamol: at m/z 152 for [M+H]
+
, at 
m/z 169 for [M+H2O]
+
, at m/z 303 for [2M+H]
+
, at m/z 304 for [2M+2H]
+2
 and at m/z 320 
for [2M+H2O]
+
. Other adduct and fragment peaks can be identified as listed in Table 4.3. 
This results indicate that the main identifying peaks here are similar to that observed of the 
pure compounds and mixture analysis, Figure 4.15. What stands out in the this Figure is 
that the ratio of components of paracetamol and caffeine in the mixture not affected on the 
identification. Mixture of paracetamol and caffeine in Panadol solution were compared 
with mixed solutions (1:1) paracetamol and caffeine, with a total acquisition time of 1 
minute, Figure 4.16. There were also big differences observed in the signal intensity of 
m/z 
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protonated paracetamol and caffeine ions. They showed that [M+H]
+
 m/z 152 is 3x more 
abundant than M
+
 m/z 194. The signal intensity of both 152 and 194 increased and reached 
a peak during ~35 seconds, after which they decreased until the end of data acquisition at 1 
minute. This is indeed similar to that used by mixed solutions (1:1) of paracetamol and 
caffeine. 
 
Figure 4. 15.PADI-MS spectrum of Panadol solution containing 50 mg/mL paracetamol 
and 6.5 mg/mL caffeine deposited on the TLC plate using helium added with water vapour 
before separation of spots with a total acquisition time of 1 minute. 
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Figure 4. 16. PADI-MS data of Panadol solution containing 50 mg/mL paracetamol and 
6.5 mg/mL of caffeine deposited on the TLC plate using helium added with water vapour 
before separation of spots with a total acquisition time of 1 minute. 
4.3.3.2. Method B: Analysis after separation of spots 
To compare the analysis with another method for detection and identification of 
pharmaceutical solutions, mixtures of paracetamol and caffeine were developed on the 
TLC plates using ethyl acetate as a solvent to obtain a better signal using the same optimal 
conditions. The second section of the analysis was concerned with depositing spots of 
paracetamol and caffeine on TLC plates and then separating these spots using ethyl acetate 
as solvent. The PADI-MS analysis was successful as it was able to identify the individual 
spots of paracetamol and caffeine which are separated on TLC plates. An increase in 
intensity was detected for pure paracetamol and caffeine solutions (both 5 µg/µL). A clear 
hydrated peak of solvent (ethyl acetate) was observed in the spectra of paracetamol and 
caffeine at m/z 106 [M+H2O]
+
, Figure 4.17. This refers to the immediate analysis of TLC 
plate after separation of spots while this peak (106) reduces on drying the TLC plate. 
Analyte spots were separated from TLC plates using ethyl acetate and then analysed 
immediately without drying by PADI-MS with, as previously an acquisition time of 1 
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minute. Diagnostic peaks for paracetamol such as [M+H]
+
 m/z 152 and [2M+H]
+
 m/z 304 
were detected, the caffeine molecular ion was also observed at m/z 194, and other peaks 
can be identified as listed in Table 4.3. However, no extra peaks for caffeine were detected. 
For example, caffeine is expected to give a fragment peak at m/z 109 M-CH3N (CO)2. 
Identification of paracetamol and caffeine spots in the mixture solutions (both 2.5 µg/µL) 
from TLC plate using PADI-MS with a total acquisition time of 1 minute is shown in 
Figure 4.18. It can be seen that a very small peak of protonated paracetamol is presented in 
the spectrum of before sampling and caffeine which we assign to contamination inside the 
mass spectrometer inlet, Figure 4.18. However, high signal intensities of protonated, 
fragment and adduct peaks of paracetamol and caffeine molecules were observed in the 
spectra after separation of spots from the same TLC plate. The results showed that 
identification of molecules‟ spots was improved after separation of spots on TLC plate 
with higher signals and lower noise. The results obtained from the different analysis times 
of paracetamol in the mixed solution (1:1) are shown in Figure 4.19. There has been a rise 
in the signal intensity of time up to ~35 seconds. These results suggest that in 5 seconds 
intervals 30-35 seconds was decided as the optimal time for the high-intensity signal of 
protonated paracetamol and the analysis can be stopped at that time. Changes in intensity 
in particular after 35 seconds may be due to that the sample can be affected by the plasma 
after this time. Changes in signal intensity of paracetamol in the mixed solutions (1:1) with 
the range of 0.01-2.5 µg/µL are presented in Figure 4.20. An increase in signal intensity of 
[M+H]
+
 m/z 152 was observed up to ~35 seconds when using 2.5 µg/µL which was 14x 
more abundant than using 0.01 µg/µL, after which they decreased by 8x up to 1 minute. 
However, with using higher concentration > 2.5 µg/µL, no increases in intensity can be 
observed. 
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Figure 4. 17. PADI-MS spectra of individual spots of paracetamol (a) and caffeine (b) 
(both 5 µg/µL) on the TLC plate after separation of spots with a total acquisition time of 1 
minute. 
 
Figure 4. 18. PADI-MS spectra of paracetamol and caffeine spots (a and b respectively) 
(both 2.5 µg/µL) on the TLC plate after separation of spots with a total acquisition time of 
1 minute. 
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Figure 4. 19. PADI-MS spectra of paracetamol spot in the mixture solution (2.5 µg/µL) on 
the TLC plate in 5 seconds intervals 0-5 (b), 30-35 (c) and 55-60 seconds (d) after 
separation of spots with a total acquisition time of 1 minute. 
 
Figure 4. 20. Signal intensity of different mixture concentrations of protonated paracetamol 
m/z = 152 measured from TLC plates after separation of spots with a total acquisition time 
of 1 minute. 
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The intensity ratio of m/z 152/195 of 1:1 mixed of paracetamol and caffeine (both 2.5 
µg/µL) was stable over the first 35 seconds, after which it decreases up to 1 minute, Figure 
4.21. It is possible, therefore, that can measure these samples using this time to get a good 
correlation without any damage of the sample. There was also an increase in signal 
intensity of diagnostic peaks of paracetamol in the mixture solution on the TLC plates after 
separation of spots up to ~35 seconds, after which they decrease up to 1 minute, Figure 
4.22. No differences between the behaviour of the intensity of paracetamol peaks and 
caffeine peaks have found before and after separation of spots on TLC plates. 
 
Figure 4. 21. Intensity ratios by a ratio of 152/195 of 1:1 mixed of paracetamol and 
caffeine (both 2.5 µg/µL) applied using TLC plate after separation of spots with a total 
acquisition time of 1 minute. 
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Figure 4. 22. Signal intensity of 1:1 mixture of [2M+2H]+2 m/z 304 and M+O-H  m/z 166 
for paracetamol (2.5 µg/µL) using TLC plate after separation of spots with a total 
acquisition time of 1 minute. 
4.3.4. Quantification 
Further experiments of the mixture solutions at lower concentrations of paracetamol and 
caffeine from TLC plates were analysed by PADI-MS. The correlation between signal 
intensity and concentration of paracetamol and caffeine was determined for the 
concentration range of 0.01 to 0.1 µg/µL in 5 seconds intervals 30-35 seconds. The 
calibration curves between peak intensity and concentrations of protonated paracetamol 
and caffeine molecular ions in the mixture solution without and after separation of spots 
are presented in Figure 4.23 and Figure 4.24. There was a positive correlation between 
signal intensity and concentrations of the mixture solutions with a very good linear 
relationship after separation of spots. 
The correlation coefficients (R
2
) values of paracetamol and the caffeine were found to be 
0.972 and 0.966 without separation of spots (Figure 4.23), 0.999 and 0.996 respectively 
136 
 
after separation of spots (Figure 4.24). The limit of detection (LOD) and limit of 
quantification (LOQ) were also determined by considering standard deviation to the slope: 
    
     
     
                                  
     
     
     
     
STEYX means the standard deviation of the y-value and x-value. 
Very promisingly, when a 1:1 mixed solution of lower concentration (both 0.01 µg/µL) 
were spotted on the TLC plate, it was not possible to identify the spot under UV light. 
Therefore, the spot was assuumed to be in the same location as after higher concentration 
experiments, and that area was analysed directly by PADI-MS. Diagnostic peaks of 
paracetamol and caffeine were detected in the 0.01 µg/µL mixture solution. This confirms 
that PADI-MS is more sensitive than UVspectroscopy as expected. 
The comparison showed significant differences between the LOD and LOQ before and 
after separation of the spots. The limits of detection for paracetamol before and after 
separation of spots were found to be 0.14 mg/mL and 15 µg/mL respectively, while for 
caffeine were 0.16 mg/mL and 49 µg/mL respectively. The limits of quantification (LOQ) 
for paracetamol before and after separation of spots were found to be 0.48 mg/mL and 50 
µg/mL respectively, while for caffeine were 0.54 mg/mL and 165 µg/mL respectively. 
These results indicate that the LOD and LOQ for paracetamol and caffeine can be 
improved when the TLC is developed by separating the spots. However, the linearity is 
limited using high concentrations of the mixture (> 0.5 µg/µL) for both before and after 
separation of spots because it causes nonlinearity including deviation in the calibration 
curve. 
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Figure 4. 23. Plot of mass spectrum intensity versus concentrations of aqueous 1:1 
paracetamol and caffeine without separation of the spots with a total acquisition time of 
30-35 seconds. 
 
Figure 4. 24. Plot of mass spectrum intensity versus concentrations of aqueous 1:1 
paracetamol and caffeine after separation of spots with a total acquisition time of 30-35 
seconds. 
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4.3.4.1. Practical evaluation 
There were differences between the results of mixture analysis using dry and wet TLC 
plates. Mixture spots of paracetamol and caffeine were  deposited on TLC plates and then 
separated using ethyl acetate as a solvent and allowed to dry for more than 30 minutes, 
prior to analysis by PADI-MS with an acquisition time of 1 minute. The results were 
inferior: the caffeine spot could not be identified in this analysis and it was also difficult to 
see all adduct and fragment peaks of paracetamol in the PADI-MS spectra. A possible 
explanation for this might be that solutions were absorbed into the porous alumino-silicate 
layer of the TLC plates during the drying. The results showed that the paracetamol 
spectrum is similar to the caffeine spectrum and no difference was observed, Figure 4.25. 
This may be due to to the solubility of paracetamol and caffeine in the solvent. 
Paracetamol moves long with ethyl acetate on TLC plate compared to caffeine which 
interacts with silica gel (polar stationary phase) more than paracetamol. Changes in signal 
intensity of paracetamol in the mixed solutions (1:1) with the range of 0.02-2.5 µg/µL are 
presented in Figure 4.26. 
There were several important differences between the results when using dry TLC plates 
and wet TLC plates to analyse a mixture of paracetamol and caffeine after separation of 
spots. With using wet TLC plates there has been a regular increase in the intensity of 
protonated paracetamol at all concentrations over interaction time up to ~35 seconds, after 
which it decreases up to 1 minute, Figure 4.20. However, an irregular behaviour of 
intensities was found with using dry TLC plates, Figure 4.26. There was a positive 
correlation between signal intensity and concentrations of the mixture solutions with a very 
good linear relationship when using wet TLC plates, Figure 4.24, while not good 
correlation between signal intensity and concentrations was found when using dry TLC 
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plates, Figure 4.27. The correlation coefficients (R
2
) values of paracetamol and the caffeine 
were found to be 0.8256 and 0.7083 respectively using dry TLC plates (Figure 4.27). 
The comparison showed differences between the LOD and LOQ using wet and dry TLC 
plates. The limits of detection using wet TLC plates were found to be 15 µg/mL for 
paracetamol and 49 µg/mL for caffeine, whereas they were 395 µg/mL and 551 µg/mL 
respectively using dry TLC plates. The limits of quantification using wet TLC plates were 
found to be 50 µg/mL for paracetamol and 165 µg/mL for caffeine, while they were 1317 
µg/mL and 1839 µg/mL respectively using dry TLC plates. That is a positive result that 
drying is not required which saves a lot of time. 
 
Figure 4. 25. PADI-MS spectra of aqueous 1:1 paracetamol and caffeine using dry TLC 
plate (both 2.5 µg/µL) after separation of spots with a total acquisition time of 1 minute. 
m/z 
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Figure 4. 26. Signal intensity of different mixture concentrations of paracetamol in aqueous 
1:1 solution measured from dry TLC plates after separation of spots with a total acquisition 
time of 1 minute. 
 
Figure 4. 27. Plot of mass spectrum intensity versus concentrations of aqueous 1:1 
paracetamol and caffeine solution after separation of spots using dry TLC plate with a total 
acquisition time of 30-35 seconds. 
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4.4. Conclusions 
PADI-MS was used in this study due to it being a sensitive technique, allowing direct 
analysis in seconds, its ease of use and in order to avoid limitations of techniques currently 
used for the analysis of mixtures in the pharmaceutical industry. This study set out to 
identify chemical components in mixture solutions of pharmaceutically relevant 
compounds on TLC plates. Paracetamol and caffeine were used as model compounds. This 
study has indicated that the PADI-MS technique is able to be used for direct analysis of 
pharmaceutical liquids using this simple substrate. The results showed that the method is 
simple, sensitive, fast and has good linearity. Small amounts of samples are required for 
analysis compared to other methods. 
The study showed that small spots containing low amounts of compounds (4 µL, which 
contained 8 ng of analyte) could easily be analysed from a TLC plate by PADI-MS without 
sample preparation in 35 seconds. Best results were achieved when immediately analysing 
the TLC plates without prior drying. In addition, the study showed that the limit of 
detection of paracetamol and caffeine using PADI detection was at least 10x better than 
using UV detection. This study has shown that a 35s acquisition was the optimal time for 
the high-intensity signal of adduct and fragment peaks for paracetamol and caffeine in the 
liquid sample. However, significantly shorter acquisition provided sufficient signal to 
identify these compounds. The results showed that identification of spots was improved 
after separation of spots on the TLC plate with higher signals and lower background. The 
intensity of protonated paracetamol (152) is 5x more abundant than caffeine molecular ion 
(194) in the mixture solution. Positive correlation was found between signal intensity and 
concentrations of the mixture solutions when measuring immediately after deposition or 
developing, but not after drying TLC plates. This might be related to the absorption of 
solution compounds into the porous alumina layer on the TLC plates. 
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The main goal of the current study was to develop a novel method that can be used for 
identification of components in complex mixtures that cannot be (conveniently) resolved 
by other methods such as chromatographic and spectroscopic techniques. Considerably 
more work needs to be carried out to detect and identify the components in mixture 
solutions from other substrates. The results of this study can be applied for identification of 
other pharmaceutical mixture solutions using TLC plates, and it also may well have a 
bearing on quantitative analysis. One of the greatest challenges for future research is the 
quantitative analysis of mixture solutions from TLC plates using this method.  
Overall, this study has found that generally, the components in a mixture can be identified 
directly from a TLC plate by PADI-MS without separation of spots (method A), and this 
can save time and solvents. However, for low concentrations of caffeine, in particular, it is 
recommended to achieve the optimal limit of detection by first separating the spots on the 
TLC plate using ethyl acetate as a solvent and then analysing the individual spots of 
paracetamol and caffeine by PADI-MS (Method B). In the experiments of this study, the 
same concentrations of 1:1 (w/w) mixed solutions of paracetamol and caffeine were used 
in the mixtures solutions. In future investigations, different concentrations and ratios of 
these mixtures should be explored in order to further investigate potential and suppression 
effects. Comparing the effect of added water vapour to the He flow, important differences 
were found. Intensities of paracetamol and caffeine in the mixture solution were noticably 
improved using this simple modification.
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CHAPTER 5: Plasma-assisted desorption ionisation 
mass spectrometry – PADI-MS for the analysis of 
pharmaceutical solids and liquids from glass slides and 
cotton swabs
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Abstract 
Compared to chapter 4, this study has identified different pharmaceutical forms (solids and 
liquids) using different substrates such as glass slides and cotton swabs. The direct mass 
spectrometric analysis of pharmaceutically relevant compounds is reported in this chapter 
using PADI-MS. Samples of paracetamol, caffeine and Panadol tablets were either 
analysed as solid clinical grade tablets, or as aqueous solutions applied to glass substrates 
or taken as swabs and analysed directly from the cotton tip. Mixtures of compounds have 
also been analysed to assess the ability of this method to provide qualitative and (semi-) 
quantitative information. The results of this study indicate that the PADI-MS technique is 
simple, sensitive, fast and suitable for analysis of pharmaceutical tablets and solutions, 
either directly from solid samples or via cotton swabs in the case of aqueous solutions. 
Calibration curves of paracetamol and caffeine were linear in the range of 10- 100 µg/mL. 
The LOD and LOQ were determined for paracetamol and caffeine in a 1:1 mixture 
solution. The LOD for paracetamol using glass slides and cotton swabs was found to be 6 
µg/mL and 5 µg/mL, while for caffeine it was found to be 22 µg/mL and 18 µg/mL 
respectively. The LOQ for paracetamol using glass slides and cotton swabs found to be 29 
µg/mL and 12 µg/mL, while for caffeine was found to be 96 µg/mL and 42 µg/mL 
respectively. Results highlight difference between the use of glass slides and cotton swabs 
as substrates for analysis of these compounds by PADI-MS. The signal intensity of 
paracetamol analysed directly from cotton swabs was higher than that found when using 
glass slides, although the opposite case was found for caffeine indicating a substrate 
dependence on sampling. Cotton swabs have been found to be more practical than glass 
slides due to being easiest in use. Both substrates are inexpensive, with the method being 
demonstrated as a rapid means to easily analyse samples with no need for any sample 
preparation. 
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5.1. Introduction: 
Direct and rapid analysis of compounds giving chemical information would be of major 
benefit in the preparation of samples where reaction mixtures need to be process 
monitored. This is particularly interesting for the pharmaceutical industry during synthesis, 
as well as in forensics for investigation of unknown samples. Real-time analysis giving 
molecular data, e.g. by mass spectrometry, without the need for any sample preparation 
and which can be carried out by a non-expert would be a major addition in key industrial 
processes. For example, paracetamol tablets containing 500 mg paracetamol per tablet 
must be monitored to ensure raw material quality and quantity, that of intermediates found 
in reaction and product mixtures. Qualitative analysis of paracetamol in the tablets is 
necessary to confirm that the tablets contain the same correct component, while a 
quantitative analysis is important to determine the content of paracetamol (1). Paracetamol 
and caffeine, as mentioned in Chapter 4, are amongst widely used groups of analgesic 
drugs by humans. 
Over the past years, there has been a dramatic increase in the analysis of pharmaceutical 
solids using analytical techniques such as nuclear magnetic resonance (NMR), near 
infrared (NIR), Fourier transformed infrared (FTIR) and Raman spectroscopy (2). As 
mentioned in the previous chapter, high-performance liquid chromatography (HPLC) is 
still the most used method in pharmaceutical analysis. A HPLC method has been 
developed for separation and quantification of a mixture of paracetamol, caffeine and 
chlorphenamine using a C18 column and the mobile phase consists of methanol and 
potassium phosphate (45:55 v/v) (3). HPLC has also been used to separate and determine 
a multi mixture components of pharmaceuticals including dextromethorphan and 
diphenhydramine hydrochloride on an ODS column using an isocratic method (4). HPLC 
using a gradient method has been developed for measurement of dextro-propoxyphene 
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with other combination components such as paracetamol, caffeine and aspirin in tablet and 
capsule formulations with a run time of 23 minutes (5). A HPLC method was described to 
determine three pharmaceutical compounds (paracetamol, caffeine and chlorpheniramine) 
in a tablet formation using on a Hypersil CN column and the mobile phase was a mixture 
of acetonitrile, an ion-pair solution and tetrahydrofuran (13:14:87 v/v) (6). In the study by 
Franeta et al., and Sawyer et al., HPLC has also been used to determine the mixture 
components including paracetamol, caffeine and aspirin in tablet formulations and 
effervescent tablets on a C18 column using a mixture of acetonitrile-water (25:75 v/v) and 
water-methanol-acetic acid respectively as a mobile phase (7, 8). However, there are 
obvious limitations in terms of necessary sample preparation, solution only sampling, the 
length of time needed for sampling, lack of inherent molecular information and the need 
for trained laboratory staff for HPLC sampling. Although HPLC is an important analysis 
technique with good limits of detection for compounds such as paracetamol and caffeine, 
these drawbacks accumulate to make this method very costly. 
Mass spectrometry is an analytical method which has unique abilities to detect a wide 
range of chemical species at low concentrations, reaching to 10
-12
 g. Due to its high 
sensitivity, rapid analysis, the need for small sample amounts, and ability to directly 
measure molecular weight hyphenated mass techniques such as liquid chromatography-
mass spectrometry (LC-MS) (9), gas chromatography-mass spectrometry (GC-MS) (10, 
11) and high-performance liquid chromatography connected with a tandem mass 
spectrometry (HPLC-MS/MS) (12, 13) are fast becoming key tools in pharmaceutical 
analysis. These hyphenated techniques support pharmaceutical development and ensure the 
quality and safety of pharmaceuticals. They have also been used for isolating and screening 
of new natural compounds for pharmaceutical application (14). However, work-up 
procedures such as extraction, filtration, and separation are required when using these 
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techniques (15). There have been several mass techniques used for online monitoring of 
compounds in many fields including biological and environmental such as  proton transfer 
reaction mass spectrometry (PTR-MS) (for more details see Chapter 1). 
Recently, there has been renewed interest in ambient mass spectrometry (AMS) for 
chemical qualitative analysis. In the AMS techniques, samples are desorbed and ionised 
directly from sample surfaces under atmosphere pressure, with the ions being directly 
generated outside the necessary vacuum of the MS itself. Methods of AMS have been 
divided into three categories based on ionisation mechanisms (16): spray methods such as 
DESI, EASI, EESI and PS; plasma methods such as DART, LTP and PADI and laser 
methods such as ELDI and LAESI. Desorption and ionisation can occur for all these 
methods. The detection of produced ions using DESI is similar to that used by DART, but 
DESI uses a solvent as a source to ionise the molecule, while DART uses a stream of gas 
(helium or nitrogen) (for more details see Chapter 2). However, these methods have some 
limitations. For example, the spray solvents in DESI make this method a bit chaotic (17), 
and DESI spectra need more investigation to draw the right analytical conclusions. The 
lack of a separation in DART causes lower detection selectivity and this makes this 
technique more vulnerable to false finding (18), and it is an expensive technique. In 
addition, the analysis of polymers is still not well known using DART (19). Analysing 
compounds using DESI and DART mostly depends on the matrix and this yields a lack of 
quantification abilities. 
The work presented here demonstrates the use of PADI analysis directly from glass slides 
and cotton swabs, using paracetamol and caffeine as models for pharmaceutically relevant 
mixtures. Mixed standard solutions and off-the-shelf pain relief pharmaceuticals were 
investigated as test samples, Panadol
 
and paracetamol, along with caffeine which is often 
used as an additive to increase pharmaceutical delivery in the body. Paracetamol and 
152 
 
caffeine were used as model drugs in this study due to their direct clinical relevance as 
small drug molecules. This study has been divided into three parts: the first part deals with 
the direct analysis of paracetamol, caffeine and Panadol tablets using PADI-MS and the 
second part examines the identification of individual and mixture solutions of paracetamol 
and caffeine from glass slides. The remaining part of the study shows the identification of 
these compounds using cotton swabs as a different substrate, with the intention that this 
sampling method will be relevant as a common sampling method. 
The specific aim of this study was to develop a novel, simple, fast, sensitive and cost-
effective analytical method that can be used for identification of unknown components in 
pharmaceutically relevant tablets and solutions using different types of substrates. This will 
help to avoid the potential problems of using the traditional methods for pharmaceutical 
analysis. In this Chapter, the objectives used to reach some conclusions about this 
sampling method were: 
1) Use glass slides and cotton swabs to present solution samples to PADI-MS. 
2) Assess limits of detection and quantification for each combination of above. 
5.2. Materials and methods 
5.2.1. Apparatus: 
In the PADI-MS instrumentation, a single quadrupole (Waters Micromass ZQ, 
Manchester, UK) was used with the front end removed to accept an in-house built Stoffels-
design plasma pencil as ionisation source using a 13.56 MHz RF power supply (20). The 
plasma pencil was fabricated to provide coaxial dual gas flow: an inner ceramic tube was 
encompassed within a quartz glass tube. Helium gas was flown through both tubes 
controlled using separate flow meters. The schematic diagram of the PADI probe and 
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source in operation is shown in Figure 8 in Chapter 1. The flow inside the ceramic tube 
will henceforth be referred to as „inner flow‟, the flow between the ceramic and quartz tube 
as „outer flow‟. The measurement conditions of plasma were optimised for all samples in 
this study and using water (for more information see Chapter 3). The effect of water on 
ionisation efficiency was investigated by flowing the helium through a water vapour added 
environment before the plasma pencil being directed to the plasma pencil outflow (for 
more information see Chapter 2). 
5.2.2. Chemicals and materials: 
Panadol Extra
TM
 tablets containing 500 mg paracetamol and 65 mg caffeine per tablets 
were used as obtained from an over the counter pharmacy. Paracetamol tablets containing 
500 mg paracetamol per tablet and Pro Plus tablets containing 50 mg caffeine were 
purchased from the Body Care shop. The paracetamol tablets containing 500 mg 
paracetamol per tablet were manufactured by Galpharm International Ltd, UK. Pro Plus 
tablet containing 50 mg caffeine is a registered trademark. Pure paracetamol was 
manufactured by Alfa Aesar, UK (purity 98%), and pure caffeine was manufactured by 
Acros Organics, China (purity 98%). Helium gas was supplied by British Oxygen 
Company (BOC) gases, UK (purity 99%). Deionised water was provided through a Pure 
Lab Option ELGA, with the resistivity 18 MΩ, Model Ultra Clear TWF UV. Standard 
glass microscope slides and cotton swabs were supplied by Fisher Scientific, UK. 
5.2.3. Preparation of sample solutions: 
Panadol solutions were prepared by dissolving 1 Panadol Extra tablet in 10 mL deionised 
water. A range of high purity paracetamol and caffeine solution concentrations of 0.02 - 5 
µg/µL were prepared by dissolving the solutes in deionised water. Paracetamol and 
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caffeine mixtures were prepared by mixing 2 mL of equally concentrated solutions. These 
were all freshly made prior to use. 
5.2.4. Procedure: 
1- Pure paracetamol, pure caffeine, paracetamol tablet (500 mg), Pro Plus tablet 
containing 50 mg caffeine and Panadol tablets were analysed directly by PADI-MS. 
2- Standard microscope glass slides were used for all analysis. 
3- One drop of single paracetamol and single caffeine (both 5 µg/µL) and Panadol 
tablet solutions (50 mg/mL paracetamol+6.5 mg/mL caffeine) were deposited on 
the glass slide using a Pasteur pipette (for more details see Chapter 4). The 
deposition spot of individual and paracetamol/caffeine mixtures on the glass slide 
was analysed immediately by PADI-MS with a total acquisition time of 1 minute. 
4- Samples analysed using cotton swabs were taken by dipping the cotton tip into a 
solution of an individual solutions and paracetamol/caffeine mixtures and analysed 
immediately by PADI-MS with a total acquisition time of 1 minute using the same 
conditions above. 
To investigate the potential effects that such heating causes on the sample during the 
analysis, and indeed the quality of mass spectral data obtained, thermal imaging was 
conducted (for more details see Chapter 3). 
5.3. Results and discussion: 
5.3.1. Method development and optimisation of PADI-MS conditions 
Sampling using the PADI probe was optimised for each type of sample and substrate 
combination. Optimised conditions used to analyse all samples (individual and 
paracetamol /caffeine mixtures in liquid) are presented in Table 5.1. 
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Table 5. 1. The optimal conditions of PADI probe for analysing of individual and 
paracetamol /caffeine mixtures in liquid. 
PADI parameters Optimised conditions 
Plasma power 8W 
Inner flow rate (He) 224 mL/min 
Sample – plasma distance 5 mm 
Outer flow composition He with water vapour 
Outer flow rate 224 mL/min 
 
The gas phase is formed by the reaction between the helium and water and then produce 
H3O
+
, and then H3O
+
 reacts with a molecule (M) to form protonated molecular (MH
+
) (20) 
(for more details see Chapter 4). 
5.3.2. Analysis of pure and tablets 
The first part of analysis studied the detection and identification of pure and 
pharmaceutical tablets using the optimised conditions for PADI-MS as outlined in Section 
5.4.1. Changes in signal intensity of the sample tablets with time were compared to that 
measured in the sample solutions. Pure paracetamol and pure caffeine were analysed 
directly using PADI-MS. 
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Figure 5. 1. PADI-MS spectra of background (a) and pure paracetamol (b) with a total 
acquisition time of 1 minute. 
 
Figure 5. 2. PADI-MS spectra of background (a) and pure caffeine (b) with a total 
acquisition time of 1 minute. 
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Figure 5. 3. PADI-MS signal intensity for [M+H]+ in pure paracetamol. 
 
Figure 5. 4. PADI-MS signal intensity for [M+H]+ in pure caffeine. 
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Paracetamol, caffeine and Panadol tablets were used as pharmaceutically relevant models. 
Paracetamol (500 mg) and Panadol (500 mg paracetamol and 65 mg caffeine) tablets were 
analysed directly using PADI-MS. Even though the paracetamol molecular ion M
+
 m/z 151 
was detected, protonated paracetamol [M+H]
+
 at m/z 152 was more abundant and easy to 
see in all spectra. As can be seen, from Figure 5.5, stable and high signal intensity of 
protonated paracetamol in both paracetamol and Panadol tablets were observed at [M+H]
+
 
m/z 152 (spectrum a and spectrum b). Another diagnostic spectral feature relating to the 
paracetamol molecular ion was observed at [2M+2H]
+
 m/z 304. The diagnostic peak M+O-
H m/z 166 could be assigned either to M+O-H or to M+NH (with nitrogen reacting from 
the air during plasma treatment), but it is most likely identified as M+O-H due to the 
paracetamol molecule gaining the hydroxyl group from the water vapour. Higher mass 
accuracy would be required to further interrogate this. Small diagnostic peaks were also 
observed relating to the caffeine molecular ion at M
+
 m/z 194, M
+
 - CN m/z and M
+
 + H2O 
m/z 212. Further diagnostic peaks of paracetamol and caffeine were identified as listed in 
Table 5.2. The results have compared 'no sample' which was taken before sampling to 
spectra taken 'with sample' in the plasma plume (Figure 5.5). No sample spectrum shows a 
little of the sample but this is fairly low level, and this may be due to contamination of the 
sniffer tube. To resolve this problem, the sniffer tube was cleaned several times to 
minimise contamination effects. 
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Figure 5. 5. PADI-MS spectra of (a) Panadol tablet containing 500 mg paracetamol and 65 
mg caffeine; (b) paracetamol tablet containing 500 mg paracetamol; (c) no sample with a 
total acquisition time of 1 minute. 
 
Table 5. 2. Diagnostic peaks for paracetamol and caffeine. 
Diagnostic peaks for 
paracetamol 
m/z Diagnostic peaks for 
caffeine 
m/z 
[M+H]
+
 152 M
+
 194 
M+O-H or M+NH 166 [M
 
+ H2O]
+
 212 
CO + [M+H]
+
 180   
[2M+H2O]
+
 - (COCH3)2 234   
[2M+H2O]
+
 - COCH 279   
[2M+2H2O]
+
 - COCH2 296   
[2M+2H]
+
 304   
 
m/z 
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5.3.2.1. Plasma-sample interaction time 
The length of interaction time between the visible plasma and sample is important in order 
to get a good signal and more information on molecules. Figure 5.6 shows the 
experimental data of intensity signal versus time in 5 seconds intervals (0-5 sec, 0-15 sec, 
0-25 sec, 0-35 sec, 0-45 sec, 0-60 sec) of 500 mg protonated paracetamol in a paracetamol 
tablet. It can be seen from the data in Figure 5.6 that the [M+H]
+ 
of paracetamol increases 
in intensity over an interaction time up to ~35 seconds, after which it decreases up to 1 
minute. As shown in Figure 5.6, 5 seconds intervals at 30-35 seconds was decided as the 
optimal time for the high-intensity signal of protonated paracetamol and the analysis can 
be stopped after that time. 
 
Figure 5. 6. Signal intensity of [H+M]+ in paracetamol tablet versus time upon binning of 
data in 5 seconds intervals up to a total acquisition time of 60 seconds. 
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To investigate the heating causes on the sample during the analysis, the temperature was 
measured using the exact same PADI parameters using a thermal camera by interacting the 
visible plasma with a tablet (21). The temperature in the middle of the paracetamol tablet 
was measured for 5 minutes. The temperature increased dramatically to 75 
o
C at 45 
seconds, after which it increased slowly to 80 
o
C at 1 minute, and then dropped to 36
 o
C 
until 5 minutes. This indicated why the [M+H]
+
 peak for paracetamol increased in intensity 
up to ~ 45 seconds, after which it decreased up to 1 minute. Little thermal changes could 
be detected within the area of the substrate exposed to the plasma, although sample heating 
does occur slowly up to a maximum of ~45 
o
C after ~30 seconds interaction. The 
behaviour of other fragments and adduct peaks of paracetamol with interaction time were 
also investigated. According to these data, we can see that all intensity signals have the 
same behaviour during analysis time. Diagnostic peaks relating to caffeine molecular ion 
were observed at M
+
 m/z 194, and [M+H2O]
+
 m/z 212 (Figure 5.5). Figure 5.7 provides the 
experimental data of both protonated paracetamol and caffeine molecules in a Panadol 
tablet. 
Results demonstrate that [M+H]
+
 m/z 152 and M
+
 m/z 194 peaks both increase in intensity 
over the first 25 seconds of plasma-sample interaction, after which they decrease; here we 
recorded up to 60 seconds. These results match those observed in earlier experiments of 
the paracetamol tablet (Figure 5.6), and there is no difference between the measurement of 
paracetamol presented in a tablet (with formulation compounds) and in when presented in 
a mixture of caffeine in a Panadol tablet (Figure 5.7). The reason for this is that the 
percentage of concentration (w/w) for paracetamol in the paracetamol tablet is 87 % by 
dividing the content of paracetamol in the tablet on the weight of tablet (500 mg/570 mg), 
while it is 77 % for paracetamol in the Panadol tablet by dividing 500 mg/694 mg. There 
were also big differences observed in the signal intensity of protonated paracetamol and 
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caffeine ions. They showed that [M+H]
+
 m/z 152 is 7x more abundant than M
+
 m/z 194. 
As shown in Figure 5.7, the behaviour of the intensity of [M+H]
+
 m/z 152 in Panadol tablet 
over time is similar to that of caffeine molecular ion. Data collected suggests that a 
minimum time of plasma interaction for good ion signal to be collected is only ~15 
seconds, with an only limited change in intensity up to 30 seconds. The results from the 
data in Figure 5.7 suggest that 15 seconds is enough to see these molecules without the 
need to wait until 1 minute. 
 
Figure 5. 7. Signal intensity of [H+M]+ (m/z = 152; left y-axis) and caffeine ions (m/z = 
194; right y-axis) in a Panadol tablet versus time with a total acquisition time of 1 minute. 
 
Optimised PADI-MS conditions were used for the analysis of a ProPlus tablet containing 
50 mg caffeine with no paracetamol (Figure 5.8). Findings are similar to Figure 5.6 (up to 
30 seconds ion intensity not much change - which is good). The percentage of 
concentration (w/w) for caffeine in Pro Plus tablet is 30 % by divided the content of 
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caffeine in the tablet on the weight of tablet (50 mg/164 mg), while it is 10 % for caffeine 
in the Panadol tablet by dividing 65 mg/694 mg. Therefore, the intensity signal of caffeine 
in the Pro Plus tablet expected to be 3x higher than that in Panadol tablet, but they are 
similar as shown in Figures 5.7 and 5.8. This may be due to caffeine amount distributed as 
an active ingredient in the sample, making the actual sampled volume of caffeine small in 
relation to previous tests, or that the Panadol tablet can be measured easier than the Pro 
Plus tablet and this can be related to the physics natural of Pro Plus tablet. On the other 
hand, additional to the caffeine molecular ion peak at M
+
 m/z 194, protonated caffeine 
[M+H]
+
  was observed at m/z 195 in the Pro Plus tablet (Figure 5.8). 
 
Figure 5. 8. Signal intensity of caffeine molecular ion in Pro Plus tablet contains 50 mg 
versus time caffeine with a total acquisition time of 1 minute. 
 
The results obtained from the different measurements of paracetamol in the Panadol tablet 
are shown in Figures 5.9 and 5.10. Comparing the two results, it can be seen that the 
analysis of protonated paracetamol in 5 second intervals (Figure 5.9) is in agreement with 
 
 
[M+H]
+
 =195 
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that used by accumulated seconds (Figure 5.10). There has been a rise in the signal 
intensity of protonated paracetamol linearly over accumulated time up to ~35 seconds, 
after which they deviate slightly up to 1 minute, Figure 5.10. These results provide further 
support for the intensity behaviour of molecules that increase up to ~35 seconds. 
 
Figure 5. 9. Signal intensity of protonated paracetamol in Panadol tablet in 5 seconds 
intervals 0-5, 5-10, 10-15, 15-20, 20-25, 25-30, 30-35, 35-40, 40-45, 45-50, 50-55 and55-
60 seconds. 
 
Figure 5. 10. Signal intensity of protonated paracetamol in Panadol tablet in accumulated 
seconds 0-5, 0-10, 0-15, 0-20, 0-25, 0-30, 0-35, 0-40, 0-45, 0-50, 0-55 and 0-60 seconds. 
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5.3.3. Analysis of individual compounds/mixtures from glass slides 
The analysis presented here demonstrates the use of PADI analysis directly from glass 
slides, using individual compounds and mixtures of paracetamol/caffeine as models for 
pharmaceutically relevant mixtures. Paracetamol, caffeine and Panadol aqueous solutions 
over a range of concentrations were deposited on a glass slide and analysed immediately 
(without the need to dry) by PADI-MS using the optimal conditions as described in Section 
5.3.1. High purity single component and mixed solutions (1:1) were used as a standard to 
optimise conditions. Changes in intensity with time were compared using initial analysis of 
pure paracetamol and caffeine solutions (both 5 µg/µL) which were measured separately 
from glass slides using He added with water vapour in time upon binning of data in 5 
seconds intervals. The experimental data of protonated paracetamol and the caffeine 
molecular ion (both 5 µg/µL) are presented in Figure 5.11. The signal intensities of 
protonated paracetamol and caffeine molecular ions increased by 1.2x for both, reaching a 
peak at up to ~35 seconds for protonated paracetamol and caffeine molecular ions. The 
intensity of protonated paracetamol ([M+H]
+
 m/z 152) was 3x higher compared to that of 
the caffeine molecular ion (M
+
 m/z 194) until the end of acquisition time of 1 minute. The 
results found dramatic differences in the intensity of protonated paracetamol and caffeine 
molecular ions between tablets and solutions to be ~ 8x and 3x respectively. 
The intensity of M
+
 for the caffeine was normalised to the intensity of [M+H]
+
 for 
paracetamol and [M+H]
+
 for caffeine in order to show the plasma effect for both intensities 
over interaction time, Figure 5.12. The ratio of intensity signal of m/z 152/194 of pure 
paracetamol and caffeine solutions (both 5 µg/µL) over time using outer He added with 
water vapour are shown in Figure 5.12. As can be seen from this Figure, this ratio is stable 
over the first 25 seconds, after which it increases up to 45 seconds then stable to 1 minute. 
From this, we can see that there is no difference in signal intensity between ([M+H]
+
 m/z 
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152) for paracetamol and (M
+
 m/z 194) for caffeine molecular ion in the beginning of 
analysis time, after which it increases to 60 seconds. These findings may help us to 
understand that the samples can be analysed easily by PADI-MS, with rapid analysis of 
less than 30 seconds giving molecular ion information without strongly affecting the 
sample due to plasma interaction until 30 seconds. This may be attributed to either thermal 
desorption of analytes from the surface, degradation or continued excitation of analytes on 
the surface or in the gas phase. The ratio of the intensity signal (m/z 194/195) remains 
steady over the first 35 seconds, after which it reduces to 1 minute. This may be due to that 
the intensity of 194 has decreased more than 195 after 35 seconds, Figure 5.13. 
 
Figure 5. 11. Signal intensity of single paracetamol and caffeine (both 5 µg/µL) using glass 
slide with a total acquisition time of 1 minute. 
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Figure 5. 12. Signal intensity ratios of paracetamol and caffeine solutions (m/z 152/194) 
(both 5 µg/µL) applied from the glass slide and measured separately using outer He added 
with water vapour in 5 seconds intervals 0-5, 10-15, 20-25, 30-35, 40-45 and 55-60 
seconds. 
 
Figure 5. 13. Signal intensity ratios of single protonated caffeine and pure caffeine 
molecular ion solutions by a factor of (m/z 194/195) (both 5 µg/µL) applied from glass 
slide using added with water vapour in 5 seconds intervals 0-5, 10-15, 25-30, 30-35, 40-45 
and 55-60 seconds. 
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Spectra of 1:1 by weight mixtures of paracetamol and caffeine (0.01 µg/µL and 0.1 µg/µL) 
were compared, with acquisition time 30-35 seconds, Figure 5.14. Two diagnostic ions 
relating to the paracetamol molecular ion were observed at [M+H]
+
 m/z 152 and 
[2M+2H]
+2
 m/z 304. Further diagnostic peaks are very similar to what has been described 
in Table 5.2. The signal intensities of paracetamol/caffeine mixtures were higher when 
using 0.1 µg/µL compared to that used by 0.01 µg/µL. Additional diagnostic peaks of these 
compounds were found when using a higher concentration of solutions, such as M-CCH3 
m/z 124 and M-H+2H2O m/z 186. As expected higher concentrations give rise to spectra 
with higher ion intensities and therefore present more opportunity for lower intensity ions 
to be observed above the noise. PADI-MS analysis of aqueous 1:1 mixtures of paracetamol 
and caffeine (both 2.5 µg/µL) deposited onto a glass slide showed differences of intensity 
behaviour between protonated paracetamol and caffeine molecular ion over time, Figure 
5.15. An increase in signal intensity of protonated paracetamol and the caffeine molecular 
ions was observed up to ~35 seconds ([M+H]
+
 m/z 152 is 4x more abundant than M
+
 m/z 
194), after which they decreased up to 1 minute. The results obtained from the PADI-MS 
analysis of a Panadol solution with an acquisition time of 1 minute is shown in Figure 5.16. 
Diagnostic, adduct and fragment peaks are apparent, such as M-CCH3 m/z 124, [M+H]
+
 
m/z 152, M+O H m/z 166 and [2M+2H]
+
 m/z 304 for paracetamol, and M
+
 m/z 194 for 
caffeine. Other diagnostic peaks of paracetamol and caffeine can be identified as listed in 
Table 5.2. 
Important differences between the Panadol solution and aqueous 1:1 mixtures showed 
increased the signal intensity of protonated paracetamol and caffeine molecular ions being 
much higher for Panadol. This is due to the concentration differences: the concentrations of 
paracetamol and caffeine in the Panadol solution were 50 µg/µL and 6.5 µg/µL 
respectively, control solutions of individual components were each 2.5 µg/µL. Figure 5.14 
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shows very high intensity of protonated paracetamol compared to those that of the caffeine 
molecular ion. The results showed there was a more intense signal of protonated 
paracetamol in comparison with caffeine molecular ion and protonated caffeine ions, 
Figures 5.11 and 5.15.  
The observed increase in the intensity of paracetamol in tablets, pure and mixture solutions 
could be attributed to pKa effect. The pKa for paracetamol and caffeine are 9.5 and 14 
respectively, therefore, caffeine is more basic than paracetamol. Although caffeine would 
be expected to give the high-intensity signal, paracetamol can gains proton easier and gives 
a higher signal. This maybe due to the fact that caffeine did not desorb enough like 
paracetamol. Another contributing factor might be related to the molecular mass of each 
compound. The molecular mass for paracetamol is 151 g/mol while for caffeine is 194 
g/mol, hence a 1/1 weight ratio means a molar ratio of 1.3 (for more details see Chapter 4). 
The results, as shown in all figures, also indicate that intensity of the caffeine molecular 
ion is bigger than protonated caffeine. This means paracetamol accepts proton easier than 
caffeine. There are several possible explanations for these results. The first reason for this 
may be related to pKa as mentioned before. The second reason could be attributed to the 
amount of molecule per droplet in the solution of an individual and the mixtures of 
paracetamol/ caffeine. For example, the number of moles of paracetamol in the individual 
and mixtures is higher than of caffeine (for more details see Table 5.1). The results also 
showed that the intensity signal of protonated paracetamol and caffeine molecular ion 
given by the aqueous 1:1 mixture (both 2.5 µg/µL) is similar to that used by the single 
compounds (both 5 µg/µL). This shows that the matrix of analytes does not affect on the 
results whether individual or mixtures of compounds have been used. The intensity ratio of 
m/z 152/195 of 1:1 mixture of paracetamol and caffeine (both 0.1 µg/µL) was stable until 
35 seconds, after which it increases up to 1 minute, Figure 5.17. This factor may explain 
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the relatively good correlation in intensity between [M+H]
+
 m/z 152 and [M+H]
+
 m/z 195 
until 35 seconds of analysis time, and the sample can be affected by plasma after this time. 
 
Figure 5. 14. PADI-MS spectra of 1:1 mixed of paracetamol and caffeine of 0.1 µg/µL (a), 
0.01 µg/µL (b) and no sample (c), using glass slide with a total acquisition time of 1 
minute. 
 
Figure 5. 15.Signal intensity of an aqueous 1:1 mixture of paracetamol and caffeine (both 
2.5 µg/µL) using a glass slide with a total acquisition time of 1 minute. 
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Figure 5. 16. PADI-MS spectra of background (a) and Panadol solution (b) using a glass 
slide with a total acquisition time of 1 minute. 
 
Figure 5. 17. Signal intensity ratio by a factor of 152/195 of 1:1 mixed of paracetamol and 
caffeine (both 0.1 µg/µL) applied using glass slides and measured in 5 seconds intervals 0-
5, 10-15, 20-25, 30-35, 40-45 and 55-60 seconds. 
 
 
m/z 
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a 
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5.3.4. Analysis of mixtures from cotton swabs 
To compare the glass slide with another substrate to analyse paracetamol and caffeine 
solutions, a cotton swab was used. A cotton swab was chosen in this study for several 
reasons such as low cost, convenience, an absorbance of liquids and to obtain a better 
signal. In this part of the analysis, individual solutions and mixtures of paracetamol 
/caffeine were analysed by PADI-MS using a cotton swab as a substrate with the same 
optimal conditions as described in Section 5.4.1. In this part, the same solutions were used 
to those used with glass slides. In the optimised analysis, a cotton swab was dipped in each 
sample solution of pure paracetamol and caffeine (both 5 µg/µL) and then measured by 
PADI-MS with a total acquisition time of 1 minute. 
The experimental data of intensity signals for these pure compounds over time are 
presented in Figure 5.18. The intensity of protonated paracetamol is higher than the 
caffeine molecular ion. This may be attributed to either thermal desorption of analytes 
from the surface, degradation or continued excitation of analytes on the surface or in the 
gas phase. The intensity of protonated paracetamol and caffeine molecular ions increased 
by 1.3x and 1.2x respectively, reaching a peak up to ~35 seconds, after which the 
difference between these intensities decreases to 1x for both until the end of data 
acquisition to 1 minute. These results are in agreement with glass slides finding which 
showed the same behaviour of intensities for these compounds over time. However, the 
intensity signals of protonated paracetamol and the caffeine molecular ion using a cotton 
swab (Figure 5.18) are higher than that given by the glass slide (Figure 5.11). 
The simple analysis was used to analyse the relationship between a factor of m/z 194/195 
of pure caffeine solution (5 µg/µL) and analysis time. This intensity ratio is relatively 
constant over the first 25 seconds, and after which it drops and remains stable until the end 
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of data acquisition at 1 minute, Figure 5.19. The results indicate that the signal intensity of 
the caffeine molecular ion (M
+ 
m/z 194) is still higher than protonated caffeine ([M+H]
+
 
m/z 195). The results also indicate that there were no changes in intensities between these 
ions of caffeine in the first 25 seconds of analysis. The behaviour of the intensity ratio of 
m/z 194/195 used by the cotton swab (Figure 5.19) is similar to that used by glass slide 
(Figure 5.13). 
 
Figure 5. 18. Signal intensity of single paracetamol and caffeine (both 5 µg/µL) using 
cotton swabs with a total acquisition time of 1 minute. 
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Figure 5. 19. Signal intensity ratios by a factor of (m/z 194/195) of single caffeine 
molecular ion and single protonated caffeine solutions (both 5 µg/µL) applied from cotton 
swabs using added with water vapour in 5 seconds intervals 0-5, 10-15, 20-25, 25-30, 30-
35, 35-40 and 45-50 seconds. 
 
1:1 Mixtures of paracetamol and caffeine solutions with concentrations in the range of 
0.01-2.5 µg/µL were prepared and analysed from cotton swabs using PADI-MS with 
acquisition time up to 60 seconds. As shown in Figure 5.20, two diagnostic peaks relating 
to paracetamol molecular ion were observed at [M+H]
+
 m/z 152 and [2M+2H]
+
 m/z 304. 
Other adduct peaks of the paracetamol were observed at M+O-H m/z 166 or M+NH, 
[M+H]
+ 
+ CO m/z 180, M-H+2H2O m/z 186, [M+2H2O]
+
 m/z 187, [2M+H2O]
+2
 - 
(COCH3)2 m/z 234, [2M+H2O]
+
 - COCH m/z 279 and [2M+2H2O]
+
 - COCH2 m/z 296. 
However, one peak that relates to the caffeine molecular ion was observed at M
+
 m/z 194, 
and another adduct peak was observed at M-2H+O at m/z 208. As expected, intensity 
signals of all diagnostic, adduct and fragment peaks using high concentrations of 
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paracetamol and caffeine (both 2.5 µg/µL) are higher than using low concentrations (both 
0.01 µg/µL). For example, the signal intensities of 152 and 194 using 2.5 µg/µL are higher 
5x and 1.5x respectively than using 0.01 µg/µL. Compared to a glass slide, the intensity 
signals of protonated paracetamol and caffeine molecular ion tend to be higher with the 
0.01 µg/µL using a cotton swab. 
The results indicated that paracetamol and caffeine peaks can be detected and identified 
even at low concentration of mixture solution (0.01 µg/µL), Figure 5.21. The signal 
intensity of protonated paracetamol in all mixture concentrations (0.01- 0.1 µg/µL) 
increased and reached a peak at 35 seconds, after it they decreased up to 1 minute. The 
results also showed that the behaviour of intensities over time for protonated paracetamol 
in the mixtures is quite similar to that found with TLC plates after separation of spots, but 
it was higher when using a cotton swab than TLC plate (see the results in Chapter 4). 
 
Figure 5. 20. PADI-MS spectra of 1:1 mix with paracetamol and caffeine of (a) 2.5 µg/µL, 
(b) 0.01 µg/µL and (c) blank using cotton swabs with a total acquisition time of 1 minute. 
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Figure 5. 21. Signal intensity of various concentrations of paracetamol in mixture solutions 
from cotton swabs with a total acquisition time of 1 minute. 
 
Intensity signal ratios by a factor of m/z 152/195 of the mixture solution of paracetamol 
and caffeine (both 2.5 µg/µL) applied from cotton swabs using added water vapour in 5 
seconds intervals 0-5, 10-15, 20-25, 30-35, 40-45, 55-60 were plotted. Further analysis was 
used to analyse the ratios of signal intensity by a factor of m/z 152/195. 1:1 Mixture of 
paracetamol and caffeine solution (both 2.5 µg/µL) was used as a model to investigate this 
ratio. No difference was found in this ratio over the first 25 seconds, after which it 
decreased up to 60 seconds, Figure 5.22. The behaviour of the intensity ratio of m/z 
152/195 used by the cotton swab (Figure 5.22) was similar to that used by glass slide 
(Figure 5.17). 
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Figure 5. 22. Signal intensity ratios by a factor of m/z 152/195 of the mixture of 
paracetamol and caffeine solution (both 2.5 µg/µL) applied from cotton swabs using added 
with water vapour in 5 seconds intervals 0-5, 10-15, 20-25, 30-35, 40-45 and 55-60 
seconds. 
 
PADI-MS analysis of a 1:1 mixture of paracetamol and caffeine solution (both 2.5 µg/µL) 
in 5 second intervals with a total acquisition time of 1 minute using cotton swabs are 
presented in Figure 5.23. The main characteristics of the diagnostic, adduct and fragment 
peaks of paracetamol and caffeine can be identified as listed in Table 5.2. The intensity of 
M
+
 m/z 194 for the caffeine and M-CCH3 m/z 124, [M+H]
+
 m/z 152 diagnostic M+O-H 
m/z 166 for paracetamol increased over time, reaching a peak up to ~ 45 seconds, after 
which they decreased up to 1 minute, and this is consistent with the results that are shown 
in Figure 5.24. This indicates the length of analysis time up to ~ 45 seconds is the best time 
to get good spectra and the analysis can be stopped after this time. 
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Figure 5. 23. PADI-MS spectra of a 1:1 mixture of paracetamol and caffeine (both 2.5 
µg/µL) in 5 seconds intervals 0-5 (a), 10-15 (b), 20-25 (c), 30-35 (d), 40-45 (e) and 55-60 
seconds (f) using cotton swabs. 
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Figure 5. 24. Signal intensity of diagnostic peaks of a paracetamol/caffeine mixture (both 
2.5 µg/µL) applied using cotton swabs and measured in 5 seconds intervals 0-5, 10-15, 20-
25, 30-35, 40-45 and 55-60 seconds. 
 
A mixture solution of Panadol tablet containing different concentrations of paracetamol 
and caffeine in (50 µg/µL and 6.5 µg/µL) was also analysed by PADI-MS with a total 
acquisition time of 1 minute using a cotton swab, Figure 5.25. There are good signals of 
diagnostic, adduct and fragment peaks of paracetamol and caffeine in this mixture as 
identified and listed in Table 5.2. These identified peaks have been compared with those 
given by 1:1 mixture solutions and found that they are similar in terms of diagnostic, 
although the concentrations of compounds were not the equal. This indicates that the 
diagnosis of peaks can not be affected whether using equal or different mixture 
concentrations. There are a number of similarities and differences between intensities of 
paracetamol and caffeine over time. Protonated paracetamol and caffeine molecular ions 
differ not only in intensity but also in behaviour. There is a dramatic increase in intensity 
for protonated paracetamol by 2x, whereas it a slight by 1x for caffeine molecular ion ~ 25 
seconds, after which they decrease by the same amount to 1 minute, Figure 5.26. 
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Figure 5. 25. PADI-MS spectrum of Panadol solution (containing paracetamol and caffeine 
50 µg/µL and 6.5 µg/µL) using cotton swab and measured in 5 seconds intervals 30-35 
seconds. 
 
Figure 5. 26. Signal intensity of protonated paracetamol and caffeine molecular ions in 
Panadol solution from cotton swab using added with water vapour in 5 seconds intervals 0-
5, 10-15, 20-25, 30-35, 40-45 and 55-60 seconds. 
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The results showed that PADI-MS is a fast and easy method to analyse compounds of a 
sample with no additional sample preparation. Although extensive research has been 
carried out in this field of analysis, no single study exists which focuses on this method by 
using these simple and inexpensive substrates to use in the pharmaceutical industry. The 
main task here is that use these substrates to identify chemical compounds in the different 
pharmaceutical forms. 
5.3.5. Quantification 
The correlation between signal intensity and concentrations of standard mixture solutions 
in this study was tested. A positive linear correlation was found between intensity and 
concentrations of paracetamol /caffeine mixture using glass slides and cotton swabs. The 
results showed that a small amount of component can be detected in pharmaceutical 
mixtures using PADI-MS, via either sampling method tested. The correlation between 
signal intensity and concentration of paracetamol and caffeine was determined for the 
concentration range of 0.01 to 0.1 µg/µL in 5 second intervals 30-35 seconds. The 
correlation coefficients (R
2
) values of paracetamol and caffeine were found to be 0.9977 
and 0.9588 using glass slide (Figure 5.27), and 0.998 and 0.995 using cotton swabs (Figure 
5.28) respectively. The limit of detection (LOD) and limit of quantification (LOQ) were 
also determined by considering standard deviation to the slope: 
    
     
     
                                  
     
     
     
     
STEYX means the standard deviation of the y-value and x-value.   
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There are differences in the PADI-MS data collected via these methods. The limits of 
detection for paracetamol using a glass slide and cotton swab were found to be 6µg/mL 
and 5µg/mL respectively, while for caffeine were 29µg/mL and 12µg/mL respectively. 
The limits of quantification (LOQ) for paracetamol using a glass slide and cotton swab 
were found to be 22µg/mL and 18µg/mL respectively, while for caffeine 96µg/mL and 
42µg/mL respectively. As can be seen from the values above, the LOD and LOQ for 
paracetamol can be improved using a cotton swab. However, the linearity is limited using 
high concentrations of the mixture (> 0.1 µg/µL) for both glass slides and cotton swabs 
because it causes nonlinearity including deviation in the calibration curve. 
 
Figure 5. 27. Calibration plot of mass intensity versus concentrations of standard mixture 
solutions of protonated paracetamol and caffeine molecular ion using glass slides. 
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Figure 5. 28. Calibration plots of mass intensity versus concentrations of standard mixture 
solutions of protonated paracetamol and caffeine molecular ion using a cotton swab. 
5.4. Conclusions 
The present study was designed and developed to understand if PADI-MS could be used to 
analyse, identify and gain quantification information for pharmaceutically relevant samples 
either directly from solids or liquids; with liquids being assessed on glass slides or by 
cotton swabs. Paracetamol and caffeine were used as model compounds, with mixtures of 
these commonly found in over the counter drugs such as Panadol. This study has 
demonstrated, for the first time that the PADI-MS technique is able to be used for direct 
analysis of solids and pharmaceutical liquids using these simple and cheap substrates. The 
results showed that the method is simple, sensitive, fast, has good linearity and small 
amounts of samples are required for analysis compared to other methods. This study has 
shown that 5 second intervals 30-35 seconds were decided as the optimal time for the high-
intensity signal of adduct and fragment peaks for paracetamol and caffeine in the solid and 
liquid sample. This confirmed that PADI-MS is able to measure samples in single or 
mixture solutions in 5 seconds. This is an important issue for future research because the 
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present study raises the possibility that can save time and cost using this method. The main 
goal of the current study was to develop a novel method that can be used for identification 
of components in complex mixtures that are not resolved by other methods such as 
chromatographic and spectroscopic techniques.  
The intensity of protonated paracetamol (152) is 7x more abundant than caffeine molecular 
ion (194) in the Panadol tablet. This study has found that the differences in the intensity of 
protonated paracetamol and caffeine molecular ion between tablets and solutions are 8x 
and 3x respectively. The results of this study show that the behaviour of the intensity ratios 
of 152/195 and 194/195 used by the cotton swab is similar to that used by the glass slide. 
The research has also shown that the limits of detection for paracetamol in the 1:1 mixture 
solution using glass slides and cotton swabs were lower than caffeine and it was found to 
be 6µg/mL and 5µg/mL respectively. There was evidence that the type of substrate has an 
influence on the signal intensity of ions observed.  
It would be interesting to compare the analysis of this study including individual and 
paracetamol /caffeine mixtures which used glass slides and cotton swabs to those used by 
TLC plates in the previous chapter (Chapter 4). There are important similarities and 
differences between these substrates for quantification analysis of paracetamol and the 
caffeine. No significant differences were found between the R
2
 of paracetamol and the 
caffeine whether use glass slides, cotton swabs or TLC plates. They found to be 0.9977, 
0.998 and 0.999 for paracetamol, and 0.9588, 0.995 and 0.996 for caffeine respectively. On 
the other hand, the differences between the LOD and LOQ were significant. Compared 
with the glass slide and TLC plate, the cotton swab was the best substrate to optimise the 
LOD and LOQ for these compounds. The LOD and LOQ were improved using the cotton 
swab and found to be 5µg/mL and 18µg/mL for paracetamol, and 12µg/mL and 42µg/mL 
for caffeine respectively. The LOD and LOQ were 6µg/mL and 22µg/mL for paracetamol, 
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and 29µg/mL and 96µg/mL for caffeine using glass slides, whereas they were 15µg/µL 
and 49µg/µL for paracetamol and 50µg/µL and 165µg/µL for caffeine using TLC plates 
respectively. In addition to these results, the cotton swab is cheap, convenient and gives 
better signal compared to a glass slide and TLC plate. 
The findings of this study have a number of important implications for future practice. In 
the future work, the technique may be applied for identification and monitoring of other 
pharmaceutical tablets and mixture solutions using these substrates. Although this study 
focuses on qualitative analysis, the findings may well have a bearing on quantitative 
analysis. Further studies on the current topic are therefore recommended. Recommendation 
for further research work is that should focus on determining components in solids/ liquids 
mixtures. It is also recommended that further research is undertaken in the following areas: 
pharmaceuticals, biomedicine and environmental pollution. The method used for this 
analysis may be carried out to other pharmaceutical applications elsewhere in the world. 
Despite the current study being based on small and simple pharmaceutical molecules, the 
findings suggest this novel method can be used to analyse big and complex pharmaceutical 
molecules. This research extends our knowledge of using this simple and easy method to 
analyse complex mixtures in many fields. The challenge now is to use this method 
confidently to identify compounds in air, breath and other gas samples.
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CHAPTER 6: PADI mass spectrometry for the 
monitoring of imine (Schiff base) formation as a model 
of pharmaceutical reaction mixtures
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Abstract 
In this chapter a novel analytical approach for monitoring of pharmaceutically relevant 
reactions using PADI-MS with cotton swabs as a substrate is reported. TLC, HPLC, FTIR 
and PADI-MS were all evaluated for the monitoring of an imine formation reaction. Even 
after extensive optimisation of the separation on TLC using ethyl acetate and petroleum 
ether (80:20 w/w) as a solvent, not all starting materials and reaction products were 
satisfactorily detected using UV illumination. RP-HPLC was successful in identifying the 
reactants 4-nitrobenzaldehyde and para-anisidine with well-resolved peaks and distinct 
retention times for each compound, but it failed to detect imine formation. This was 
arguably due to that the reaction being driven back in the direction of the reactants during 
HPLC analysis. HPLC did not detect product, FTIR then revealed it was definitely formed. 
This result may be explained if in the HPLC process the reaction may have been reversed 
as the imine should have been detected if present. FTIR has been used to identify the 
appearance and disappearance of functional groups for products and reactants. The results 
showed that (ƔC=O) stretching peak of 4-nitrobenzaldehyde and imine (N-H) stretch of para-
anisidine decreased in intensity with time and completely disappeared after 45 minutes. At 
the same time, they show an increase in area for the ƔC=N and ƔC=C stretching peaks 
indicating the formation of the imine reaction product up to approximately 60 minutes. 
PADI-MS has been optimised for monitoring of the imine formation using a cheap and 
simple substrate. Samples of reaction as aqueous solutions were taken as swabs and 
analysed directly from the cotton tip. The results of this study indicate that the PADI-MS 
technique is simple, sensitive, fast and suitable for monitoring of pharmaceutical reaction 
mixtures via cotton swabs.   
191 
 
6.1. Introduction 
Reaction monitoring is important for a wide range of scientific and industrial processes. 
Process analytical technologies (PAT) have been developed to follow a wide range of 
reaction processes in the pharmaceutical and chemical industries (1). Monitoring methods 
provide important aspects of reaction pathways of chemical synthesis during the reaction 
process. Imine synthesis from aldehydes or ketones is an important chemical reaction due 
to its relevance to biological processes (2, 3), role as an intermediates in the organic 
synthesis of compounds, and directly to manufacture compounds for several applications 
(4). Therefore, it is very important to monitor this reaction. The reaction between carbonyl 
group in aldehyde and primary imine, known as Schiff base, was discovered by German 
chemist Hugo Schiff in 1864 (5). Schiff base formation is important in organic synthesis 
because it is used to make carbon-nitrogen bonds. Intermediate compounds of Schiff bases 
that are formed by enzyme reaction with carbonyl and amino group are also important in 
the biochemical process (6). Due to the biological activities presented by Schiff bases 
compounds, they known as antimicrobial agents (7). Schiff bases and their metal 
compounds have beneficial biological applications, as anticancer, antivirus antimalarial, 
antimicrobial, antioxidant and antidepressant agents (8-12). 
Several analytical techniques such as nuclear magnetic resonance (NMR), infrared (IR), 
Raman spectroscopy and HPLC have been used to monitor pharmaceutical reaction 
mixtures (13). In a study by Kim et al., UV-Vis spectroscopy has been used to determine 
the surface density of imine synthesis which is formed by Schiff‟s base reaction between 
the carbonyl group of 4-nitrobenzaldehyde and the amine group of ethylenediamine (14). 
FTIR spectroscopy has been used to monitor the Schiff‟s base reaction between the 
carbonyl group of pyruvic acid and amine group of amino alcohols at different 
temperatures (15).  
192 
 
However, these methods have crucial limitations and disadvantages. NMR has limited 
sensitivity and hence requires a relatively a large amount of sample for analysis. FTIR is 
unable to detect all compounds and it is not well-suited for quantitative analysis (16). In 
the TLC method, the length of the plate is limited and hence separation takes place only up 
to a certain length. The TLC method operates in open system, hence the temperature and 
humidity may effect on the results. The retention factor (Rf) of molecules must be known 
before. Specificity is another problem in the TLC method. For example, different 
compounds with comparable polarity may have the same Rf value. HPLC tends to be 
relatively expensive, consumes chemicals, takes a considerable amount of time and sample 
preparation is often required. 
Mass spectrometry is a fast, sensitive and specific tool for identification and quantification 
of chemical compounds. MS provides information about molecular weights through 
(quasi-) molecular ions and chemical structures via fragmentation patterns of the analytes 
(17). Mass spectrometry techniques have been used to monitor chemical reactions in order 
to save time, sample amounts and solvents whilst identifying analytes by providing 
information about the chemical structure of compounds (18, 19). Hyphenated 
chromatographic mass techniques such as gas chromatography (GC-MS) and liquid 
chromatography (LC-MS) have been used for the monitoring of chemical reactions 
combining the strengths of both techniques. However, the chromatographic sample 
preparation such as extraction, filtration, and separation is needed before analysis by GC-
MS and LC-MS (18), which adds a considerable time and cost factor. 
During the last decade, ambient mass spectrometry (AMS) has been developed for direct 
analysis of chemical compounds with no or little sample preparation (20). Desorption 
electrospray ionisation-mass spectrometry (DESI-MS) is an important AMS method used 
to analyse samples directly (21). DESI applications involve environmental analysis, 
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clinical diagnostics and reaction monitoring of drugs manufacture. Direct analysis in real 
time (DART) was introduced shortly after DESI and can be applied for direct analysis of 
liquids and solid samples without the need for extraction (22). DART-MS has been used to 
monitor organic reactions and to confirm the final products in drug discovery (23). Due to 
consume and spray solvent, DESI is not always practical (24). DART has lower detection 
selectivity and makes this technique more vulnerable to false finding (25). PADI uses non-
thermal visible plasma as a source to produce ions from the surfaces of molecules. It can 
analyse different kinds of compounds directly from a surface including solids, creams and 
liquids, at room temperature (26, 27). Compared to DART, PADI uses different plasma 
that causes minimal damage to the sample surface. 
In this study, the Schiff base is formed by reacting 4-nitrobenzaldehyde with para-methoxy 
aniline (para-anisidine) at room temperature, Figure 6.1. This reaction is easy to follow 
without the need to isolate the intermediate compound, and it would expect to give a stable 
amine. This reaction was chosen in this study as a model for pharmaceutically and 
biological relevant mixtures, as it is readily controlled, requires readily available 
chemicals, requires no heating and the product can, in principle, readily be analysed by 
TLC, HPLC and IR. 
The specific objective of this study was to develop a fast, versatile yet simple, sensitive 
and cost-effective analytical method for monitoring the imine synthesis, including 
identification of a suitable substrate. In this work, several analytical techniques namely 
TLC, HPLC and FTIR, in addition to PADI-MS, have been used to monitor the reaction of 
4-nitrobenzaldehyde with para-anisidine over time. Another objective of this study was 
that using a cotton swab as a substrate in this reaction can give better signals in the PADI 
spectra in comparison with TLC plates and glass slides. The aim of this study was to find 
out which technique is best to monitor the reaction. 
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6.2. Materials and methods 
6.2.1. Apparatus: 
6.2.1.1. UV-Vis spectrophotometer 
A Cary 50 Bio (Varian UK), version 3.00, dual beam spectrophotometer was used. 
Absorbance spectra of blank (solvent) and samples were recorded using quartz cells. The 
wavelength ranges used for all samples was 200-800 nm. The scan rate was 600 nm/min, 
with a 1.00 nm data interval and an average acquisition time of 100 milliseconds. The 
wavelengths of maximum absorbance of the starting materials and the final product were 
measured and observed at 265 nm for 4-nitrobenzaldehyde, 241 nm for para-anisidine and 
258 nm for the product. 
6.2.1.2. Thin layer chromatography (TLC) 
Silica gel TLC plates were used (for more details see Chapter 4), and developed using 
ethyl acetate and petroleum ether ratio as mobile phase. TLC spots were visualised by 
means of a handheld UV lamp (Upland CA, City, U.S.A). 
6.2.1.3. High performance liquid chromatography (HPLC) 
HPLC was carried out using a Perkin Elmer system consisting of Flexar LC Autosampler, 
Flexar LC Detector, Flexar Quaternary LC pump and ODS-C18 column 150 mm × 4.6 mm 
(Matlab, UK). After thorough optimisation, the following settings were used throughout: 
all chromatographic experiments were performed in the isocratic mode. The mobile phase 
consisted of acetonitrile and deionised water (25%: 75%, v/v). The flow rate and detection 
wavelength were set to be 1 mL/min and 300 nm respectively. 
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6.2.1.4. Fourier transform infrared spectroscopy (FTIR) 
FTIR spectroscopy was carried out using a Thermo Fisher Scientific iS10 instrument 
(Hemel Hempstead, UK) fitted with a DTGS detector and a single bounce germanium 
ATR smart accessory. The number of scans and the resolution were optimised to 64 and 4 
cm
-1
 respectively. 
6.2.1.5. Plasma assisted desorption ionisation mass spectrometry (PADI-MS) 
In the PADI-MS instrumentation, a single quadrupole (Waters Micromass ZQ, 
Manchester, UK) was used with the front end removed to accept a modified Stoffels-
design plasma pen ionisation source using a 13.56 MHz RF power source (27). The plasma 
pencil was fabricated to provide coaxial dual gas flow; an inner ceramic tube was 
encompassed within a quartz glass tube. Helium gas was flown through both tubes 
controlled using separate flow meters, the flow inside the ceramic tube will henceforth be 
referred to as inner flow, the flow between the ceramic and quartz tube as outer flow. Mass 
conditions including inner flow, flow gas and plasma power were set up for all 
experiments. The conditions for PADI-MS were optimised and the same settings used for 
all samples in this study: plasma power of 8 W, helium inner flow of 224 mL/min and the 
distance between the plasma flame and sample of 5 mm. The effect of water vapour on 
ionisation efficiency was investigated by flowing the helium through a water vapour added 
environment (outflow) before the plasma pencil (for more information see Chapter 2). 
6.2.2. Chemicals: 
4-nitrobenzaldehyde was supplied by AVOCADO Research Chemicals Ltd (purity 99%). 
Para-anisidine was obtained from Alfa Aesar, UK. Laboratory reagent grade ethyl acetate 
(GLC > 99%) was supplied by Fisher Scientific, UK. Petroleum ether and dichloromethane 
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were supplied by VWR Prolabo BDH chemicals, International SAS, France (impurities < 
0.1 %). Acetonitrile was supplied by Sigma–Aldrich Chemical Company, UK (purity 
99%). Deionised water was provided through a Pure Lab Option system (ELGA, UK) with 
conductivity of 0.067 MS/cm. Helium gas was supplied by British Oxygen Company 
(BOC) gases, UK (purity 99%). Standard glass microscope slides and cotton swabs were 
supplied by Fisher Scientific, UK. 
6.2.3. Schiff base reaction  
Schiff base formation was carried out at room temperature in around-bottom reaction flask 
of 100 mL using a magnetic stirrer. 10 mmol of each starting material (4-
nitrobenzaldehyde and para-anisidine) was prepared by dissolving 75.5 mg and 61.5 mg 
respectively in 50 mL of dichloromethane. A schematic of the chemical reaction used for 
the synthesis of the imine is shown in Figure 6.1. It illustrates the synthesis of N-(4-
methoxyphenyl)-1-(4-nitrophenyl) methanimine (N-4-MP-1-4-NPM). The reaction 
progress was monitored by TLC, HPLC, FTIR and PADI-MS. 
Para-anisidine          4-Nitrobenzaldehyde             N-(4-methoxyphenyl)-1-(4-nitrophenyl) methanimine 
Figure 6. 1. The schematic reaction of the imine formation. 
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6.2.4. Monitoring Methods 
6.2.4.1. Monitoring of the Schiff base formation by TLC 
1- A large TLC sheet was cut horizontally into plates 6.5 cm by 2.5 cm. 
2- Small spots of individual compounds of 4-nitrobenzaldehyde and para-anisidine (both 
10 mM) were deposited on TLC plate using a spotter tube as a control for identification. 
The droplet size was 0.8 µL and the amount of reactant per droplet was 4 µg. 
3- The spots were developed using a mixture of ethyl acetate and petroleum ether as 
mobile phase, with optimal separation requiring a 80:20 (w:w) mixture. 
4- The separated spots were identified under the UV light after drying before any further 
analysis. 
5- The reaction was carried out for a total time of 1 hour. After this time no further changes 
were observed. The reaction mixture samples were taken every 10 minutes.  
6- All samples including starting materials and reaction mixture were deposited 
immediately on TLC plates and separated. 
6.2.4.2. Monitoring of the Schiff base reaction by HPLC 
1- The wavelengths of the starting materials and product were measured by UV-Vis 
spectrophotometry. 
2- Both pure reactants 4-nitrobenzaldehyde and para-anisidine were detected after 
conditions were optimised. 
3- The reaction was repeated and run for 2 hours and the reaction mixture was sampled 
every 15 minutes using a Pasteur pipette. 
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4- Each sample of the reaction mixture was injected (20 µL) immediately into the HPLC 
instrument for analysis. 
6.2.4.3. Monitoring of the Schiff base reaction by FTIR 
1- Single compounds of the starting materials were analysed by FTIR. 
2- The reaction was repeated and run for 2 hours and the reaction mixtures were taken 
every 15 minutes. 
3- The collected samples of the reaction mixtures were analysed immediately by FTIR, 
without drying. 
6.2.4.4. Monitoring of the Schiff base reaction by PADI-MS 
1- Both pure reactants were analysed by PADI-MS using the optimal conditions using 
different substrates such as TLC plate, glass slide and cotton swab in order to find out the 
best one. 
2- The reaction was repeated and run for 2 hours and the reaction mixtures were taken 
every 15 minutes. 
3- The reaction mixtures were analysed immediately (without drying) by PADI-MS using a 
cotton swab. 
6.3. Results and discussion 
6.3.1. Wavelength measurements of the starting materials and product using UV-Vis 
spectrophotometry 
The λmax values of the starting materials (4-nitrobenzaldehyde and para-anisidine) and the 
product were determined using UV-Vis spectrophotometry, Figure 6.2. The samples were 
prepared in the same solvent used for the reaction (dichloromethane). Absorbance spectra 
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of blank (solvent) were recorded before any measurement of the sample. The wavelength 
ranges were set between 200-800 nm. Because the absorbance of 4-nitrobenzaldehyde and 
product were too high (off-scale), their concentrations were diluted to 50 times in a 
comparison with para-anisidine. 
 
Figure 6. 2. UV/Vis spectra of 4-nitrobenzaldehyde (a), para-anisidine (b) and product (N-
4-MP-1-4-NPM) (c) (10 mmol each). 
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6.3.2. Reaction monitoring of imine formation using TLC 
TLC method is in principle a convenient choice to monitor the reaction between 4-
nitrobenzaldehyde and para-anisidine for several reasons. It is simple, fast, inexpensive, 
and very little equipment is required. TLC is one of the most widely used analytical 
techniques and has been used extensively for the separation and detection of components 
in a mixture. In addition, it can be used to monitor the progress of a reaction. The solvent is 
removed before detection of the analyte molecules, and hence the solvent cannot interfere 
with the measurements. 
The samples were taken during the reaction (0 min, 10 min, 20 min, 30 min, 40 min, 50 
min and 60 min) and checked by comparing with starting materials spots. UV light was 
used to visualize compounds on a TLC plate after developing the plates. Several solvents 
including methanol, ethanol, hexane, petroleum spirit, dichloromethane and ethyl acetate 
were trialled as mobile phase to separate the mixtures. A mixture of ethyl acetate and 
petroleum ether with a ratio of 80:20 (w:w) was found to be the most suitable solvent for 
this purpose. Although equimolar solutions (10 mM) of the starting materials were used, 
the TLC plate showed an unclear spot of para-anisidine compared to a well-defined 4-
nitrobenzaldehyde spot. In addition, all reaction mixture samples showed only one spot on 
TLC plate with the same Rf value as for the 4-nitrobenzaldehyde spot. A possible 
explanation for this might be that the imine is unstable on silica or TLC using UV 
detection is not sensitive enough for para-anisidine. Although the para-anisidine solution 
was concentrated, no spot was seen on the plate. Therefore, TLC analysis was not 
successful to monitor the progress of this reaction because not all reaction components 
could be identified. The problem with this work is that all samples of the reaction mixtures 
showed the same results with a single spot. 
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6.3.3. Reaction monitoring of imine formation using HPLC 
HPLC is a more advanced chromatographic method that was used in this study to monitor 
the imine synthesis. The advantages of HPLC over TLC method are: significantly higher 
resolution and sensitivity and capability for quantitative analysis. HPLC has a range of 
variables that can be optimised, things such as mobile phase, column, detector, separation 
method (normal or reverse phase column), mobile phase modifier (isocratic or gradient), 
flow rate, buffer concentration and wavelength. There is a wide range of stationary phases 
and detectors available to use with HPLC. In addition, mass spectrometry can be coupled 
with HPLC to significantly improve specificity and sensitivity. The ratio of mobile phase 
(acetonitrile and deionised water) was iteratively modified and optimised (25%: 75%, v/v). 
Although different wavelengths were used, 300 nm was chosen to identify concentrations 
of starting materials in solutions with good resolution. RP-HPLC was carried out using the 
optimal conditions (as detailed in the Materials and Methods section) to monitor the 
reaction between 4-nitrobenzaldehyde and para-anisidine. All peaks were detected in 15 
minutes. The solutions of starting materials (4-nitrobenzaldehyde and para-anisidine) and 
all reaction samples were injected immediately into the column at the same time. The 
HPLC results showed that the method is able to identify the starting materials easily from 
the retention time for each peak in the chromatogram, Figure 6.3. Para-anisidine had a 
peak absorbance of 485 mAU (milli-Absorbance Units) and retention time at 1.8 min, 
while 4-nitrobenzaldehyde has a peak of 261 mAU and retention time at 5.8 min. The peak 
areas were also measured for para-anisidine and 4-nitrobenzaldehyde, and they were 
6169167 mV and 9067008 mV respectively. These results are likely to be related to the 
molecular mass of each compound. The molecular mass for para-anisidine is 123 g/mole 
while for 4-nitrobenzaldehyde is 151 g/mole. Both reactants are polar, therefore, they spent 
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less time in the column. Para-anisidine, as expected, elute from the column first and this 
due to the difference between their molecular mass. 
Although HPLC could determine para-anisidine, and 4-nitrobenzaldehyde, Figure 6.3, it 
was unable to determine the presence of the product in any of the reaction mixture 
samples. HPLC appeared to indicate that the reaction was not proceeding, as the 
chromatograms were reproducible only showing the reactants. The results in fact did not 
show any change during reaction until the end of acquisition time of 2 hours, Figure 6.4. 
Efforts at overcoming this through changing mobile phase and UV detection wavelength 
were unsuccessful. HPLC measurements were repeated on a 7 day old sample, for which 
the reaction was known from FTIR results to be complete and contain no remaining 
reactants, in accordance with the use of equimolar amounts (see section 6.3.4). The HPLC 
still showed only the reactants, and no evidence for the reaction even taking place. This 
indicates that the reaction was difficult to monitor by HPLC method. A possible 
explanation for this might be that the chemical equilibrium of the reaction was changed. 
The reaction could be driven back in the direction of the reactants during HPLC. The high 
pressure of the HPLC column is one of the factors that could affect to change in conditions 
of chemical equilibrium for this reaction. Using water 75% as mobile phase and the 
reaction contains water could be another reason to drive back the reaction in the direction 
of the reactants. Regardless of the underlying cause, the results clearly indicate that this 
reaction could not be monitored by HPLC. 
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Figure 6. 3. HPLC chromatogram for para-anisidine and 4-nitrobenzaldehyde (both 5 
mmol) using ODS-C18 column 150 mm × 4.6 mm, acetonitrile and deionised water (25%: 
75%, v/v) mobile phase, flow rate of 1 mL/min and detection at a wavelength of 300 nm. 
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Figure 6. 4. HPLC chromatograms for the reaction mixtures (both 2.5 mmole) at different 
reaction times using conditions as for Figure 6. 4. 
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6.3.4. Reaction monitoring of imine formation using FTIR spectroscopy 
FTIR as a vibrational technique has been extensively used to identify the functional groups 
of molecules. Compared to other techniques such as HPLC and NMR, FTIR is fast, cheap 
and can measure the samples immediately without drying such as solids and liquids. 
Therefore, FTIR was used in this study to provide some details of the monitoring for this 
reaction. 
FTIR was carried out to establish whether it would be possible to monitor the imine 
formation reaction. The model reaction of the imine formation is shown in Figure 6.1. To 
monitor the intensity changes of the vibration peaks during the reaction, FTIR spectra were 
taken every 15 minutes over 2 hours. The results showed that the method is able to monitor 
the reaction by identifying the vibrations for the starting materials and the reaction 
mixtures. Solids and solutions samples of 4-nitrobenzaldehyde and para-anisidine were 
analysed as a control sample. Diagnostic peaks for 4-nitrobenzaldehyde and para-anisidine 
were observed and identified. The FTIR spectra of solid 4-nitrobenzaldehyde and solid 
para-anisidine are shown in Figures 6.5 and 6.6 respectively. 
The FTIR spectrum of 4-nitrobenzaldehyde shows the intensity changes of the peaks at 
1700 cm
-1
 for carbonyl group (C=O stretch) and 2850 cm
-1
 for C-H stretch (aldehyde). 
Other vibrations were observed at 1110 cm
-1
 for C-C, 1190 cm
-1
 for C-N, 1615 cm
-1
 for 
C=C. The nitro group (N=O stretch) was also observed at 1530 cm-1 and 1340 cm-1, Figure 
6.6. The main vibrations of para-anisidine were also detected and identified. These peaks 
were observed at 1180 cm
-1 
for C-N, 1230 cm
-1
 for C-O, 1630 cm
-1
 for C=C and 3350 cm
-1
 
for N-H, Figure 6.7. 
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Figure 6. 5. FTIR spectrum of 4-nitrobenzaldehyde (solid). 
 
Figure 6. 6. FTIR spectrum of para-anisidine (solid). 
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To compare the results with the solid materials, single solutions of 4-nitrobenzaldehyde 
and para-anisidine (both 5 mM) were analysed as a liquid. The spectra did not show any 
differences between the solids and solutions for identified peaks. However, vibrations of 
solid compounds showed higher signal intensity in comparison with those in solutions. For 
example, the intensity of C=O group of solid 4-nitrobenzaldehyde was higher ~15x 
compared to that of the solution, while the intensity of N-H group of solid para-anisidine 
was also ~15x more intense compared to that of the solution, reflecting the higher amount 
of material sampled. Compared with the intensities of the reference solutions of pure 4-
nitrobenzaldehyde and para-anisidine (both 5 mM), the reaction mixture samples display 
the expected changes, Figure 6.7. The spectra show that the C=O stretch of 4-
nitrobenzaldehyde and imine stretch (N-H) of para-anisidine decreased in intensity with 
time and completely disappeared after 45 minutes. The spectra indicate no further changes 
for the reaction samples between 60 minutes and 120 minutes. Hence 1 hour was decided 
as the time for the imine formation to complete. 
The peak area ratios of some vibrations of the starting materials and product were further 
studied as a function of reaction time in order to confirm that the reactants were indeed 
fully converted to the product. Decreases of the peak area for C=O stretch and increases of 
the peak area for C=N stretch and C=C stretch over reaction time indicate the reaction was 
fully completed towards imine formation. The ratios of the peak area for C=O/C=C and 
C=O/C=N for the reaction mixtures were calculated and plotted versus reaction time, 
Figures 6.8 and 6.9. The results showed that the peak area for C=O decreases up to ~ 60 
minutes while it increases for C=C and C=N up to this time. These plots do not show any 
changes for the reaction samples between 1 hour and 2 hours. These results consistent with 
the fact that the reaction between 4-nitrobenzaldehyde and para-anisidine was achieved in 
less than 1 hour and the reactants are fully converted to the product (N-4-MP-1-4-NPM). 
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The increases in intensity and area for the C=C stretching peak, in principle, be attributed 
to the ring stretching virtually affected by the conjugation of π electrons, and this is 
maximised in the product (see Figure 6.1). 
FTIR measurement was also re-done on a 7 days old sample for which the reaction was 
expected to be complete and no reactants should be present given that an equimolar 
amount was used. The FTIR results indicated the reaction was complete which means there 
is an issue with the HPLC results. However, compared to MS techniques, FTIR is difficult 
and often indeed not possible to determine what precise molecules are present, in particular 
in complex mixtures. In FTIR, not all molecules can be detected. For example, the 
different samples can have the same functional group and that IR peaks are inherently 
fairly broad hence overlap is an issue. Moreover, water strongly absorbs IR radiation, so 
direct analysis of aqueous solutions is a problem for IR. 
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Figure 6. 7. FTIR spectra for reactants 4-nitrobenzaldehyde (a) , para-anisidine (b) and 
reaction mixtures during reaction times: 5 min (c), 15 min (d), 30 min (e), 45 min (f), 60 
min (g) and 120 min (h). 
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Figure 6. 8. Ratios of the normalised area for C=O/C=C during reaction time.  
 
Figure 6. 9. Ratios of the normalised area for C=O/C=N during reaction time.  
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6.3.5. Reaction monitoring of imine formation using PADI-MS 
6.3.5.1. Para-anisidine and 4-nitrobenzaldehyde standards 
PADI-MS was selected and developed for AMS monitoring of the imine formation 
reaction and compared to the TLC, HPLC and FTIR results. In a qualitative approach, 
PADI-MS was used for identifying starting materials and reaction products. In order to 
identify the optimal substrate to analyse the samples, the following substrates were tested: 
TLC plate, glass slide and a cotton swab. Pure samples of 4-nitrobenzaldehyde and para-
anisidine were used as a standard to identify and optimise methodology by maximising the 
(quasi-) molecular ion peaks for both compounds. The conditions of PADI-MS were 
optimised for all samples in this study (see the materials and methods section). These 
samples were all analysed directly by PADI-MS using these three substrates without 
drying and with a total acquisition time of 1 minute. 
Different substrates such as a TLC plate, glass slide and cotton swab were used in this 
work in order to increase the sensitivity and minimise the contamination. The results 
showed that using a cotton swab can give a higher signal-to-noise ratio (S/N). The peak 
heights of 4-nitrobenzaldehyde m/z 152 and para-anisidine m/z 124 using cotton swab are 
higher and more useful and easy to use in the analysis of the reaction components 
compared to those of a TLC plate and glass slide, Figure 6.10. This could be attributed to 
the solvent (dichloromethane) absorb very quickly by the cotton. Changes in signal 
intensity of the starting materials with time were compared to that measured in the reaction 
mixtures. 4-nitrobenzaldehyde and para-anisidine were analysed directly from cotton 
swabs using PADI-MS with a total acquisition time of 1 minute, Figure 6.11. The spectra 
in this Figure show clear and high-intensity signals of these compounds. They showed that 
[M+H]
+
 m/z 123 for para-anisidine is 4x more abundant than [M+H]
+
 m/z 152 for 4-
212 
 
nitrobenzaldehyde. The observed increase in the intensity of para-anisidine in pure and 
mixture solutions could be explored by considering their molecular mass values. The 
molecular mass for para-anisidine is 123 g/mol while for 4-nitrobenzaldehyde is 151 
g/mol, so each gramme of para-anisidine contains 0.0081 moles whereas each gramme of 
4-nitrobenzaldehyde contains 0.0066 moles. Hence a 1/1 weight ratio means a molar ratio 
of (81/66), and then [M+H]
+
 m/z 152 for 4-nitrobenzaldehyde could be expected to give a 
small signal intensity. Another possible explanation for this is that desorbtion and 
ionisation of molecules could well be different for different molecules. Para-anisidine 
showed a bigger (quasi-) molecular ion peak and lower level of fragmentation compared to 
those for 4-nitrobenzaldehyde. 
Interestingly, there were differences between the results from PADI-MS analysis and TLC, 
HPLC and FTIR. The samples could be analysed easily by PADI-MS, with rapid analysis 
of fewer than 35 seconds giving molecular ion information, while the samples required a 
total acquisition time of 15 minutes for each sample using HPLC. These findings also 
showed that PADI-MS is very sensitive particularly for para-anisidine, while the TLC 
method was not sensitive enough to detect this compound, even for the standard. PADI-
MS showed a general increase in all peak intensities over the first ~35 seconds, after which 
the intensity of all peaks reduced, Figure 6.12. The observed  increase in intensity with 
time could be attributed to thermal desorption of analytes from the surface, while decreases 
in intensity may be attributed to degradation of analytes on the surface or in the gas phase. 
As expected, the temperature could cause heating of the sample during the interaction 
between the plasma flame and the sample. Therefore, during this acquisition period, the 
temperature increased and reached a peak when the analysis time reached 45 seconds, after 
which it decreased until the end of acquisition time of 1 minute. Because the samples were 
analysed immediately without drying, it also may be that de-solvation could be an issue. 
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Adduct peaks relating to 4-nitrobenzaldehyde were observed an
 
m/z 166 for [M-H]+O and 
m/z 304 for [2M+2H]
+2
, while only one adduct peak that could be related to para-anisidine 
was observed at m/z 135 for M-2H+N, Figure 6.11. The intensity of [M+H]
+
 m/z 123 for 
para-anisidine was higher by ~2x compared to that of [M+H]
+
 m/z 152 for 4-
nitrobenzaldehyde in 5 second intervals 0-5, 10-15, 20-25, 30-35, 40-45, 55-60 seconds.   
 
Figure 6. 10. Peak height for 4-nitrobenzaldehyde m/z 152 and para-anisidine m/z 124 
using different substrates with a total acquisition time of 1 minute. 
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Figure 6. 11. PADI-MS spectra of 4-nitrobenzaldehyde (a) and para-anisidine (b) using 
cotton swabs with a total acquisition time of 1 minute. 
 
Figure 6. 12. Signals intensity of protonated 4-nitrobenzaldehyde and protonated para-
anisidine using cotton swabs in 5 second intervals 0-5, 10-15, 20-25, 30-35, 40-45 and 55-
60 seconds. 
  m/z 
[M+H]
+
 m/z 152 
[M-H]+O m/z 166 2[M+H]
+
 m/z 304 
Background 
[M+H]
+
 m/z 124 
M-2H+N m/z 135 
a 
b 
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6.3.5.2. Analysis of reaction mixtures 
The reaction of imine formation was monitored as a model system for pharmaceutical 
reaction mixtures. The reaction was achieved between 4-nitrobenzaldehyde and para-
anisidine for 2 hours at room temperature. Samples were taken every 15 minutes during the 
reaction. This part aimed to monitor the imine formation directly by PADI-MS without the 
need for preparation or pre-concentration of sample solutions. Reaction mixtures were 
sampled using cotton swabs as the best substrate as indicated before, and analysed directly 
from the cotton tip. The PADI-MS analysis of the reaction mixtures over reaction times in 
5 second intervals of 30-35 seconds using cotton swabs are presented in Figure 6.13. The 
intensity of [M+H]
+
 m/z 152 for the reactants decreased over reaction times, while the 
product signal increased (N-4-MP-1-4-NPM) up to 1 hours. These results confirm that the 
reaction between 4-nitrobenzaldehyde and para-anisidine was complete in 45 minutes and 
the reactants are fully converted to the product. The results show that the [M+H]
+
 peaks for 
both 4-nitrobenzaldehyde and a para-anisidine decrease in intensity up to ~ 45 minutes, 
and then settle at a constant value up to 2 hours, Figure 6.14. Even though the signals for 
reactants drop by less than 50%, the reaction does not appear to be complete and this due 
to contamination of the sniffer tube, although the sniffer tube was cleaned several times to 
minimise contamination effects. The observed peaks here at m/z 124 and m/z 152 might be 
related to the diagnostic peaks for paracetamol M-CCH3 and [M+H]
+
 respectively (for 
more details see Chapter 5). However, the signal intensity of the product increased and 
reached a peak up to ~ 45 minutes, and then remained steady until the end of data 
acquisition at 2 hours. 
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Figure 6. 13. PADI-MS spectra of the reaction mixtures over reaction times in 5 seconds 
intervals of 30-35 seconds. 
 
 
Figure 6. 14. Reaction progress of the synthesis of N-4-MP-1-4-NPM over reaction time in 
5 seconds intervals of 30-35 seconds. 
m/z 
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The values of the peak height of the product and starting materials were normalised by 
determining peak height / peak area ratios for the following masses and plotting this 
against reaction time for an acquisition time of 30-35 seconds: 256/152 and 256/124, 
Figure 6.15. It can be seen that the ratios of these intensities increased over the first 1 hour 
of the reaction time, after which they remain steady up to 2 hours. These results also 
indicate that the reaction between 4-nitrobenzaldehyde and para-anisidine was completely 
finished in 45 minutes and the imine was formed. The intensity of [M+H]
+
 for both 4-
nitrobenzaldehyde and para-anisidine decreased over reaction times (from 0 to 2 hours) by 
a factor of 2x and 3x respectively, while it increased for the product by approximately 6x, 
Figures 6.16, 6.17 and 6.18. These results indicate that the time up to 1 hour is enough to 
complete the reaction. The length of time up to 35 seconds also is enough to detect and 
identify the reaction mixtures using PADI-MS. In addition, the results showed that PADI-
MS using the optimal conditions was a convenient and simple and fast technique to 
monitor the reaction of imine formation. The results also found that cotton swabs gave 
better spectra and were more practical in comparison with the TLC plate and glass slide, 
hence it was used in the PADI-MS analysis to monitor the reaction.   
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Figure 6. 15.Peak intensity ratios of 4-nitrobenzaldehyde, para-anisidine and the product 
by a factor of 256/152 and 256/124 over reaction time with an acquisition time of 30-35 
seconds. 
 
Figure 6. 16. Signal intensity of [M+H]+ m/z 152 for 4-nitrobenzaldehyde over different 
reaction times with an acquisition time of 55 seconds. 
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Figure 6. 17. Signal intensity of [M+H]+ m/z 124 for para-anisidine over different reaction 
times with an acquisition time of 55 seconds. 
 
Figure 6. 18. Signal intensity of N-4-MP-1-4-NPM with an acquisition time of 60 seconds 
at different reaction times. 
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6.4. Conclusions 
The aim of the present study was to develop a novel, fast and sensitive method for 
monitoring of pharmaceutical synthesis reactions. A relevant model reaction was used to 
do this. Chromatographic, spectroscopic and ambient mass spectrometric methods have 
been used for monitoring imine formation. HPLC was found to be unsuitable to monitor 
the reaction, possibly because the process of HPLC analysis drove the reaction back 
towards the reactants. TLC was found not to be capable to detect all relevant molecules: it 
could detect all starting materials, albeit with limited sensitivity for one reactant, and could 
not detect the product at all. All reaction mixture samples showed only one spot on the 
TLC plate from 0 times to the end of the reaction. The results also showed that the reaction 
was difficult to monitor by HPLC. It was unable to identify the peaks of the reaction 
mixtures and all chromatograms of reaction mixtures only showed the reactants. This 
might be that the reaction could be driven back in the direction of the reactants during 
analysis. It appears that in this case, the HPLC measurement may have affected the 
reaction it was supposed to measure. The IR showed that the reaction was complete, and 
the reaction of imine formation was monitored successfully by identifying the vibrations of 
the starting materials and the reaction product over reaction times. The FTIR spectra 
showed that C=O stretching peaks of the 4-nitrobenzaldehyde and a imine groups (N-H) of 
para-anisidine decreases in intensity with time and completely disappears after 45 minutes. 
At the same time, they show an increase in area for the C=N and C=C stretching peaks 
with the formation of the product up to ~ 1 hour. The FTIR spectra of the reaction mixtures 
after this time including 75 minutes, 90 minutes, 105 minutes and 120 minutes are quite 
similar to that for 60 minutes. These results indicate that the reaction between 4-
nitrobenzaldehyde and para-anisidine was achieved in less than 1 hour and the reactants 
are fully converted to the product (N-4-MP-1-4-NPM). However, FTIR only identifies 
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functional groups and when investigating more complex molecules and reactions it may 
not be possible to determine what precise molecules are present. Sensitivity can also be an 
issue. 
PADI-MS was chosen in this study as an ambient mass technique, that was intended to 
overcome the shortfalls of TLC, HPLC and FTIR. The PADI-MS method has improved 
using the optimal conditions including plasma power, helium inner flow and the distance 
between the plasma flame and sample and found to 8 W, 224 mL/min and 5 mm 
respectively. All PADI-MS spectra showed good signals of [M+H]
+
 for both 4-
nitrobenzaldehyde and para-anisidine at m/z 152 and m/z 124 respectively. However, the 
spectra showed a small peak of the product molecular ion at M
+
 m/z 256. The [M+H]
+
 
intensity for both 4-nitrobenzaldehyde and para-anisidine decreased over reaction times, 
while it increased for the M
+
 reaction product to 45 minutes, after which they remained 
steady up to 2 hours. These results can confirm that the reaction does not need more than 
one hour to convert the full reactants to the product. These results also confirmed that a 5 
seconds interval 30-35 seconds is the best time to analyse the starting materials and 
reaction mixtures from a cotton swab using PADI-MS. 
Overall, the results of this study indicate that PADI-MS has been successful for monitoring 
this reaction due to being highly sensitive, simple, inexpensive and has the ablity to detect 
different kinds of the sample such as solid, liquid and gas. This study has found that PADI-
MS has the potential to monitor pharmaceutically relevant reactions, although the observed 
carry-over issues will need addressing through a redesigned inlet system. 
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CHAPTER 7: General discussions and conclusions
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This project was undertaken to develop a novel simple, fast, sensitive and cost-effective 
ambient mass spectrometric method, that can be used to monitor the progress of chemical 
reactions. The results of these investigations have shown that PADI-MS has the potential 
to fill this important gap in the pharmaceutical industry. Analytical methods based on 
spectroscopy, separation and mass spectrometry were developed for the identification and 
monitoring of pharmaceutically relevant mixtures. The research has also found distinct 
differences between PADI-MS and other traditional techniques such as TLC, HPLC, FTIR 
and Raman spectroscopy. This study has found that generally PADI-MS is easy to set up, 
little or no sample preparation is required, analysis time is short and can be applied for 
direct analysis of solids and liquids. In addition, the use of PADI-MS provides structural 
information on the molecules in seconds. The visible non-thermal plasma plume emerging 
from a coaxial helium gas flow 13.65 MHz RF plasma pen (modified Stoffel‟s design) was 
used. 
In the first experimental chapter (Chapter 3), the direct analysis of PADI-MS used helium 
directly from a cylinder with flow rate of 224 mL/min, and the distance between the 
plasma flame and sample was 5 mm.  Investigation of the use of direct PADI-MS and 
Raman analysis for paracetamol tablets, as a model for pharmaceutically relevant solids, 
gave good results without the need for sample preparation. PADI-MS showed that the time 
exposing of the sample to plasma up to ~50 seconds is enough to avoid damage to the 
sample, and 30 seconds was the time required to get a reasonable spectrum and the analysis 
can be stopped after this time. In this investigation, the aim was to determine the effect of 
non-thermal plasma on the chemical structure of molecules. The results of this 
investigation showed that the chemistry of tablet can be affected after 50 seconds exposure 
to visible non-thermal plasma (NTP) as evident from the changes in intensities of the 
diagnostic, adduct and fragment peaks. Although Raman microscopy was used to analyse 
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the chemical composition of the top layer of the exposed tablets, changes and behaviours 
of intensity for the adduct and fragment peaks of these exposed tablets were seen using 
PADI-MS. Raman showed some changes in an area of vibration peaks for paracetamol 
after exposure times to plasma, but it did not show any important shift for any peak. This 
result indicated that the positions of vibrations were not affected by exposure to visible 
plasma. Therefore, for this purpose, Raman microscopy could not indicate adducts and 
fragments as that is specific to MS. In this part of analysis, the PADI-MS spectra showed a 
good signal intensity of [M+H]
+
 m/z 152 (protonated molecular ion) and other fragment 
peaks. However, the PADI-MS conditions need to be improved using carrier gas additives 
such as outer helium flow with water vapour prior to interacting with the plasma plume in 
order to increase the sensitivity. This was achieved for the next experimental chapters and 
PADI-MS parameters were optimised to use for following experiments. The plasma was 
near-contact (5 mm separation) with the sample under investigation, using 8 W and a 
carrier gas flow of 224 mL/min (inner flow) and (224 mL/min outer flow). 
The second aim of this study was to identify chemical components in mixtures of 
pharmaceutically relevant compounds deposited onto TLC plates (Chapter 4). Paracetamol 
and caffeine were used as model analytes. The results showed that the separation is not 
always necessary for identification, and spots can be identified on TLC plates using PADI-
MS without separation. However, the separation of the spots can give higher signal-to-
noise ratio (S/N) of molecules, and hence the sensitivity of diagnostic, adduct and fragment 
peaks can be improved. The TLC results indicated that the sensitivity of diagnostic, adduct 
and fragment peaks for paracetamol without separation of the spots was improved and the 
damage was reduced when water vapour was added as outer flow gas. In addition, when 
using water vapour, the protonated caffeine ion ([M+H]
+
 m/z 195) was detected. In all 
cases, the sensitivity was better for paracetamol than caffeine in the mixture solution. In 
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this investigation, degradation excitation of analytes on the surface or in the gas phase was 
found to cause changes in intensity with time. The temperature was measured using the 
exact same PADI parameters using a thermocouple (chromel-alumel type) by contact of 
the visible plasma with under TLC plate, and using a thermal camera by contact the visible 
plasma with the top of the TLC plate without a sample. The temperature in the middle of 
the TLC plate was measured for 2 minutes. The temperature increased quickly to 45
 o
C, 
after which it increased slowly to 60 
o
C, and then dropped until 2 minutes. It was below 60 
o
C when the analysis time reached 45 seconds. This indicated why the [M+H]
+
 peaks of 
both paracetamol and caffeine increase in intensity up to ~ 45 seconds, after which they 
decrease up to 1 minute. Little thermal changes could be detected within the area of the 
substrate exposed to the plasma, although sample heating does occur slowly up to a 
maximum of ~45 
o
C after ~30 seconds interaction. 
The study has also identified pharmaceutical solids and liquids from glass slides and cotton 
swabs using direct mass spectrometric analysis (Chapter 5). This study has found that the 
differences in the intensity of protonated paracetamol and caffeine molecular ion between 
tablets and solutions and found to be 8x and 3x respectively. There no differences were 
observed in the behaviour of intensity ratios of 152/195 and 194/195 between cotton swab 
and glass slide. Quantification analysis was also showed that no significant differences 
were found between the R
2
 of paracetamol and caffeine whether using glass slides, cotton 
swabs or TLC plates. However, compared with the glass slide and TLC plate, the LOD and 
LOQ can be improved when using cotton swabs as a substrate. The results have also shown 
that the LOD for paracetamol was lower than caffeine in the 1:1 mixture solution using 
glass slides and cotton swabs. To investigate the heating causes on the sample during the 
analysis, The temperature was measured using the exact same PADI parameters using a 
thermal camera by interacting the visible plasma with a tablet. The temperature in the 
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middle of paracetamol tablet was measured for 5 minutes. The temperature increased 
dramatically to 75 
o
C at 45 seconds, after which it increased slowly to 80 
o
C at 1 minute, 
and then dropped to 36
 o
C until 5 minutes. This indicated why the [M+H]
+
 peak for 
paracetamol increased in intensity up to ~ 45 seconds, after which they decrease up to 1 
minute.  
Another important finding of this study was that PADI mass spectrometry can be used for 
monitoring imine (Schiff base) formation as a model for pharmaceutical production 
(Chapter 6). This reaction was selected because there is possible to follow the reaction 
without the need to isolate the intermediate compound, and the reaction between aromatic 
amine and aromatic aldehyde would expect to give stable imine. The PADI-MS and FTIR 
results confirmed that the reaction between 4-nitrobenzaldehyde and para-anisidine was 
complete in less than 1 hour. However, the reaction was difficult to monitor by TLC and 
HPLC methods. The HPLC only showed the reactants and this may be due to the reaction 
being driven back in the direction of the reactants during HPLC. There were differences in 
the results of PADI-MS and FTIR with that by TLC and HPLC. PADI-MS has been used 
directly to monitor the imine formation using cotton swabs to sample without the need for 
preparation or pre-concentration. The results indicated the cotton swab to be better than the 
TLC plate and glass slide, giving good signals in the PADI spectra, which were in 
accordance with FTIR measurements. PADI-MS was a convenient and simple and fast 
technique to monitor the reaction of imine formation and provided more details about the 
chemical structure of the reaction materials. Together these results show that use of an 
optimised PADI-MS method has been able to monitor the progress of chemical reactions. 
The results of the study showed that the PADI-MS method is simple, sensitive, fast, has 
good linearity and small amounts of samples are required for analysis compared to other 
methods. The PADI-MS conditions were optimised of 8 W and a carrier gas flow of 224 
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mL/min (inner flow) and (224 mL/min outer flow). It is important to increase protonation 
as a way to improve sensitivity, and this was achieved by passing the helium flow over a 
water-filled reservoir. Results suggest that the analysis of paracetamol and caffeine mixture 
using helium with water vapour as gas flow is indeed more sensitive than using dry helium. 
In addition, the diagnostic [M+H]
+
 at m/z 195 peak of caffeine was only observed when 
using helium with water vapour. This may be explained by referring the pKa. The pKa for 
caffeine is 14 (basic compound), therefore, it can readily gain a proton from water. The 
results indicate the length of analysis time up to ~ 45 seconds was the optimum time to get 
good spectra. These findings suggest in general that the samples can be analysed easily by 
PADI-MS, with rapid analysis in less than 45 seconds giving molecular ion information. 
Minor effects from the plasma can be seen from 30 s and that it only becomes problematic 
after 45 seconds. There is no difference observed between the measurement of paracetamol 
presented in a tablet and when presented in a mixture of caffeine in a Panadol tablet, while 
a significant difference was observed between tablets and solutions. The observed higher 
sensitivity for paracetamol in tablets, pure and mixture solutions in comparison with 
caffeine could be attributed to either pKa or that the caffeine did not desorb as readily as 
paracetamol. The amount of molecules per droplet could also be another reason for this. 
The number of moles for paracetamol in the individual and mixtures is higher than for 
caffeine. The results did not show any important differences of the signal intensity of 
[M+H]
+
 for paracetamol and caffeine whether used pure or mixture solutions, and this 
indicates that matrix of analytes was not affected. 
On the other hand, a limitation of the PADI-MS technique is that the length of interaction 
time between the visible plasma and sample should be up to 45 seconds. This can give a 
good signal and more information of molecules, and the samples can be analysed easily by 
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this technique. With a long analysis time, it can see minor effects from the plasma that 
starts from 30 seconds, which becomes a problem after 45 seconds. 
Quantitative analysis using a TLC plate, glass slide and cotton swab was compared for 
individual and paracetamol /caffeine mixtures and there were important similarities and 
differences between these substrates. A positive linear correlation was found between 
intensity and concentrations of paracetamol /caffeine mixture using glass slides and cotton 
swabs. No significant differences were found between the R
2
 of paracetamol and the 
caffeine whether use glass slides, cotton swabs or TLC plates. Compared to a glass slide 
and TLC plate, the cotton swab was the best substrate to optimise the LOD and LOQ for 
individual and paracetamol /caffeine mixtures due to higher signal intensities compared to 
glass slide and TLC plate. The results also showed that using a cotton swab can give a 
higher signal-to-noise ratio (S/N) of 4-nitrobenzaldehyde and para-anisidine compared to 
those of a TLC plate and glass slide when studying pharmaceutically relevant reactions. 
This could be attributed to the solvent (dichloromethane) being absorbed very quickly by 
the cotton. 
There are some recommendations for further research work including the findings and 
contribution of the study. The analysis of analytical methods provided an important 
opportunity to advance the understanding of the behaviour of molecules tablets with time 
after exposure to the NTP. These findings enhance our understanding of the plasma 
interaction with samples and investigation of chemical ionisation methods. The method 
presented here may be applied for future practice in several areas including biomedical, 
food industry and environmental. In future work, this NTP of PADI should be compared 
with other plasmas to analyse pharmaceutical tablets by demonstrating the findings of this 
study such as numerous micro-discharge produce streamer of LTP and weakly visible 
plume, discharge gas heated of DART. Future research should also concentrate on the 
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quantitative analysis of mixture solutions from TLC plates using this method. It would also 
be useful to use accurate mass and tandem-MS to identify more ions and develop a better 
understanding of the ionisation process. Further studies using the potential such as 
induction of chemicals in the carrier gas to aid with chemical ionisation, e.g., formic acid 
and ammonia need to be carried out in order to ionise samples and stabilise specific 
fragments due to e.g., proton donor effects. Another possible area of future research would 
be to investigate use of other plasma sources that are cheaper than helium and have 
different energy such as argon and nitrogen. The PADI-MS technique may be applied for 
identification and monitoring of other pharmaceutical tablets and mixture solutions using 
these substrates. This study has also found that PADI-MS can applicable to monitor many 
types of pharmaceutical reactions. 
